id	sid	tid	token	lemma	pos
ct-11250	1	1	2012	2012	NUM
ct-11250	1	2	:	:	PUNCT
ct-11250	1	3	safe	safe	ADJ
ct-11250	1	4	handling	handling	NOUN
ct-11250	1	5	of	of	ADP
ct-11250	1	6	reproductive	reproductive	ADJ
ct-11250	1	7	hormones	hormone	NOUN
ct-11250	1	8	routinely	routinely	ADV
ct-11250	1	9	used	use	VERB
ct-11250	1	10	in	in	ADP
ct-11250	1	11	equine	equine	NOUN
ct-11250	1	12	practice	practice	NOUN
ct-11250	1	13	safe	safe	ADJ
ct-11250	1	14	handling	handling	NOUN
ct-11250	1	15	of	of	ADP
ct-11250	1	16	reproductive	reproductive	ADJ
ct-11250	1	17	hormones	hormone	NOUN
ct-11250	1	18	routinely	routinely	ADV
ct-11250	1	19	used	use	VERB
ct-11250	1	20	in	in	ADP
ct-11250	1	21	equine	equine	NOUN
ct-11250	1	22	practice	practice	NOUN
ct-11250	1	23	dirk	dirk	PROPN
ct-11250	1	24	k.	k.	PROPN
ct-11250	2	1	vanderwall	vanderwall	PROPN
ct-11250	2	2	department	department	PROPN
ct-11250	2	3	of	of	ADP
ct-11250	2	4	clinical	clinical	ADJ
ct-11250	2	5	studies	study	NOUN
ct-11250	2	6	,	,	PUNCT
ct-11250	2	7	new	new	ADJ
ct-11250	2	8	bolton	bolton	PROPN
ct-11250	2	9	center	center	NOUN
ct-11250	2	10	,	,	PUNCT
ct-11250	2	11	school	school	NOUN
ct-11250	2	12	of	of	ADP
ct-11250	2	13	veterinary	veterinary	ADJ
ct-11250	2	14	medicine	medicine	NOUN
ct-11250	2	15	,	,	PUNCT
ct-11250	2	16	university	university	NOUN
ct-11250	2	17	of	of	ADP
ct-11250	2	18	pennsylvania	pennsylvania	PROPN
ct-11250	2	19	,	,	PUNCT
ct-11250	2	20	kennett	kennett	PROPN
ct-11250	2	21	square	square	PROPN
ct-11250	2	22	,	,	PUNCT
ct-11250	2	23	pa	pa	PROPN
ct-11250	2	24	introduction	introduction	NOUN
ct-11250	2	25	the	the	DET
ct-11250	2	26	use	use	NOUN
ct-11250	2	27	of	of	ADP
ct-11250	2	28	exogenous	exogenous	ADJ
ct-11250	2	29	reproductive	reproductive	ADJ
ct-11250	2	30	hormones	hormone	NOUN
ct-11250	2	31	and/or	and/or	CCONJ
ct-11250	2	32	hormone	hormone	NOUN
ct-11250	2	33	analogs	analog	NOUN
ct-11250	2	34	is	be	AUX
ct-11250	2	35	a	a	DET
ct-11250	2	36	mainstay	mainstay	NOUN
ct-11250	2	37	of	of	ADP
ct-11250	2	38	both	both	CCONJ
ct-11250	2	39	clinical	clinical	ADJ
ct-11250	2	40	practice	practice	NOUN
ct-11250	2	41	and	and	CCONJ
ct-11250	2	42	research	research	NOUN
ct-11250	2	43	activities	activity	NOUN
ct-11250	2	44	in	in	ADP
ct-11250	2	45	equine	equine	NOUN
ct-11250	2	46	reproduction	reproduction	NOUN
ct-11250	2	47	.	.	PUNCT
ct-11250	3	1	the	the	DET
ct-11250	3	2	national	national	PROPN
ct-11250	3	3	institute	institute	PROPN
ct-11250	3	4	for	for	ADP
ct-11250	3	5	occupational	occupational	ADJ
ct-11250	3	6	safety	safety	NOUN
ct-11250	3	7	and	and	CCONJ
ct-11250	3	8	health	health	PROPN
ct-11250	3	9	(	(	PUNCT
ct-11250	3	10	niosh	niosh	PROPN
ct-11250	3	11	)	)	PUNCT
ct-11250	3	12	defines	define	VERB
ct-11250	3	13	hazardous	hazardous	ADJ
ct-11250	3	14	drugs	drug	NOUN
ct-11250	3	15	as	as	SCONJ
ct-11250	3	16	those	those	PRON
ct-11250	3	17	that	that	PRON
ct-11250	3	18	are	be	AUX
ct-11250	3	19	known	know	VERB
ct-11250	3	20	or	or	CCONJ
ct-11250	3	21	suspected	suspect	VERB
ct-11250	3	22	to	to	PART
ct-11250	3	23	cause	cause	VERB
ct-11250	3	24	adverse	adverse	ADJ
ct-11250	3	25	health	health	NOUN
ct-11250	3	26	effects	effect	NOUN
ct-11250	3	27	in	in	ADP
ct-11250	3	28	people	people	NOUN
ct-11250	3	29	from	from	ADP
ct-11250	3	30	exposure	exposure	NOUN
ct-11250	3	31	in	in	ADP
ct-11250	3	32	the	the	DET
ct-11250	3	33	workplace	workplace	NOUN
ct-11250	3	34	,	,	PUNCT
ct-11250	3	35	and	and	CCONJ
ct-11250	3	36	reproductive	reproductive	ADJ
ct-11250	3	37	hormones	hormone	NOUN
ct-11250	3	38	such	such	ADJ
ct-11250	3	39	as	as	ADP
ct-11250	3	40	those	those	PRON
ct-11250	3	41	routinely	routinely	ADV
ct-11250	3	42	used	use	VERB
ct-11250	3	43	in	in	ADP
ct-11250	3	44	equine	equine	NOUN
ct-11250	3	45	practice	practice	NOUN
ct-11250	3	46	are	be	AUX
ct-11250	3	47	considered	consider	VERB
ct-11250	3	48	hazardous.1	hazardous.1	NOUN
ct-11250	3	49	therefore	therefore	ADV
ct-11250	3	50	,	,	PUNCT
ct-11250	3	51	these	these	DET
ct-11250	3	52	agents	agent	NOUN
ct-11250	3	53	can	can	AUX
ct-11250	3	54	have	have	AUX
ct-11250	3	55	inadvertent	inadvertent	ADJ
ct-11250	3	56	deleterious	deleterious	ADJ
ct-11250	3	57	effects	effect	NOUN
ct-11250	3	58	on	on	ADP
ct-11250	3	59	personnel	personnel	NOUN
ct-11250	3	60	(	(	PUNCT
ct-11250	3	61	discussed	discuss	VERB
ct-11250	3	62	later	later	ADV
ct-11250	3	63	)	)	PUNCT
ct-11250	3	64	,	,	PUNCT
ct-11250	3	65	particularly	particularly	ADV
ct-11250	3	66	women	woman	NOUN
ct-11250	3	67	,	,	PUNCT
ct-11250	3	68	who	who	PRON
ct-11250	3	69	handle	handle	VERB
ct-11250	3	70	and	and	CCONJ
ct-11250	3	71	administer	administer	VERB
ct-11250	3	72	them	they	PRON
ct-11250	3	73	if	if	SCONJ
ct-11250	3	74	appropriate	appropriate	ADJ
ct-11250	3	75	precautions	precaution	NOUN
ct-11250	3	76	are	be	AUX
ct-11250	3	77	not	not	PART
ct-11250	3	78	taken	take	VERB
ct-11250	3	79	.	.	PUNCT
ct-11250	4	1	there	there	PRON
ct-11250	4	2	are	be	VERB
ct-11250	4	3	multiple	multiple	ADJ
ct-11250	4	4	steps	step	NOUN
ct-11250	4	5	during	during	ADP
ct-11250	4	6	which	which	PRON
ct-11250	4	7	veterinarians	veterinarian	NOUN
ct-11250	4	8	and	and	CCONJ
ct-11250	4	9	other	other	ADJ
ct-11250	4	10	veterinary	veterinary	ADJ
ct-11250	4	11	healthcare	healthcare	NOUN
ct-11250	4	12	workers	worker	NOUN
ct-11250	4	13	such	such	ADJ
ct-11250	4	14	as	as	ADP
ct-11250	4	15	veterinary	veterinary	ADJ
ct-11250	4	16	students	student	NOUN
ct-11250	4	17	,	,	PUNCT
ct-11250	4	18	technicians	technician	NOUN
ct-11250	4	19	and	and	CCONJ
ct-11250	4	20	support	support	NOUN
ct-11250	4	21	staff	staff	NOUN
ct-11250	4	22	may	may	AUX
ct-11250	4	23	be	be	AUX
ct-11250	4	24	exposed	expose	VERB
ct-11250	4	25	to	to	ADP
ct-11250	4	26	hazardous	hazardous	ADJ
ct-11250	4	27	reproductive	reproductive	ADJ
ct-11250	4	28	drugs	drug	NOUN
ct-11250	4	29	including	include	VERB
ct-11250	4	30	preparing	prepare	VERB
ct-11250	4	31	a	a	DET
ct-11250	4	32	drug	drug	NOUN
ct-11250	4	33	for	for	ADP
ct-11250	4	34	administration	administration	NOUN
ct-11250	4	35	;	;	PUNCT
ct-11250	4	36	administering	administer	VERB
ct-11250	4	37	a	a	DET
ct-11250	4	38	drug	drug	NOUN
ct-11250	4	39	to	to	ADP
ct-11250	4	40	an	an	DET
ct-11250	4	41	animal	animal	NOUN
ct-11250	4	42	;	;	PUNCT
ct-11250	4	43	and/or	and/or	CCONJ
ct-11250	4	44	during	during	ADP
ct-11250	4	45	disposal	disposal	NOUN
ct-11250	4	46	or	or	CCONJ
ct-11250	4	47	cleaning	cleaning	NOUN
ct-11250	4	48	of	of	ADP
ct-11250	4	49	materials	material	NOUN
ct-11250	4	50	used	use	VERB
ct-11250	4	51	during	during	ADP
ct-11250	4	52	preparation	preparation	NOUN
ct-11250	4	53	or	or	CCONJ
ct-11250	4	54	administration	administration	NOUN
ct-11250	4	55	of	of	ADP
ct-11250	4	56	a	a	DET
ct-11250	4	57	drug	drug	NOUN
ct-11250	4	58	(	(	PUNCT
ct-11250	4	59	e.g.	e.g.	ADV
ct-11250	4	60	,	,	PUNCT
ct-11250	4	61	iv	iv	NUM
ct-11250	4	62	syringes	syrinx	NOUN
ct-11250	4	63	,	,	PUNCT
ct-11250	4	64	dose	dose	NOUN
ct-11250	4	65	syringes	syrinx	NOUN
ct-11250	4	66	,	,	PUNCT
ct-11250	4	67	etc.).2	etc.).2	NUM
ct-11250	4	68	veterinary	veterinary	ADJ
ct-11250	4	69	workers	worker	NOUN
ct-11250	4	70	are	be	AUX
ct-11250	4	71	most	most	ADV
ct-11250	4	72	likely	likely	ADJ
ct-11250	4	73	to	to	PART
ct-11250	4	74	be	be	AUX
ct-11250	4	75	exposed	expose	VERB
ct-11250	4	76	to	to	ADP
ct-11250	4	77	hazardous	hazardous	ADJ
ct-11250	4	78	drugs	drug	NOUN
ct-11250	4	79	via	via	ADP
ct-11250	4	80	skin	skin	NOUN
ct-11250	4	81	contact	contact	NOUN
ct-11250	4	82	/	/	SYM
ct-11250	4	83	absorption	absorption	NOUN
ct-11250	4	84	,	,	PUNCT
ct-11250	4	85	ingestion	ingestion	NOUN
ct-11250	4	86	or	or	CCONJ
ct-11250	4	87	inhalation	inhalation	NOUN
ct-11250	4	88	,	,	PUNCT
ct-11250	4	89	though	though	SCONJ
ct-11250	4	90	needle	needle	NOUN
ct-11250	4	91	stick	stick	PROPN
ct-11250	4	92	or	or	CCONJ
ct-11250	4	93	sharps	sharps	NOUN
ct-11250	4	94	injuries	injury	NOUN
ct-11250	4	95	also	also	ADV
ct-11250	4	96	pose	pose	VERB
ct-11250	4	97	a	a	DET
ct-11250	4	98	risk	risk	NOUN
ct-11250	4	99	for	for	ADP
ct-11250	4	100	inadvertent	inadvertent	ADJ
ct-11250	4	101	drug	drug	NOUN
ct-11250	4	102	exposure.2	exposure.2	ADP
ct-11250	4	103	the	the	DET
ct-11250	4	104	objective	objective	NOUN
ct-11250	4	105	of	of	ADP
ct-11250	4	106	this	this	DET
ct-11250	4	107	article	article	NOUN
ct-11250	4	108	is	be	AUX
ct-11250	4	109	to	to	PART
ct-11250	4	110	provide	provide	VERB
ct-11250	4	111	an	an	DET
ct-11250	4	112	overview	overview	NOUN
ct-11250	4	113	of	of	ADP
ct-11250	4	114	the	the	DET
ct-11250	4	115	various	various	ADJ
ct-11250	4	116	formulations	formulation	NOUN
ct-11250	4	117	of	of	ADP
ct-11250	4	118	exogenous	exogenous	ADJ
ct-11250	4	119	hormones	hormone	NOUN
ct-11250	4	120	currently	currently	ADV
ct-11250	4	121	available	available	ADJ
ct-11250	4	122	in	in	ADP
ct-11250	4	123	the	the	DET
ct-11250	4	124	united	united	PROPN
ct-11250	4	125	states	states	PROPN
ct-11250	4	126	for	for	ADP
ct-11250	4	127	equine	equine	NOUN
ct-11250	4	128	reproductive	reproductive	ADJ
ct-11250	4	129	management	management	NOUN
ct-11250	4	130	and	and	CCONJ
ct-11250	4	131	discuss	discuss	VERB
ct-11250	4	132	personal	personal	ADJ
ct-11250	4	133	safety	safety	NOUN
ct-11250	4	134	considerations	consideration	NOUN
ct-11250	4	135	when	when	SCONJ
ct-11250	4	136	handling	handle	VERB
ct-11250	4	137	and	and	CCONJ
ct-11250	4	138	administering	administer	VERB
ct-11250	4	139	these	these	DET
ct-11250	4	140	agents	agent	NOUN
ct-11250	4	141	.	.	PUNCT
ct-11250	5	1	keywords	keyword	NOUN
ct-11250	5	2	:	:	PUNCT
ct-11250	5	3	exogenous	exogenous	ADJ
ct-11250	5	4	hormone	hormone	NOUN
ct-11250	5	5	,	,	PUNCT
ct-11250	5	6	equine	equine	NOUN
ct-11250	5	7	,	,	PUNCT
ct-11250	5	8	mare	mare	NOUN
ct-11250	5	9	,	,	PUNCT
ct-11250	5	10	stallion	stallion	NOUN
ct-11250	5	11	,	,	PUNCT
ct-11250	5	12	personal	personal	ADJ
ct-11250	5	13	safety	safety	NOUN
ct-11250	5	14	exogenous	exogenous	ADJ
ct-11250	5	15	hormone	hormone	NOUN
ct-11250	5	16	preparations	preparation	NOUN
ct-11250	5	17	with	with	ADP
ct-11250	5	18	the	the	DET
ct-11250	5	19	exception	exception	NOUN
ct-11250	5	20	of	of	ADP
ct-11250	5	21	equine	equine	NOUN
ct-11250	5	22	follicle	follicle	NOUN
ct-11250	5	23	stimulating	stimulate	VERB
ct-11250	5	24	hormone	hormone	NOUN
ct-11250	5	25	(	(	PUNCT
ct-11250	5	26	efsh	efsh	NOUN
ct-11250	5	27	)	)	PUNCT
ct-11250	5	28	all	all	PRON
ct-11250	5	29	of	of	ADP
ct-11250	5	30	the	the	DET
ct-11250	5	31	major	major	ADJ
ct-11250	5	32	hormones	hormone	NOUN
ct-11250	5	33	secreted	secrete	VERB
ct-11250	5	34	by	by	ADP
ct-11250	5	35	the	the	DET
ct-11250	5	36	hypothalmic	hypothalmic	ADJ
ct-11250	5	37	-	-	PUNCT
ct-11250	5	38	pituitary	pituitary	NOUN
ct-11250	5	39	-	-	PUNCT
ct-11250	5	40	gonadal	gonadal	NOUN
ct-11250	5	41	axis	axis	NOUN
ct-11250	5	42	are	be	AUX
ct-11250	5	43	available	available	ADJ
ct-11250	5	44	as	as	ADP
ct-11250	5	45	exogenous	exogenous	ADJ
ct-11250	5	46	formulations	formulation	NOUN
ct-11250	5	47	that	that	PRON
ct-11250	5	48	are	be	AUX
ct-11250	5	49	used	use	VERB
ct-11250	5	50	to	to	PART
ct-11250	5	51	regulate	regulate	VERB
ct-11250	5	52	physiological	physiological	ADJ
ct-11250	5	53	and/or	and/or	CCONJ
ct-11250	5	54	behavioral	behavioral	ADJ
ct-11250	5	55	reproductive	reproductive	ADJ
ct-11250	5	56	phenomena	phenomenon	NOUN
ct-11250	5	57	in	in	ADP
ct-11250	5	58	horses	horse	NOUN
ct-11250	5	59	(	(	PUNCT
ct-11250	5	60	table	table	NOUN
ct-11250	5	61	1	1	NUM
ct-11250	5	62	)	)	PUNCT
ct-11250	5	63	.	.	PUNCT
ct-11250	6	1	although	although	SCONJ
ct-11250	6	2	native	native	ADJ
ct-11250	6	3	gonadotropin	gonadotropin	NOUN
ct-11250	6	4	releasing	release	VERB
ct-11250	6	5	hormone	hormone	NOUN
ct-11250	6	6	(	(	PUNCT
ct-11250	6	7	gnrh	gnrh	NOUN
ct-11250	6	8	)	)	PUNCT
ct-11250	6	9	is	be	AUX
ct-11250	6	10	commercially	commercially	ADV
ct-11250	6	11	available	available	ADJ
ct-11250	6	12	in	in	ADP
ct-11250	6	13	aqueous	aqueous	ADJ
ct-11250	6	14	injectable	injectable	ADJ
ct-11250	6	15	formulations	formulation	NOUN
ct-11250	6	16	(	(	PUNCT
ct-11250	6	17	e.g.	e.g.	ADV
ct-11250	6	18	,	,	PUNCT
ct-11250	6	19	cystorelin	cystorelin	PROPN
ct-11250	6	20	®	®	PROPN
ct-11250	6	21	,	,	PUNCT
ct-11250	6	22	merial	merial	PROPN
ct-11250	6	23	ltd	ltd	PROPN
ct-11250	6	24	.	.	PROPN
ct-11250	6	25	,	,	PUNCT
ct-11250	6	26	duluth	duluth	PROPN
ct-11250	6	27	,	,	PUNCT
ct-11250	6	28	ga	ga	PROPN
ct-11250	6	29	;	;	PUNCT
ct-11250	6	30	factrel	factrel	PROPN
ct-11250	6	31	®	®	PROPN
ct-11250	6	32	,	,	PUNCT
ct-11250	6	33	fort	fort	PROPN
ct-11250	6	34	dodge	dodge	PROPN
ct-11250	6	35	animal	animal	PROPN
ct-11250	6	36	health	health	NOUN
ct-11250	6	37	,	,	PUNCT
ct-11250	6	38	fort	fort	NOUN
ct-11250	6	39	dodge	dodge	PROPN
ct-11250	6	40	,	,	PUNCT
ct-11250	6	41	ia	ia	PROPN
ct-11250	6	42	)	)	PUNCT
ct-11250	6	43	,	,	PUNCT
ct-11250	6	44	their	their	PRON
ct-11250	6	45	short	short	ADJ
ct-11250	6	46	half	half	ADJ
ct-11250	6	47	-	-	PUNCT
ct-11250	6	48	life	life	NOUN
ct-11250	6	49	limits	limit	VERB
ct-11250	6	50	the	the	DET
ct-11250	6	51	usefulness	usefulness	NOUN
ct-11250	6	52	of	of	ADP
ct-11250	6	53	these	these	DET
ct-11250	6	54	products	product	NOUN
ct-11250	6	55	in	in	ADP
ct-11250	6	56	mares	mare	NOUN
ct-11250	6	57	;	;	PUNCT
ct-11250	6	58	therefore	therefore	ADV
ct-11250	6	59	,	,	PUNCT
ct-11250	6	60	the	the	DET
ct-11250	6	61	potent	potent	ADJ
ct-11250	6	62	gnrh	gnrh	NOUN
ct-11250	6	63	analog	analog	NOUN
ct-11250	6	64	deslorelin	deslorelin	NOUN
ct-11250	6	65	is	be	AUX
ct-11250	6	66	widely	widely	ADV
ct-11250	6	67	used	use	VERB
ct-11250	6	68	instead.3	instead.3	NOUN
ct-11250	6	69	deslorelin	deslorelin	NOUN
ct-11250	6	70	is	be	AUX
ct-11250	6	71	primarily	primarily	ADV
ct-11250	6	72	used	use	VERB
ct-11250	6	73	to	to	PART
ct-11250	6	74	induce	induce	VERB
ct-11250	6	75	ovulation	ovulation	NOUN
ct-11250	6	76	in	in	ADP
ct-11250	6	77	mares	mare	NOUN
ct-11250	6	78	that	that	PRON
ct-11250	6	79	are	be	AUX
ct-11250	6	80	in	in	ADP
ct-11250	6	81	estrus	estrus	NOUN
ct-11250	6	82	with	with	ADP
ct-11250	6	83	a	a	DET
ct-11250	6	84	growing	grow	VERB
ct-11250	6	85	dominant	dominant	ADJ
ct-11250	6	86	follicle	follicle	NOUN
ct-11250	6	87	(	(	PUNCT
ct-11250	6	88	≥30	≥30	PROPN
ct-11250	6	89	mm).4	mm).4	PROPN
ct-11250	6	90	administration	administration	NOUN
ct-11250	6	91	of	of	ADP
ct-11250	6	92	deslorelin	deslorelin	NOUN
ct-11250	6	93	stimulates	stimulate	VERB
ct-11250	6	94	the	the	DET
ct-11250	6	95	release	release	NOUN
ct-11250	6	96	of	of	ADP
ct-11250	6	97	luteinizing	luteinize	VERB
ct-11250	6	98	hormone	hormone	NOUN
ct-11250	6	99	(	(	PUNCT
ct-11250	6	100	lh	lh	PROPN
ct-11250	6	101	)	)	PUNCT
ct-11250	6	102	from	from	ADP
ct-11250	6	103	the	the	DET
ct-11250	6	104	anterior	anterior	ADJ
ct-11250	6	105	pituitary	pituitary	ADJ
ct-11250	6	106	gland	gland	NOUN
ct-11250	6	107	,	,	PUNCT
ct-11250	6	108	which	which	PRON
ct-11250	6	109	initiates	initiate	VERB
ct-11250	6	110	follicular	follicular	ADJ
ct-11250	6	111	/	/	SYM
ct-11250	6	112	oocyte	oocyte	ADJ
ct-11250	6	113	maturation	maturation	NOUN
ct-11250	6	114	and	and	CCONJ
ct-11250	6	115	subsequent	subsequent	ADJ
ct-11250	6	116	ovulation	ovulation	NOUN
ct-11250	6	117	approximately	approximately	ADV
ct-11250	6	118	36	36	NUM
ct-11250	6	119	to	to	PART
ct-11250	6	120	48	48	NUM
ct-11250	6	121	hours	hour	NOUN
ct-11250	6	122	after	after	ADP
ct-11250	6	123	administration	administration	NOUN
ct-11250	6	124	.	.	PUNCT
ct-11250	7	1	in	in	ADP
ct-11250	7	2	2011	2011	NUM
ct-11250	7	3	,	,	PUNCT
ct-11250	7	4	a	a	DET
ct-11250	7	5	new	new	ADJ
ct-11250	7	6	fdaapproved	fdaapprove	VERB
ct-11250	7	7	deslorelin	deslorelin	NOUN
ct-11250	7	8	product	product	NOUN
ct-11250	7	9	(	(	PUNCT
ct-11250	7	10	sucromate	sucromate	VERB
ct-11250	7	11	™	™	ADJ
ct-11250	7	12	equine	equine	NOUN
ct-11250	7	13	,	,	PUNCT
ct-11250	7	14	thorn	thorn	PROPN
ct-11250	7	15	bioscience	bioscience	PROPN
ct-11250	7	16	llc	llc	PROPN
ct-11250	7	17	,	,	PUNCT
ct-11250	7	18	louisville	louisville	PROPN
ct-11250	7	19	,	,	PUNCT
ct-11250	7	20	ky	ky	PROPN
ct-11250	7	21	)	)	PUNCT
ct-11250	7	22	became	become	VERB
ct-11250	7	23	commercially	commercially	ADV
ct-11250	7	24	available	available	ADJ
ct-11250	7	25	,	,	PUNCT
ct-11250	7	26	which	which	PRON
ct-11250	7	27	supplanted	supplant	VERB
ct-11250	7	28	the	the	DET
ct-11250	7	29	use	use	NOUN
ct-11250	7	30	of	of	ADP
ct-11250	7	31	compounded	compound	VERB
ct-11250	7	32	deslorelin	deslorelin	NOUN
ct-11250	7	33	products	product	NOUN
ct-11250	7	34	that	that	PRON
ct-11250	7	35	had	have	AUX
ct-11250	7	36	been	be	AUX
ct-11250	7	37	used	use	VERB
ct-11250	7	38	previously	previously	ADV
ct-11250	7	39	.	.	PUNCT
ct-11250	8	1	human	human	ADJ
ct-11250	8	2	chorionic	chorionic	ADJ
ct-11250	8	3	gonadotropin	gonadotropin	NOUN
ct-11250	8	4	(	(	PUNCT
ct-11250	8	5	hcg	hcg	PROPN
ct-11250	8	6	)	)	PUNCT
ct-11250	8	7	is	be	AUX
ct-11250	8	8	routinely	routinely	ADV
ct-11250	8	9	used	use	VERB
ct-11250	8	10	to	to	PART
ct-11250	8	11	induce	induce	VERB
ct-11250	8	12	ovulation	ovulation	NOUN
ct-11250	8	13	in	in	ADP
ct-11250	8	14	mares	mare	NOUN
ct-11250	8	15	because	because	SCONJ
ct-11250	8	16	of	of	ADP
ct-11250	8	17	its	its	PRON
ct-11250	8	18	lh	lh	NOUN
ct-11250	8	19	-	-	PUNCT
ct-11250	8	20	like	like	ADJ
ct-11250	8	21	activity.5	activity.5	PROPN
ct-11250	8	22	like	like	ADP
ct-11250	8	23	deslorelin	deslorelin	NOUN
ct-11250	8	24	,	,	PUNCT
ct-11250	8	25	hcg	hcg	PROPN
ct-11250	8	26	is	be	AUX
ct-11250	8	27	typically	typically	ADV
ct-11250	8	28	administered	administer	VERB
ct-11250	8	29	to	to	ADP
ct-11250	8	30	mares	mare	NOUN
ct-11250	8	31	that	that	PRON
ct-11250	8	32	are	be	AUX
ct-11250	8	33	in	in	ADP
ct-11250	8	34	estrus	estrus	NOUN
ct-11250	8	35	with	with	ADP
ct-11250	8	36	a	a	DET
ct-11250	8	37	growing	grow	VERB
ct-11250	8	38	dominant	dominant	ADJ
ct-11250	8	39	follicle	follicle	NOUN
ct-11250	8	40	(	(	PUNCT
ct-11250	8	41	≥35	≥35	INTJ
ct-11250	8	42	mm	mm	NOUN
ct-11250	8	43	)	)	PUNCT
ct-11250	8	44	.	.	PUNCT
ct-11250	9	1	the	the	DET
ct-11250	9	2	lh	lh	NOUN
ct-11250	9	3	-	-	PUNCT
ct-11250	9	4	activity	activity	NOUN
ct-11250	9	5	of	of	ADP
ct-11250	9	6	hcg	hcg	PROPN
ct-11250	9	7	induces	induce	VERB
ct-11250	9	8	follicular	follicular	ADJ
ct-11250	9	9	/	/	SYM
ct-11250	9	10	oocyte	oocyte	ADJ
ct-11250	9	11	maturation	maturation	NOUN
ct-11250	9	12	resulting	result	VERB
ct-11250	9	13	in	in	ADP
ct-11250	9	14	ovulation	ovulation	NOUN
ct-11250	9	15	approximately	approximately	ADV
ct-11250	9	16	36	36	NUM
ct-11250	9	17	to	to	PART
ct-11250	9	18	48	48	NUM
ct-11250	9	19	hours	hour	NOUN
ct-11250	9	20	after	after	ADP
ct-11250	9	21	treatment	treatment	NOUN
ct-11250	9	22	.	.	PUNCT
ct-11250	10	1	because	because	SCONJ
ct-11250	10	2	hcg	hcg	PROPN
ct-11250	10	3	is	be	AUX
ct-11250	10	4	a	a	DET
ct-11250	10	5	large	large	ADJ
ct-11250	10	6	foreign	foreign	ADJ
ct-11250	10	7	(	(	PUNCT
ct-11250	10	8	nonequine	nonequine	ADJ
ct-11250	10	9	)	)	PUNCT
ct-11250	10	10	protein	protein	NOUN
ct-11250	10	11	,	,	PUNCT
ct-11250	10	12	repeated	repeat	VERB
ct-11250	10	13	administration	administration	NOUN
ct-11250	10	14	to	to	ADP
ct-11250	10	15	mares	mare	NOUN
ct-11250	10	16	will	will	AUX
ct-11250	10	17	induce	induce	VERB
ct-11250	10	18	antibody	antibody	NOUN
ct-11250	10	19	formation	formation	NOUN
ct-11250	10	20	against	against	ADP
ct-11250	10	21	the	the	DET
ct-11250	10	22	hcg	hcg	PROPN
ct-11250	10	23	molecule	molecule	NOUN
ct-11250	10	24	.	.	PUNCT
ct-11250	11	1	although	although	SCONJ
ct-11250	11	2	the	the	DET
ct-11250	11	3	development	development	NOUN
ct-11250	11	4	of	of	ADP
ct-11250	11	5	anti	anti	ADJ
ct-11250	11	6	-	-	ADJ
ct-11250	11	7	hcg	hcg	ADJ
ct-11250	11	8	antibodies	antibody	NOUN
ct-11250	11	9	has	have	AUX
ct-11250	11	10	not	not	PART
ct-11250	11	11	been	be	AUX
ct-11250	11	12	documented	document	VERB
ct-11250	11	13	to	to	PART
ct-11250	11	14	interfere	interfere	VERB
ct-11250	11	15	with	with	ADP
ct-11250	11	16	the	the	DET
ct-11250	11	17	efficacy	efficacy	NOUN
ct-11250	11	18	of	of	ADP
ct-11250	11	19	hcg	hcg	PROPN
ct-11250	11	20	,	,	PUNCT
ct-11250	11	21	it	it	PRON
ct-11250	11	22	has	have	AUX
ct-11250	11	23	been	be	AUX
ct-11250	11	24	demonstrated	demonstrate	VERB
ct-11250	11	25	that	that	SCONJ
ct-11250	11	26	aged	aged	ADJ
ct-11250	11	27	mares	mare	NOUN
ct-11250	11	28	(	(	PUNCT
ct-11250	11	29	>	>	SYM
ct-11250	11	30	15	15	NUM
ct-11250	11	31	years	year	NOUN
ct-11250	11	32	of	of	ADP
ct-11250	11	33	age	age	NOUN
ct-11250	11	34	)	)	PUNCT
ct-11250	11	35	tend	tend	VERB
ct-11250	11	36	to	to	PART
ct-11250	11	37	be	be	AUX
ct-11250	11	38	less	less	ADV
ct-11250	11	39	responsive	responsive	ADJ
ct-11250	11	40	to	to	ADP
ct-11250	11	41	hcg.4,5	hcg.4,5	PROPN
ct-11250	11	42	for	for	ADP
ct-11250	11	43	mares	mare	NOUN
ct-11250	11	44	in	in	ADP
ct-11250	11	45	which	which	PRON
ct-11250	11	46	hcg	hcg	PROPN
ct-11250	11	47	has	have	AUX
ct-11250	11	48	not	not	PART
ct-11250	11	49	reliably	reliably	ADV
ct-11250	11	50	induced	induce	VERB
ct-11250	11	51	ovulation	ovulation	NOUN
ct-11250	11	52	,	,	PUNCT
ct-11250	11	53	or	or	CCONJ
ct-11250	11	54	there	there	PRON
ct-11250	11	55	is	be	VERB
ct-11250	11	56	simply	simply	ADV
ct-11250	11	57	concern	concern	NOUN
ct-11250	11	58	that	that	SCONJ
ct-11250	11	59	a	a	DET
ct-11250	11	60	mare	mare	NOUN
ct-11250	11	61	will	will	AUX
ct-11250	11	62	not	not	PART
ct-11250	11	63	respond	respond	VERB
ct-11250	11	64	reliably	reliably	ADV
ct-11250	11	65	to	to	ADP
ct-11250	11	66	hcg	hcg	PROPN
ct-11250	11	67	(	(	PUNCT
ct-11250	11	68	i.e.	i.e.	X
ct-11250	11	69	,	,	PUNCT
ct-11250	11	70	aged	aged	ADJ
ct-11250	11	71	mares	mare	NOUN
ct-11250	11	72	)	)	PUNCT
ct-11250	11	73	,	,	PUNCT
ct-11250	11	74	the	the	DET
ct-11250	11	75	use	use	NOUN
ct-11250	11	76	of	of	ADP
ct-11250	11	77	deslorelin	deslorelin	NOUN
ct-11250	11	78	is	be	AUX
ct-11250	11	79	generally	generally	ADV
ct-11250	11	80	warranted	warrant	VERB
ct-11250	11	81	.	.	PUNCT
ct-11250	12	1	in	in	ADP
ct-11250	12	2	addition	addition	NOUN
ct-11250	12	3	to	to	ADP
ct-11250	12	4	its	its	PRON
ct-11250	12	5	use	use	NOUN
ct-11250	12	6	in	in	ADP
ct-11250	12	7	mares	mare	NOUN
ct-11250	12	8	,	,	PUNCT
ct-11250	12	9	because	because	SCONJ
ct-11250	12	10	of	of	ADP
ct-11250	12	11	its	its	PRON
ct-11250	12	12	lh	lh	ADJ
ct-11250	12	13	-	-	PUNCT
ct-11250	12	14	like	like	ADJ
ct-11250	12	15	activity	activity	NOUN
ct-11250	12	16	,	,	PUNCT
ct-11250	12	17	hcg	hcg	PROPN
ct-11250	12	18	is	be	AUX
ct-11250	12	19	also	also	ADV
ct-11250	12	20	used	use	VERB
ct-11250	12	21	in	in	ADP
ct-11250	12	22	male	male	ADJ
ct-11250	12	23	horses	horse	NOUN
ct-11250	12	24	as	as	ADP
ct-11250	12	25	a	a	DET
ct-11250	12	26	diagnostic	diagnostic	ADJ
ct-11250	12	27	test	test	NOUN
ct-11250	12	28	for	for	ADP
ct-11250	12	29	the	the	DET
ct-11250	12	30	presence	presence	NOUN
ct-11250	12	31	of	of	ADP
ct-11250	12	32	testicular	testicular	ADJ
ct-11250	12	33	tissue	tissue	NOUN
ct-11250	12	34	in	in	ADP
ct-11250	12	35	suspected	suspect	VERB
ct-11250	12	36	cryptorchid	cryptorchid	NOUN
ct-11250	12	37	horses.6	horses.6	PROPN
ct-11250	12	38	if	if	SCONJ
ct-11250	12	39	testicular	testicular	ADJ
ct-11250	12	40	tissue	tissue	NOUN
ct-11250	12	41	is	be	AUX
ct-11250	12	42	present	present	ADJ
ct-11250	12	43	in	in	ADP
ct-11250	12	44	these	these	DET
ct-11250	12	45	animals	animal	NOUN
ct-11250	12	46	,	,	PUNCT
ct-11250	12	47	administration	administration	NOUN
ct-11250	12	48	of	of	ADP
ct-11250	12	49	hcg	hcg	PROPN
ct-11250	12	50	will	will	AUX
ct-11250	12	51	stimulate	stimulate	VERB
ct-11250	12	52	synthesis	synthesis	NOUN
ct-11250	12	53	and	and	CCONJ
ct-11250	12	54	secretion	secretion	NOUN
ct-11250	12	55	of	of	ADP
ct-11250	12	56	testosterone	testosterone	NOUN
ct-11250	12	57	from	from	ADP
ct-11250	12	58	leydig	leydig	NOUN
ct-11250	12	59	cells	cell	NOUN
ct-11250	12	60	within	within	ADP
ct-11250	12	61	the	the	DET
ct-11250	12	62	testicular	testicular	ADJ
ct-11250	12	63	tissue	tissue	NOUN
ct-11250	12	64	.	.	PUNCT
ct-11250	13	1	a	a	DET
ct-11250	13	2	typical	typical	ADJ
ct-11250	13	3	hcg	hcg	NOUN
ct-11250	13	4	-	-	PUNCT
ct-11250	13	5	stimulation	stimulation	NOUN
ct-11250	13	6	protocol	protocol	NOUN
ct-11250	13	7	begins	begin	VERB
ct-11250	13	8	clinical	clinical	ADJ
ct-11250	13	9	theriogenology	theriogenology	NOUN
ct-11250	13	10	•	•	NOUN
ct-11250	13	11	volume	volume	NOUN
ct-11250	13	12	3	3	NUM
ct-11250	13	13	number	number	NOUN
ct-11250	13	14	4	4	NUM
ct-11250	13	15	•	•	NOUN
ct-11250	13	16	december	december	PROPN
ct-11250	13	17	2011clinical	2011clinical	ADJ
ct-11250	13	18	theriogenology	theriogenology	NOUN
ct-11250	13	19	•	•	NOUN
ct-11250	13	20	volume	volume	NOUN
ct-11250	13	21	4	4	NUM
ct-11250	13	22	number	number	NOUN
ct-11250	13	23	1	1	NUM
ct-11250	13	24	•	•	NUM
ct-11250	13	25	march	march	PROPN
ct-11250	13	26	201239	201239	NUM
ct-11250	13	27	clinical	clinical	ADJ
ct-11250	13	28	theriogenology	theriogenology	NOUN
ct-11250	13	29	•	•	NOUN
ct-11250	13	30	volume	volume	NOUN
ct-11250	13	31	4	4	NUM
ct-11250	13	32	number	number	NOUN
ct-11250	13	33	1	1	NUM
ct-11250	13	34	•	•	NUM
ct-11250	13	35	march	march	PROPN
ct-11250	13	36	2012	2012	NUM
ct-11250	13	37	with	with	ADP
ct-11250	13	38	the	the	DET
ct-11250	13	39	collection	collection	NOUN
ct-11250	13	40	of	of	ADP
ct-11250	13	41	an	an	DET
ct-11250	13	42	initial	initial	ADJ
ct-11250	13	43	blood	blood	NOUN
ct-11250	13	44	sample	sample	NOUN
ct-11250	13	45	for	for	ADP
ct-11250	13	46	assessment	assessment	NOUN
ct-11250	13	47	of	of	ADP
ct-11250	13	48	the	the	DET
ct-11250	13	49	baseline	baseline	NOUN
ct-11250	13	50	testosterone	testosterone	NOUN
ct-11250	13	51	level	level	NOUN
ct-11250	13	52	that	that	PRON
ct-11250	13	53	is	be	AUX
ct-11250	13	54	immediately	immediately	ADV
ct-11250	13	55	followed	follow	VERB
ct-11250	13	56	by	by	ADP
ct-11250	13	57	administration	administration	NOUN
ct-11250	13	58	of	of	ADP
ct-11250	13	59	6,000	6,000	NUM
ct-11250	13	60	to	to	PART
ct-11250	13	61	12,000	12,000	NUM
ct-11250	13	62	units	unit	NOUN
ct-11250	13	63	of	of	ADP
ct-11250	13	64	hcg	hcg	PROPN
ct-11250	13	65	iv	iv	PROPN
ct-11250	13	66	.	.	PUNCT
ct-11250	14	1	post	post	ADJ
ct-11250	14	2	-	-	ADJ
ct-11250	14	3	treatment	treatment	ADJ
ct-11250	14	4	blood	blood	NOUN
ct-11250	14	5	samples	sample	NOUN
ct-11250	14	6	are	be	AUX
ct-11250	14	7	collected	collect	VERB
ct-11250	14	8	between	between	ADP
ct-11250	14	9	one	one	NUM
ct-11250	14	10	and	and	CCONJ
ct-11250	14	11	three	three	NUM
ct-11250	14	12	hours	hour	NOUN
ct-11250	14	13	after	after	ADP
ct-11250	14	14	hcg	hcg	PROPN
ct-11250	14	15	treatment	treatment	NOUN
ct-11250	14	16	and	and	CCONJ
ct-11250	14	17	again	again	ADV
ct-11250	14	18	24	24	NUM
ct-11250	14	19	hours	hour	NOUN
ct-11250	14	20	after	after	ADP
ct-11250	14	21	treatment	treatment	NOUN
ct-11250	14	22	in	in	ADP
ct-11250	14	23	order	order	NOUN
ct-11250	14	24	to	to	PART
ct-11250	14	25	detect	detect	VERB
ct-11250	14	26	a	a	DET
ct-11250	14	27	resultant	resultant	NOUN
ct-11250	14	28	rise	rise	NOUN
ct-11250	14	29	in	in	ADP
ct-11250	14	30	testosterone	testosterone	NOUN
ct-11250	14	31	.	.	PUNCT
ct-11250	15	1	horses	horse	NOUN
ct-11250	15	2	with	with	ADP
ct-11250	15	3	testicular	testicular	ADJ
ct-11250	15	4	tissue	tissue	NOUN
ct-11250	15	5	generally	generally	ADV
ct-11250	15	6	have	have	VERB
ct-11250	15	7	a	a	DET
ct-11250	15	8	>	>	ADJ
ct-11250	15	9	four	four	NUM
ct-11250	15	10	-	-	ADJ
ct-11250	15	11	fold	fold	ADJ
ct-11250	15	12	rise	rise	NOUN
ct-11250	15	13	in	in	ADP
ct-11250	15	14	testosterone	testosterone	NOUN
ct-11250	15	15	in	in	ADP
ct-11250	15	16	one	one	NUM
ct-11250	15	17	or	or	CCONJ
ct-11250	15	18	both	both	DET
ct-11250	15	19	post	post	ADJ
ct-11250	15	20	-	-	ADJ
ct-11250	15	21	treatment	treatment	ADJ
ct-11250	15	22	samples.6	samples.6	PROPN
ct-11250	15	23	although	although	SCONJ
ct-11250	15	24	follicle	follicle	AUX
ct-11250	15	25	stimulating	stimulate	VERB
ct-11250	15	26	hormone	hormone	NOUN
ct-11250	15	27	(	(	PUNCT
ct-11250	15	28	fsh	fsh	NOUN
ct-11250	15	29	)	)	PUNCT
ct-11250	15	30	products	product	NOUN
ct-11250	15	31	are	be	AUX
ct-11250	15	32	used	use	VERB
ct-11250	15	33	extensively	extensively	ADV
ct-11250	15	34	for	for	ADP
ct-11250	15	35	superovulation	superovulation	NOUN
ct-11250	15	36	prior	prior	ADV
ct-11250	15	37	to	to	ADP
ct-11250	15	38	embryo	embryo	NOUN
ct-11250	15	39	transfer	transfer	NOUN
ct-11250	15	40	in	in	ADP
ct-11250	15	41	cattle	cattle	NOUN
ct-11250	15	42	and	and	CCONJ
ct-11250	15	43	other	other	ADJ
ct-11250	15	44	livestock	livestock	NOUN
ct-11250	15	45	species	specie	NOUN
ct-11250	15	46	,	,	PUNCT
ct-11250	15	47	the	the	DET
ct-11250	15	48	fsh	fsh	ADJ
ct-11250	15	49	products	product	NOUN
ct-11250	15	50	that	that	PRON
ct-11250	15	51	are	be	AUX
ct-11250	15	52	used	use	VERB
ct-11250	15	53	(	(	PUNCT
ct-11250	15	54	e.g.	e.g.	ADV
ct-11250	15	55	,	,	PUNCT
ct-11250	15	56	folltropin	folltropin	NOUN
ct-11250	15	57	®	®	NOUN
ct-11250	15	58	-v	-v	NOUN
ct-11250	15	59	,	,	PUNCT
ct-11250	15	60	bioniche	bioniche	NOUN
ct-11250	15	61	animal	animal	NOUN
ct-11250	15	62	health	health	PROPN
ct-11250	15	63	canada	canada	PROPN
ct-11250	15	64	inc	inc	PROPN
ct-11250	15	65	.	.	PROPN
ct-11250	15	66	,	,	PUNCT
ct-11250	15	67	belleville	belleville	PROPN
ct-11250	15	68	,	,	PUNCT
ct-11250	15	69	ontario	ontario	PROPN
ct-11250	15	70	,	,	PUNCT
ct-11250	15	71	canada	canada	PROPN
ct-11250	15	72	;	;	PUNCT
ct-11250	15	73	pluset	pluset	PROPN
ct-11250	15	74	®	®	PROPN
ct-11250	15	75	,	,	PUNCT
ct-11250	15	76	minitube	minitube	PROPN
ct-11250	15	77	of	of	ADP
ct-11250	15	78	america	america	PROPN
ct-11250	15	79	inc	inc	PROPN
ct-11250	15	80	.	.	PROPN
ct-11250	15	81	,	,	PUNCT
ct-11250	15	82	verona	verona	PROPN
ct-11250	15	83	,	,	PUNCT
ct-11250	15	84	wi	wi	PROPN
ct-11250	15	85	)	)	PUNCT
ct-11250	15	86	are	be	AUX
ct-11250	15	87	of	of	ADP
ct-11250	15	88	porcine	porcine	NOUN
ct-11250	15	89	origin	origin	NOUN
ct-11250	15	90	and	and	CCONJ
ct-11250	15	91	have	have	AUX
ct-11250	15	92	not	not	PART
ct-11250	15	93	been	be	AUX
ct-11250	15	94	reliably	reliably	ADV
ct-11250	15	95	efficacious	efficacious	ADJ
ct-11250	15	96	for	for	ADP
ct-11250	15	97	superovulating	superovulate	VERB
ct-11250	15	98	mares.7	mares.7	NOUN
ct-11250	15	99	for	for	ADP
ct-11250	15	100	a	a	DET
ct-11250	15	101	period	period	NOUN
ct-11250	15	102	of	of	ADP
ct-11250	15	103	time	time	NOUN
ct-11250	15	104	,	,	PUNCT
ct-11250	15	105	an	an	DET
ct-11250	15	106	efsh	efsh	NOUN
ct-11250	15	107	preparation	preparation	NOUN
ct-11250	15	108	was	be	AUX
ct-11250	15	109	commercially	commercially	ADV
ct-11250	15	110	available	available	ADJ
ct-11250	15	111	(	(	PUNCT
ct-11250	15	112	efsh	efsh	PROPN
ct-11250	15	113	,	,	PUNCT
ct-11250	15	114	bioniche	bioniche	NOUN
ct-11250	15	115	animal	animal	PROPN
ct-11250	15	116	health	health	PROPN
ct-11250	15	117	inc	inc	PROPN
ct-11250	15	118	.	.	PROPN
ct-11250	15	119	,	,	PUNCT
ct-11250	15	120	athens	athens	PROPN
ct-11250	15	121	,	,	PUNCT
ct-11250	15	122	ga	ga	PROPN
ct-11250	15	123	)	)	PUNCT
ct-11250	15	124	for	for	ADP
ct-11250	15	125	superovulating	superovulate	VERB
ct-11250	15	126	mares;8	mares;8	NOUN
ct-11250	15	127	however	however	ADV
ct-11250	15	128	,	,	PUNCT
ct-11250	15	129	that	that	DET
ct-11250	15	130	product	product	NOUN
ct-11250	15	131	was	be	AUX
ct-11250	15	132	subsequently	subsequently	ADV
ct-11250	15	133	withdrawn	withdraw	VERB
ct-11250	15	134	from	from	ADP
ct-11250	15	135	the	the	DET
ct-11250	15	136	market	market	NOUN
ct-11250	15	137	.	.	PUNCT
ct-11250	16	1	as	as	ADP
ct-11250	16	2	an	an	DET
ct-11250	16	3	alternative	alternative	NOUN
ct-11250	16	4	,	,	PUNCT
ct-11250	16	5	a	a	DET
ct-11250	16	6	recombinant	recombinant	ADJ
ct-11250	16	7	equine	equine	NOUN
ct-11250	16	8	fsh	fsh	NOUN
ct-11250	16	9	(	(	PUNCT
ct-11250	16	10	refsh	refsh	NOUN
ct-11250	16	11	)	)	PUNCT
ct-11250	16	12	product	product	NOUN
ct-11250	16	13	is	be	AUX
ct-11250	16	14	currently	currently	ADV
ct-11250	16	15	being	be	AUX
ct-11250	16	16	evaluated	evaluate	VERB
ct-11250	16	17	for	for	ADP
ct-11250	16	18	superovulating	superovulate	VERB
ct-11250	16	19	mares	mare	NOUN
ct-11250	16	20	,	,	PUNCT
ct-11250	16	21	but	but	CCONJ
ct-11250	16	22	it	it	PRON
ct-11250	16	23	is	be	AUX
ct-11250	16	24	not	not	PART
ct-11250	16	25	commercially	commercially	ADV
ct-11250	16	26	available	available	ADJ
ct-11250	16	27	at	at	ADP
ct-11250	16	28	this	this	DET
ct-11250	16	29	time.9	time.9	NOUN
ct-11250	16	30	exogenous	exogenous	ADJ
ct-11250	16	31	formulations	formulation	NOUN
ct-11250	16	32	of	of	ADP
ct-11250	16	33	the	the	DET
ct-11250	16	34	ovarian	ovarian	ADJ
ct-11250	16	35	steroid	steroid	NOUN
ct-11250	16	36	hormones	hormone	NOUN
ct-11250	16	37	estrogen	estrogen	NOUN
ct-11250	16	38	and	and	CCONJ
ct-11250	16	39	progesterone	progesterone	NOUN
ct-11250	16	40	are	be	AUX
ct-11250	16	41	used	use	VERB
ct-11250	16	42	extensively	extensively	ADV
ct-11250	16	43	,	,	PUNCT
ct-11250	16	44	both	both	CCONJ
ct-11250	16	45	alone	alone	ADJ
ct-11250	16	46	and	and	CCONJ
ct-11250	16	47	in	in	ADP
ct-11250	16	48	combination	combination	NOUN
ct-11250	16	49	,	,	PUNCT
ct-11250	16	50	to	to	PART
ct-11250	16	51	regulate	regulate	VERB
ct-11250	16	52	and/or	and/or	CCONJ
ct-11250	16	53	treat	treat	VERB
ct-11250	16	54	numerous	numerous	ADJ
ct-11250	16	55	physiological	physiological	ADJ
ct-11250	16	56	and	and	CCONJ
ct-11250	16	57	pathological	pathological	ADJ
ct-11250	16	58	reproductive	reproductive	ADJ
ct-11250	16	59	conditions	condition	NOUN
ct-11250	16	60	in	in	ADP
ct-11250	16	61	mares	mare	NOUN
ct-11250	16	62	(	(	PUNCT
ct-11250	16	63	table	table	NOUN
ct-11250	16	64	1).10,11	1).10,11	NUM
ct-11250	16	65	estrogen	estrogen	NOUN
ct-11250	16	66	is	be	AUX
ct-11250	16	67	administered	administer	VERB
ct-11250	16	68	to	to	AUX
ct-11250	16	69	ovariectomized	ovariectomize	VERB
ct-11250	16	70	mares	mare	NOUN
ct-11250	16	71	to	to	PART
ct-11250	16	72	induce	induce	VERB
ct-11250	16	73	estrous	estrous	ADJ
ct-11250	16	74	behavior	behavior	NOUN
ct-11250	16	75	for	for	ADP
ct-11250	16	76	breeding	breed	VERB
ct-11250	16	77	shed	shed	NOUN
ct-11250	16	78	activities	activity	NOUN
ct-11250	16	79	;	;	PUNCT
ct-11250	16	80	to	to	PART
ct-11250	16	81	spring	spring	VERB
ct-11250	16	82	“	"	PUNCT
ct-11250	16	83	transitional	transitional	ADJ
ct-11250	16	84	”	"	PUNCT
ct-11250	16	85	mares	mare	NOUN
ct-11250	16	86	prior	prior	ADV
ct-11250	16	87	to	to	ADP
ct-11250	16	88	administration	administration	NOUN
ct-11250	16	89	of	of	ADP
ct-11250	16	90	dopamine	dopamine	NOUN
ct-11250	16	91	antagonists	antagonist	NOUN
ct-11250	16	92	such	such	ADJ
ct-11250	16	93	as	as	ADP
ct-11250	16	94	sulpiride	sulpiride	NOUN
ct-11250	16	95	to	to	PART
ct-11250	16	96	hasten	hasten	VERB
ct-11250	16	97	the	the	DET
ct-11250	16	98	onset	onset	NOUN
ct-11250	16	99	of	of	ADP
ct-11250	16	100	ovulation	ovulation	NOUN
ct-11250	16	101	;	;	PUNCT
ct-11250	16	102	and	and	CCONJ
ct-11250	16	103	to	to	ADP
ct-11250	16	104	noncycling	noncycle	VERB
ct-11250	16	105	(	(	PUNCT
ct-11250	16	106	or	or	CCONJ
ct-11250	16	107	ovariectomized	ovariectomized	ADJ
ct-11250	16	108	)	)	PUNCT
ct-11250	16	109	oocyte	oocyte	NOUN
ct-11250	16	110	or	or	CCONJ
ct-11250	16	111	embryo	embryo	NOUN
ct-11250	16	112	recipient	recipient	NOUN
ct-11250	16	113	mares	mare	NOUN
ct-11250	16	114	to	to	PART
ct-11250	16	115	enhance	enhance	VERB
ct-11250	16	116	the	the	DET
ct-11250	16	117	responsiveness	responsiveness	NOUN
ct-11250	16	118	of	of	ADP
ct-11250	16	119	the	the	DET
ct-11250	16	120	uterus	uterus	NOUN
ct-11250	16	121	to	to	ADP
ct-11250	16	122	subsequent	subsequent	ADJ
ct-11250	16	123	progesterone	progesterone	NOUN
ct-11250	16	124	treatment	treatment	NOUN
ct-11250	16	125	.	.	PUNCT
ct-11250	17	1	in	in	ADP
ct-11250	17	2	addition	addition	NOUN
ct-11250	17	3	,	,	PUNCT
ct-11250	17	4	estrogen	estrogen	NOUN
ct-11250	17	5	may	may	AUX
ct-11250	17	6	be	be	AUX
ct-11250	17	7	used	use	VERB
ct-11250	17	8	as	as	ADP
ct-11250	17	9	an	an	DET
ct-11250	17	10	adjunctive	adjunctive	ADJ
ct-11250	17	11	therapy	therapy	NOUN
ct-11250	17	12	in	in	ADP
ct-11250	17	13	highrisk	highrisk	NOUN
ct-11250	17	14	pregnant	pregnant	ADJ
ct-11250	17	15	mares	mare	NOUN
ct-11250	17	16	,	,	PUNCT
ct-11250	17	17	such	such	ADJ
ct-11250	17	18	as	as	ADP
ct-11250	17	19	those	those	PRON
ct-11250	17	20	with	with	ADP
ct-11250	17	21	placentitis	placentitis	PROPN
ct-11250	17	22	.	.	PUNCT
ct-11250	18	1	estrogen	estrogen	NOUN
ct-11250	18	2	in	in	ADP
ct-11250	18	3	combination	combination	NOUN
ct-11250	18	4	with	with	ADP
ct-11250	18	5	progesterone	progesterone	NOUN
ct-11250	18	6	is	be	AUX
ct-11250	18	7	routinely	routinely	ADV
ct-11250	18	8	used	use	VERB
ct-11250	18	9	for	for	ADP
ct-11250	18	10	synchronizing	synchronize	VERB
ct-11250	18	11	estrus	estrus	NOUN
ct-11250	18	12	/	/	SYM
ct-11250	18	13	ovulation	ovulation	NOUN
ct-11250	18	14	in	in	ADP
ct-11250	18	15	cycling	cycling	NOUN
ct-11250	18	16	mares	mare	NOUN
ct-11250	18	17	and	and	CCONJ
ct-11250	18	18	it	it	PRON
ct-11250	18	19	can	can	AUX
ct-11250	18	20	be	be	AUX
ct-11250	18	21	used	use	VERB
ct-11250	18	22	in	in	ADP
ct-11250	18	23	postpartum	postpartum	NOUN
ct-11250	18	24	mares	mare	NOUN
ct-11250	18	25	to	to	PART
ct-11250	18	26	delay	delay	VERB
ct-11250	18	27	estrus	estrus	NOUN
ct-11250	18	28	/	/	SYM
ct-11250	18	29	ovulation	ovulation	NOUN
ct-11250	18	30	in	in	ADP
ct-11250	18	31	an	an	DET
ct-11250	18	32	effort	effort	NOUN
ct-11250	18	33	to	to	PART
ct-11250	18	34	enhance	enhance	VERB
ct-11250	18	35	the	the	DET
ct-11250	18	36	fertility	fertility	NOUN
ct-11250	18	37	of	of	ADP
ct-11250	18	38	foal	foal	NOUN
ct-11250	18	39	-	-	PUNCT
ct-11250	18	40	heat	heat	NOUN
ct-11250	18	41	breeding.10,11	breeding.10,11	NOUN
ct-11250	18	42	progesterone	progesterone	NOUN
ct-11250	18	43	and	and	CCONJ
ct-11250	18	44	the	the	DET
ct-11250	18	45	synthetic	synthetic	ADJ
ct-11250	18	46	progestin	progestin	NOUN
ct-11250	18	47	altrenogest	altrenog	ADJ
ct-11250	18	48	are	be	AUX
ct-11250	18	49	widely	widely	ADV
ct-11250	18	50	used	use	VERB
ct-11250	18	51	for	for	ADP
ct-11250	18	52	reproductive	reproductive	ADJ
ct-11250	18	53	management	management	NOUN
ct-11250	18	54	in	in	ADP
ct-11250	18	55	both	both	CCONJ
ct-11250	18	56	nonpregnant	nonpregnant	NOUN
ct-11250	18	57	and	and	CCONJ
ct-11250	18	58	pregnant	pregnant	ADJ
ct-11250	18	59	mares.11	mares.11	NOUN
ct-11250	18	60	these	these	DET
ct-11250	18	61	hormones	hormone	NOUN
ct-11250	18	62	are	be	AUX
ct-11250	18	63	used	use	VERB
ct-11250	18	64	to	to	PART
ct-11250	18	65	suppress	suppress	VERB
ct-11250	18	66	estrous	estrous	ADJ
ct-11250	18	67	behavior	behavior	NOUN
ct-11250	18	68	in	in	ADP
ct-11250	18	69	nonpregnant	nonpregnant	ADJ
ct-11250	18	70	performance	performance	NOUN
ct-11250	18	71	horses	horse	NOUN
ct-11250	18	72	and	and	CCONJ
ct-11250	18	73	in	in	ADP
ct-11250	18	74	spring	spring	NOUN
ct-11250	18	75	“	"	PUNCT
ct-11250	18	76	transitional	transitional	ADJ
ct-11250	18	77	”	"	PUNCT
ct-11250	18	78	mares	mare	NOUN
ct-11250	18	79	to	to	PART
ct-11250	18	80	hasten	hasten	VERB
ct-11250	18	81	the	the	DET
ct-11250	18	82	onset	onset	NOUN
ct-11250	18	83	of	of	ADP
ct-11250	18	84	ovulatory	ovulatory	ADJ
ct-11250	18	85	activity	activity	NOUN
ct-11250	18	86	.	.	PUNCT
ct-11250	19	1	in	in	ADP
ct-11250	19	2	pregnant	pregnant	ADJ
ct-11250	19	3	mares	mare	NOUN
ct-11250	19	4	exogenous	exogenous	ADJ
ct-11250	19	5	progestins	progestin	NOUN
ct-11250	19	6	are	be	AUX
ct-11250	19	7	used	use	VERB
ct-11250	19	8	extensively	extensively	ADV
ct-11250	19	9	(	(	PUNCT
ct-11250	19	10	whether	whether	SCONJ
ct-11250	19	11	warranted	warrant	VERB
ct-11250	19	12	or	or	CCONJ
ct-11250	19	13	not	not	PART
ct-11250	19	14	)	)	PUNCT
ct-11250	19	15	to	to	PART
ct-11250	19	16	augment	augment	VERB
ct-11250	19	17	endogenous	endogenous	ADJ
ct-11250	19	18	progesterone	progesterone	NOUN
ct-11250	19	19	levels	level	NOUN
ct-11250	19	20	in	in	ADP
ct-11250	19	21	an	an	DET
ct-11250	19	22	effort	effort	NOUN
ct-11250	19	23	to	to	PART
ct-11250	19	24	enhance	enhance	VERB
ct-11250	19	25	pregnancy	pregnancy	NOUN
ct-11250	19	26	maintenance	maintenance	NOUN
ct-11250	19	27	during	during	ADP
ct-11250	19	28	early	early	ADJ
ct-11250	19	29	gestation	gestation	NOUN
ct-11250	19	30	(	(	PUNCT
ct-11250	19	31	<	<	X
ct-11250	19	32	100	100	NUM
ct-11250	19	33	days	day	NOUN
ct-11250	19	34	)	)	PUNCT
ct-11250	19	35	.	.	PUNCT
ct-11250	20	1	exogenous	exogenous	ADJ
ct-11250	20	2	progestins	progestin	NOUN
ct-11250	20	3	are	be	AUX
ct-11250	20	4	also	also	ADV
ct-11250	20	5	used	use	VERB
ct-11250	20	6	for	for	ADP
ct-11250	20	7	maintenance	maintenance	NOUN
ct-11250	20	8	of	of	ADP
ct-11250	20	9	pregnancy	pregnancy	NOUN
ct-11250	20	10	in	in	ADP
ct-11250	20	11	nonovulating	nonovulate	VERB
ct-11250	20	12	(	(	PUNCT
ct-11250	20	13	or	or	CCONJ
ct-11250	20	14	ovariectomized	ovariectomized	ADJ
ct-11250	20	15	)	)	PUNCT
ct-11250	20	16	oocyte	oocyte	NOUN
ct-11250	20	17	or	or	CCONJ
ct-11250	20	18	embryo	embryo	NOUN
ct-11250	20	19	recipient	recipient	NOUN
ct-11250	20	20	mares	mare	NOUN
ct-11250	20	21	that	that	PRON
ct-11250	20	22	lack	lack	VERB
ct-11250	20	23	an	an	DET
ct-11250	20	24	endogenous	endogenous	ADJ
ct-11250	20	25	source	source	NOUN
ct-11250	20	26	of	of	ADP
ct-11250	20	27	progesterone	progesterone	NOUN
ct-11250	20	28	(	(	PUNCT
ct-11250	20	29	until	until	SCONJ
ct-11250	20	30	fetal	fetal	ADJ
ct-11250	20	31	-	-	PUNCT
ct-11250	20	32	placental	placental	NOUN
ct-11250	20	33	production	production	NOUN
ct-11250	20	34	begins	begin	VERB
ct-11250	20	35	)	)	PUNCT
ct-11250	20	36	and	and	CCONJ
ct-11250	20	37	as	as	ADP
ct-11250	20	38	an	an	DET
ct-11250	20	39	adjunctive	adjunctive	ADJ
ct-11250	20	40	therapy	therapy	NOUN
ct-11250	20	41	in	in	ADP
ct-11250	20	42	high	high	ADJ
ct-11250	20	43	-	-	PUNCT
ct-11250	20	44	risk	risk	NOUN
ct-11250	20	45	pregnant	pregnant	ADJ
ct-11250	20	46	mares	mare	NOUN
ct-11250	20	47	,	,	PUNCT
ct-11250	20	48	such	such	ADJ
ct-11250	20	49	as	as	ADP
ct-11250	20	50	those	those	PRON
ct-11250	20	51	with	with	ADP
ct-11250	20	52	placentitis	placentitis	PROPN
ct-11250	20	53	or	or	CCONJ
ct-11250	20	54	severe	severe	ADJ
ct-11250	20	55	systemic	systemic	ADJ
ct-11250	20	56	disease	disease	NOUN
ct-11250	20	57	.	.	PUNCT
ct-11250	21	1	as	as	SCONJ
ct-11250	21	2	noted	note	VERB
ct-11250	21	3	above	above	ADV
ct-11250	21	4	for	for	ADP
ct-11250	21	5	estrogen	estrogen	NOUN
ct-11250	21	6	products	product	NOUN
ct-11250	21	7	,	,	PUNCT
ct-11250	21	8	progesterone	progesterone	NOUN
ct-11250	21	9	in	in	ADP
ct-11250	21	10	combination	combination	NOUN
ct-11250	21	11	with	with	ADP
ct-11250	21	12	estrogen	estrogen	NOUN
ct-11250	21	13	is	be	AUX
ct-11250	21	14	routinely	routinely	ADV
ct-11250	21	15	used	use	VERB
ct-11250	21	16	for	for	ADP
ct-11250	21	17	synchronizing	synchronize	VERB
ct-11250	21	18	estrus	estrus	NOUN
ct-11250	21	19	/	/	SYM
ct-11250	21	20	ovulation	ovulation	NOUN
ct-11250	21	21	in	in	ADP
ct-11250	21	22	cycling	cycling	NOUN
ct-11250	21	23	mares	mare	NOUN
ct-11250	21	24	and	and	CCONJ
ct-11250	21	25	it	it	PRON
ct-11250	21	26	can	can	AUX
ct-11250	21	27	be	be	AUX
ct-11250	21	28	used	use	VERB
ct-11250	21	29	in	in	ADP
ct-11250	21	30	postpartum	postpartum	NOUN
ct-11250	21	31	mares	mare	NOUN
ct-11250	21	32	to	to	PART
ct-11250	21	33	delay	delay	VERB
ct-11250	21	34	estrus	estrus	NOUN
ct-11250	21	35	/	/	SYM
ct-11250	21	36	ovulation	ovulation	NOUN
ct-11250	21	37	in	in	ADP
ct-11250	21	38	an	an	DET
ct-11250	21	39	effort	effort	NOUN
ct-11250	21	40	to	to	PART
ct-11250	21	41	enhance	enhance	VERB
ct-11250	21	42	the	the	DET
ct-11250	21	43	fertility	fertility	NOUN
ct-11250	21	44	of	of	ADP
ct-11250	21	45	foal	foal	NOUN
ct-11250	21	46	-	-	PUNCT
ct-11250	21	47	heat	heat	NOUN
ct-11250	21	48	breeding.10,11	breeding.10,11	NOUN
ct-11250	21	49	in	in	ADP
ct-11250	21	50	addition	addition	NOUN
ct-11250	21	51	to	to	ADP
ct-11250	21	52	its	its	PRON
ct-11250	21	53	use	use	NOUN
ct-11250	21	54	in	in	ADP
ct-11250	21	55	mares	mare	NOUN
ct-11250	21	56	,	,	PUNCT
ct-11250	21	57	altrenogest	altrenog	ADJ
ct-11250	21	58	has	have	AUX
ct-11250	21	59	also	also	ADV
ct-11250	21	60	been	be	AUX
ct-11250	21	61	administered	administer	VERB
ct-11250	21	62	to	to	ADP
ct-11250	21	63	stallions	stallion	NOUN
ct-11250	21	64	to	to	PART
ct-11250	21	65	temporarily	temporarily	ADV
ct-11250	21	66	suppress	suppress	VERB
ct-11250	21	67	sexual	sexual	ADJ
ct-11250	21	68	and	and	CCONJ
ct-11250	21	69	aggressive	aggressive	ADJ
ct-11250	21	70	behavior	behavior	NOUN
ct-11250	21	71	during	during	ADP
ct-11250	21	72	training	training	NOUN
ct-11250	21	73	and	and	CCONJ
ct-11250	21	74	related	related	ADJ
ct-11250	21	75	performance	performance	NOUN
ct-11250	21	76	activities	activity	NOUN
ct-11250	21	77	.	.	PUNCT
ct-11250	22	1	oral	oral	ADJ
ct-11250	22	2	administration	administration	NOUN
ct-11250	22	3	of	of	ADP
ct-11250	22	4	twice	twice	DET
ct-11250	22	5	the	the	DET
ct-11250	22	6	labeled	label	VERB
ct-11250	22	7	dose	dose	NOUN
ct-11250	22	8	(	(	PUNCT
ct-11250	22	9	0.088	0.088	NUM
ct-11250	22	10	mg	mg	PROPN
ct-11250	22	11	/	/	SYM
ct-11250	22	12	kg	kg	NOUN
ct-11250	22	13	)	)	PUNCT
ct-11250	22	14	of	of	ADP
ct-11250	22	15	altrenogest	altrenogest	ADV
ct-11250	22	16	significantly	significantly	ADV
ct-11250	22	17	suppressed	suppress	VERB
ct-11250	22	18	reproductive	reproductive	ADJ
ct-11250	22	19	behavior	behavior	NOUN
ct-11250	22	20	in	in	ADP
ct-11250	22	21	stallions	stallion	NOUN
ct-11250	22	22	between	between	ADP
ct-11250	22	23	two	two	NUM
ct-11250	22	24	and	and	CCONJ
ct-11250	22	25	18	18	NUM
ct-11250	22	26	years	year	NOUN
ct-11250	22	27	of	of	ADP
ct-11250	22	28	age.12,13	age.12,13	PROPN
ct-11250	22	29	in	in	ADP
ct-11250	22	30	contrast	contrast	NOUN
ct-11250	22	31	,	,	PUNCT
ct-11250	22	32	oral	oral	ADJ
ct-11250	22	33	altrenogest	altrenog	ADJ
ct-11250	22	34	treatment	treatment	NOUN
ct-11250	22	35	at	at	ADP
ct-11250	22	36	the	the	DET
ct-11250	22	37	labeled	label	VERB
ct-11250	22	38	dose	dose	NOUN
ct-11250	22	39	(	(	PUNCT
ct-11250	22	40	0.044	0.044	NUM
ct-11250	22	41	mg	mg	PROPN
ct-11250	22	42	/	/	SYM
ct-11250	22	43	kg	kg	PROPN
ct-11250	22	44	)	)	PUNCT
ct-11250	22	45	had	have	VERB
ct-11250	22	46	only	only	ADV
ct-11250	22	47	a	a	DET
ct-11250	22	48	slight	slight	ADJ
ct-11250	22	49	effect	effect	NOUN
ct-11250	22	50	on	on	ADP
ct-11250	22	51	reproductive	reproductive	ADJ
ct-11250	22	52	behavior	behavior	NOUN
ct-11250	22	53	in	in	ADP
ct-11250	22	54	mature	mature	ADJ
ct-11250	22	55	stallions	stallion	NOUN
ct-11250	22	56	greater	great	ADJ
ct-11250	22	57	than	than	ADP
ct-11250	22	58	five	five	NUM
ct-11250	22	59	years	year	NOUN
ct-11250	22	60	of	of	ADP
ct-11250	22	61	age.14	age.14	NOUN
ct-11250	22	62	it	it	PRON
ct-11250	22	63	should	should	AUX
ct-11250	22	64	be	be	AUX
ct-11250	22	65	noted	note	VERB
ct-11250	22	66	however	however	ADV
ct-11250	22	67	,	,	PUNCT
ct-11250	22	68	that	that	SCONJ
ct-11250	22	69	in	in	ADP
ct-11250	22	70	the	the	DET
ct-11250	22	71	later	later	ADJ
ct-11250	22	72	study	study	NOUN
ct-11250	22	73	the	the	DET
ct-11250	22	74	altrenogest	altrenogest	NOUN
ct-11250	22	75	was	be	AUX
ct-11250	22	76	administered	administer	VERB
ct-11250	22	77	for	for	ADP
ct-11250	22	78	only	only	ADV
ct-11250	22	79	30	30	NUM
ct-11250	22	80	days,14	days,14	ADV
ct-11250	22	81	whereas	whereas	SCONJ
ct-11250	22	82	it	it	PRON
ct-11250	22	83	was	be	AUX
ct-11250	22	84	administered	administer	VERB
ct-11250	22	85	for	for	ADP
ct-11250	22	86	5713	5713	NUM
ct-11250	22	87	and	and	CCONJ
ct-11250	22	88	24012	24012	NUM
ct-11250	22	89	days	day	NOUN
ct-11250	22	90	in	in	ADP
ct-11250	22	91	the	the	DET
ct-11250	22	92	two	two	NUM
ct-11250	22	93	previously	previously	ADV
ct-11250	22	94	cited	cite	VERB
ct-11250	22	95	studies	study	NOUN
ct-11250	22	96	.	.	PUNCT
ct-11250	23	1	additionally	additionally	ADV
ct-11250	23	2	,	,	PUNCT
ct-11250	23	3	it	it	PRON
ct-11250	23	4	is	be	AUX
ct-11250	23	5	important	important	ADJ
ct-11250	23	6	to	to	PART
ct-11250	23	7	note	note	VERB
ct-11250	23	8	that	that	SCONJ
ct-11250	23	9	there	there	PRON
ct-11250	23	10	are	be	VERB
ct-11250	23	11	limited	limited	ADJ
ct-11250	23	12	data	datum	NOUN
ct-11250	23	13	on	on	ADP
ct-11250	23	14	the	the	DET
ct-11250	23	15	long	long	ADJ
ct-11250	23	16	-	-	PUNCT
ct-11250	23	17	term	term	NOUN
ct-11250	23	18	effects	effect	NOUN
ct-11250	23	19	of	of	ADP
ct-11250	23	20	this	this	DET
ct-11250	23	21	treatment	treatment	NOUN
ct-11250	23	22	on	on	ADP
ct-11250	23	23	future	future	ADJ
ct-11250	23	24	fertility	fertility	NOUN
ct-11250	23	25	in	in	ADP
ct-11250	23	26	stallions	stallion	NOUN
ct-11250	23	27	(	(	PUNCT
ct-11250	23	28	particularly	particularly	ADV
ct-11250	23	29	when	when	SCONJ
ct-11250	23	30	used	use	VERB
ct-11250	23	31	in	in	ADP
ct-11250	23	32	young	young	ADJ
ct-11250	23	33	stallions	stallion	NOUN
ct-11250	23	34	)	)	PUNCT
ct-11250	23	35	;	;	PUNCT
ct-11250	23	36	therefore	therefore	ADV
ct-11250	23	37	,	,	PUNCT
ct-11250	23	38	the	the	DET
ct-11250	23	39	use	use	NOUN
ct-11250	23	40	of	of	ADP
ct-11250	23	41	exogenous	exogenous	ADJ
ct-11250	23	42	altrenogest	altrenogest	NOUN
ct-11250	23	43	in	in	ADP
ct-11250	23	44	stallions	stallion	NOUN
ct-11250	23	45	that	that	PRON
ct-11250	23	46	will	will	AUX
ct-11250	23	47	subsequently	subsequently	ADV
ct-11250	23	48	be	be	AUX
ct-11250	23	49	used	use	VERB
ct-11250	23	50	for	for	ADP
ct-11250	23	51	breeding	breeding	NOUN
ct-11250	23	52	should	should	AUX
ct-11250	23	53	be	be	AUX
ct-11250	23	54	pursued	pursue	VERB
ct-11250	23	55	very	very	ADV
ct-11250	23	56	cautiously	cautiously	ADV
ct-11250	23	57	.	.	PUNCT
ct-11250	24	1	exogenous	exogenous	ADJ
ct-11250	24	2	progesterone	progesterone	NOUN
ct-11250	24	3	has	have	AUX
ct-11250	24	4	also	also	ADV
ct-11250	24	5	been	be	AUX
ct-11250	24	6	used	use	VERB
ct-11250	24	7	empirically	empirically	ADV
ct-11250	24	8	to	to	PART
ct-11250	24	9	treat	treat	VERB
ct-11250	24	10	selfmutilation	selfmutilation	NOUN
ct-11250	24	11	behavior	behavior	NOUN
ct-11250	24	12	in	in	ADP
ct-11250	24	13	stallions	stallion	NOUN
ct-11250	24	14	and	and	CCONJ
ct-11250	24	15	geldings	gelding	NOUN
ct-11250	24	16	and	and	CCONJ
ct-11250	24	17	anecdotally	anecdotally	ADV
ct-11250	24	18	it	it	PRON
ct-11250	24	19	has	have	AUX
ct-11250	24	20	been	be	AUX
ct-11250	24	21	useful	useful	ADJ
ct-11250	24	22	in	in	ADP
ct-11250	24	23	some	some	PRON
ct-11250	24	24	of	of	ADP
ct-11250	24	25	these	these	DET
ct-11250	24	26	cases.15	cases.15	NOUN
ct-11250	24	27	it	it	PRON
ct-11250	24	28	is	be	AUX
ct-11250	24	29	important	important	ADJ
ct-11250	24	30	to	to	PART
ct-11250	24	31	diagnose	diagnose	VERB
ct-11250	24	32	the	the	DET
ct-11250	24	33	underlying	underlie	VERB
ct-11250	24	34	cause	cause	NOUN
ct-11250	24	35	of	of	ADP
ct-11250	24	36	the	the	DET
ct-11250	24	37	behavior	behavior	NOUN
ct-11250	24	38	in	in	ADP
ct-11250	24	39	these	these	DET
ct-11250	24	40	horses	horse	NOUN
ct-11250	24	41	before	before	ADP
ct-11250	24	42	initiating	initiate	VERB
ct-11250	24	43	treatment	treatment	NOUN
ct-11250	24	44	,	,	PUNCT
ct-11250	24	45	because	because	SCONJ
ct-11250	24	46	some	some	DET
ct-11250	24	47	root	root	NOUN
ct-11250	24	48	causes	cause	NOUN
ct-11250	24	49	will	will	AUX
ct-11250	24	50	not	not	PART
ct-11250	24	51	respond	respond	VERB
ct-11250	24	52	to	to	ADP
ct-11250	24	53	progesterone	progesterone	NOUN
ct-11250	24	54	therapy	therapy	NOUN
ct-11250	24	55	(	(	PUNCT
ct-11250	24	56	e.g.	e.g.	ADV
ct-11250	24	57	,	,	PUNCT
ct-11250	24	58	pain	pain	NOUN
ct-11250	24	59	-	-	PUNCT
ct-11250	24	60	induced	induce	VERB
ct-11250	24	61	self	self	NOUN
ct-11250	24	62	-	-	PUNCT
ct-11250	24	63	mutilation).15	mutilation).15	NOUN
ct-11250	24	64	although	although	SCONJ
ct-11250	24	65	exogenous	exogenous	ADJ
ct-11250	24	66	testosterone	testosterone	NOUN
ct-11250	24	67	and	and	CCONJ
ct-11250	24	68	related	relate	VERB
ct-11250	24	69	androgens	androgen	NOUN
ct-11250	24	70	are	be	AUX
ct-11250	24	71	not	not	PART
ct-11250	24	72	widely	widely	ADV
ct-11250	24	73	used	use	VERB
ct-11250	24	74	in	in	ADP
ct-11250	24	75	equine	equine	NOUN
ct-11250	24	76	reproduction	reproduction	NOUN
ct-11250	24	77	they	they	PRON
ct-11250	24	78	are	be	AUX
ct-11250	24	79	occasionally	occasionally	ADV
ct-11250	24	80	utilized	utilize	VERB
ct-11250	24	81	for	for	ADP
ct-11250	24	82	behavior	behavior	NOUN
ct-11250	24	83	/	/	SYM
ct-11250	24	84	libido	libido	ADJ
ct-11250	24	85	modification	modification	NOUN
ct-11250	24	86	in	in	ADP
ct-11250	24	87	stallions	stallion	NOUN
ct-11250	24	88	with	with	ADP
ct-11250	24	89	sub	sub	ADJ
ct-11250	24	90	-	-	ADJ
ct-11250	24	91	optimal	optimal	ADJ
ct-11250	24	92	clinical	clinical	ADJ
ct-11250	24	93	theriogenology	theriogenology	NOUN
ct-11250	25	1	•	•	NOUN
ct-11250	25	2	volume	volume	NOUN
ct-11250	25	3	3	3	NUM
ct-11250	25	4	number	number	NOUN
ct-11250	25	5	4	4	NUM
ct-11250	25	6	•	•	NOUN
ct-11250	25	7	december	december	PROPN
ct-11250	25	8	2011clinical	2011clinical	ADJ
ct-11250	25	9	theriogenology	theriogenology	NOUN
ct-11250	25	10	•	•	NOUN
ct-11250	25	11	volume	volume	NOUN
ct-11250	25	12	4	4	NUM
ct-11250	25	13	number	number	NOUN
ct-11250	25	14	1	1	NUM
ct-11250	25	15	•	•	NUM
ct-11250	25	16	march	march	PROPN
ct-11250	25	17	2012	2012	NUM
ct-11250	25	18	40clinical	40clinical	ADJ
ct-11250	25	19	theriogenology	theriogenology	NOUN
ct-11250	25	20	•	•	NOUN
ct-11250	25	21	volume	volume	NOUN
ct-11250	25	22	4	4	NUM
ct-11250	25	23	number	number	NOUN
ct-11250	25	24	1	1	NUM
ct-11250	25	25	•	•	NUM
ct-11250	25	26	march	march	PROPN
ct-11250	25	27	2012	2012	NUM
ct-11250	25	28	endogenous	endogenous	ADJ
ct-11250	25	29	androgen	androgen	NOUN
ct-11250	25	30	levels	level	NOUN
ct-11250	25	31	(	(	PUNCT
ct-11250	25	32	table	table	NOUN
ct-11250	25	33	1).16	1).16	PROPN
ct-11250	25	34	compounded	compound	VERB
ct-11250	25	35	injectable	injectable	ADJ
ct-11250	25	36	preparations	preparation	NOUN
ct-11250	25	37	of	of	ADP
ct-11250	25	38	testosterone	testosterone	NOUN
ct-11250	25	39	or	or	CCONJ
ct-11250	25	40	longacting	longacting	NOUN
ct-11250	25	41	testosterone	testosterone	NOUN
ct-11250	25	42	conjugates	conjugate	NOUN
ct-11250	25	43	have	have	AUX
ct-11250	25	44	been	be	AUX
ct-11250	25	45	used	use	VERB
ct-11250	25	46	for	for	ADP
ct-11250	25	47	this	this	DET
ct-11250	25	48	purpose	purpose	NOUN
ct-11250	25	49	,	,	PUNCT
ct-11250	25	50	and	and	CCONJ
ct-11250	25	51	more	more	ADV
ct-11250	25	52	recently	recently	ADV
ct-11250	25	53	transdermal	transdermal	ADJ
ct-11250	25	54	delivery	delivery	NOUN
ct-11250	25	55	has	have	AUX
ct-11250	25	56	been	be	AUX
ct-11250	25	57	used	use	VERB
ct-11250	25	58	by	by	ADP
ct-11250	25	59	applying	apply	VERB
ct-11250	25	60	testosterone	testosterone	NOUN
ct-11250	25	61	in	in	ADP
ct-11250	25	62	oil	oil	NOUN
ct-11250	25	63	to	to	ADP
ct-11250	25	64	hairless	hairless	ADJ
ct-11250	25	65	skin	skin	NOUN
ct-11250	25	66	in	in	ADP
ct-11250	25	67	the	the	DET
ct-11250	25	68	perineum	perineum	NOUN
ct-11250	25	69	or	or	CCONJ
ct-11250	25	70	directly	directly	ADV
ct-11250	25	71	on	on	ADP
ct-11250	25	72	the	the	DET
ct-11250	25	73	shaft	shaft	NOUN
ct-11250	25	74	of	of	ADP
ct-11250	25	75	the	the	DET
ct-11250	25	76	penis.16	penis.16	PROPN
ct-11250	25	77	when	when	SCONJ
ct-11250	25	78	exogenous	exogenous	ADJ
ct-11250	25	79	testosterone	testosterone	NOUN
ct-11250	25	80	is	be	AUX
ct-11250	25	81	used	use	VERB
ct-11250	25	82	in	in	ADP
ct-11250	25	83	stallions	stallion	NOUN
ct-11250	25	84	it	it	PRON
ct-11250	25	85	is	be	AUX
ct-11250	25	86	important	important	ADJ
ct-11250	25	87	to	to	PART
ct-11250	25	88	monitor	monitor	VERB
ct-11250	25	89	preand	preand	NOUN
ct-11250	25	90	posttreatment	posttreatment	NOUN
ct-11250	25	91	androgen	androgen	NOUN
ct-11250	25	92	levels	level	NOUN
ct-11250	25	93	in	in	ADP
ct-11250	25	94	order	order	NOUN
ct-11250	25	95	to	to	PART
ct-11250	25	96	avoid	avoid	VERB
ct-11250	25	97	an	an	DET
ct-11250	25	98	excessive	excessive	ADJ
ct-11250	25	99	negative	negative	ADJ
ct-11250	25	100	feedback	feedback	NOUN
ct-11250	25	101	effect	effect	NOUN
ct-11250	25	102	of	of	ADP
ct-11250	25	103	the	the	DET
ct-11250	25	104	exogenous	exogenous	ADJ
ct-11250	25	105	testosterone	testosterone	NOUN
ct-11250	25	106	and	and	CCONJ
ct-11250	25	107	a	a	DET
ct-11250	25	108	subsequent	subsequent	ADJ
ct-11250	25	109	down	down	NOUN
ct-11250	25	110	-	-	PUNCT
ct-11250	25	111	regulation	regulation	NOUN
ct-11250	25	112	of	of	ADP
ct-11250	25	113	the	the	DET
ct-11250	25	114	hypothalamic	hypothalamic	ADJ
ct-11250	25	115	-	-	PUNCT
ct-11250	25	116	pituitary	pituitary	ADJ
ct-11250	25	117	-	-	PUNCT
ct-11250	25	118	testicular	testicular	NOUN
ct-11250	25	119	axis	axis	NOUN
ct-11250	25	120	.	.	PUNCT
ct-11250	26	1	prostaglandin	prostaglandin	VERB
ct-11250	26	2	f2α	f2α	PROPN
ct-11250	26	3	(	(	PUNCT
ct-11250	26	4	pgf2α	pgf2α	X
ct-11250	26	5	)	)	PUNCT
ct-11250	26	6	has	have	VERB
ct-11250	26	7	applications	application	NOUN
ct-11250	26	8	in	in	ADP
ct-11250	26	9	nonpregnant	nonpregnant	NOUN
ct-11250	26	10	and	and	CCONJ
ct-11250	26	11	pregnant	pregnant	ADJ
ct-11250	26	12	mares.17	mares.17	PROPN
ct-11250	26	13	two	two	NUM
ct-11250	26	14	formulations	formulation	NOUN
ct-11250	26	15	of	of	ADP
ct-11250	26	16	pgf2α	pgf2α	PROPN
ct-11250	26	17	are	be	AUX
ct-11250	26	18	currently	currently	ADV
ct-11250	26	19	available	available	ADJ
ct-11250	26	20	,	,	PUNCT
ct-11250	26	21	native	native	ADJ
ct-11250	26	22	pgf2α	pgf2α	PROPN
ct-11250	26	23	(	(	PUNCT
ct-11250	26	24	dinoprost	dinoprost	PROPN
ct-11250	26	25	tromethamine	tromethamine	PROPN
ct-11250	26	26	)	)	PUNCT
ct-11250	26	27	or	or	CCONJ
ct-11250	26	28	the	the	DET
ct-11250	26	29	synthetic	synthetic	ADJ
ct-11250	26	30	analog	analog	NOUN
ct-11250	26	31	cloprostenol	cloprostenol	NOUN
ct-11250	26	32	(	(	PUNCT
ct-11250	26	33	table	table	NOUN
ct-11250	26	34	1	1	NUM
ct-11250	26	35	)	)	PUNCT
ct-11250	26	36	.	.	PUNCT
ct-11250	27	1	the	the	DET
ct-11250	27	2	most	most	ADV
ct-11250	27	3	common	common	ADJ
ct-11250	27	4	use	use	NOUN
ct-11250	27	5	of	of	ADP
ct-11250	27	6	pgf2α	pgf2α	PROPN
ct-11250	27	7	in	in	ADP
ct-11250	27	8	nonpregnant	nonpregnant	ADJ
ct-11250	27	9	mares	mare	NOUN
ct-11250	27	10	is	be	AUX
ct-11250	27	11	to	to	PART
ct-11250	27	12	induce	induce	VERB
ct-11250	27	13	luteolysis	luteolysis	NOUN
ct-11250	27	14	in	in	ADP
ct-11250	27	15	order	order	NOUN
ct-11250	27	16	to	to	PART
ct-11250	27	17	terminate	terminate	VERB
ct-11250	27	18	corpus	corpus	PROPN
ct-11250	27	19	luteum	luteum	NOUN
ct-11250	27	20	(	(	PUNCT
ct-11250	27	21	cl	cl	NOUN
ct-11250	27	22	)	)	PUNCT
ct-11250	27	23	function	function	NOUN
ct-11250	27	24	and	and	CCONJ
ct-11250	27	25	bring	bring	VERB
ct-11250	27	26	mares	mare	NOUN
ct-11250	27	27	into	into	ADP
ct-11250	27	28	heat	heat	NOUN
ct-11250	27	29	.	.	PUNCT
ct-11250	28	1	more	more	ADV
ct-11250	28	2	specifically	specifically	ADV
ct-11250	28	3	,	,	PUNCT
ct-11250	28	4	pgf2α	pgf2α	PROPN
ct-11250	28	5	can	can	AUX
ct-11250	28	6	be	be	AUX
ct-11250	28	7	used	use	VERB
ct-11250	28	8	to	to	PART
ct-11250	28	9	abbreviate	abbreviate	VERB
ct-11250	28	10	the	the	DET
ct-11250	28	11	normal	normal	ADJ
ct-11250	28	12	luteal	luteal	ADJ
ct-11250	28	13	phase	phase	NOUN
ct-11250	28	14	to	to	ADP
ct-11250	28	15	“	"	PUNCT
ct-11250	28	16	short	short	ADJ
ct-11250	28	17	-	-	PUNCT
ct-11250	28	18	cycle	cycle	NOUN
ct-11250	28	19	”	"	PUNCT
ct-11250	28	20	mares	mare	NOUN
ct-11250	28	21	or	or	CCONJ
ct-11250	28	22	it	it	PRON
ct-11250	28	23	can	can	AUX
ct-11250	28	24	be	be	AUX
ct-11250	28	25	used	use	VERB
ct-11250	28	26	to	to	PART
ct-11250	28	27	interrupt	interrupt	VERB
ct-11250	28	28	an	an	DET
ct-11250	28	29	abnormally	abnormally	ADV
ct-11250	28	30	prolonged	prolong	VERB
ct-11250	28	31	luteal	luteal	ADJ
ct-11250	28	32	phase	phase	NOUN
ct-11250	28	33	in	in	ADP
ct-11250	28	34	order	order	NOUN
ct-11250	28	35	to	to	PART
ct-11250	28	36	restore	restore	VERB
ct-11250	28	37	normal	normal	ADJ
ct-11250	28	38	cyclical	cyclical	ADJ
ct-11250	28	39	ovarian	ovarian	ADJ
ct-11250	28	40	activity	activity	NOUN
ct-11250	28	41	.	.	PUNCT
ct-11250	29	1	although	although	SCONJ
ct-11250	29	2	administration	administration	NOUN
ct-11250	29	3	of	of	ADP
ct-11250	29	4	two	two	NUM
ct-11250	29	5	doses	dose	NOUN
ct-11250	29	6	of	of	ADP
ct-11250	29	7	pgf2α	pgf2α	PROPN
ct-11250	29	8	14	14	NUM
ct-11250	29	9	days	day	NOUN
ct-11250	29	10	apart	apart	ADV
ct-11250	29	11	has	have	AUX
ct-11250	29	12	been	be	AUX
ct-11250	29	13	used	use	VERB
ct-11250	29	14	to	to	PART
ct-11250	29	15	synchronize	synchronize	VERB
ct-11250	29	16	estrus	estrus	NOUN
ct-11250	29	17	/	/	SYM
ct-11250	29	18	ovulation	ovulation	NOUN
ct-11250	29	19	,	,	PUNCT
ct-11250	29	20	it	it	PRON
ct-11250	29	21	is	be	AUX
ct-11250	29	22	not	not	PART
ct-11250	29	23	a	a	DET
ct-11250	29	24	very	very	ADV
ct-11250	29	25	reliable	reliable	ADJ
ct-11250	29	26	way	way	NOUN
ct-11250	29	27	of	of	ADP
ct-11250	29	28	achieving	achieve	VERB
ct-11250	29	29	that	that	DET
ct-11250	29	30	goal	goal	NOUN
ct-11250	29	31	in	in	ADP
ct-11250	29	32	mares	mare	NOUN
ct-11250	29	33	,	,	PUNCT
ct-11250	29	34	so	so	ADV
ct-11250	29	35	more	more	ADV
ct-11250	29	36	efficacious	efficacious	ADJ
ct-11250	29	37	methods	method	NOUN
ct-11250	29	38	of	of	ADP
ct-11250	29	39	estrus	estrus	NOUN
ct-11250	29	40	/	/	SYM
ct-11250	29	41	ovulation	ovulation	NOUN
ct-11250	29	42	synchronization	synchronization	NOUN
ct-11250	29	43	are	be	AUX
ct-11250	29	44	used	use	VERB
ct-11250	29	45	(	(	PUNCT
ct-11250	29	46	e.g.	e.g.	ADV
ct-11250	29	47	,	,	PUNCT
ct-11250	29	48	treatment	treatment	NOUN
ct-11250	29	49	with	with	ADP
ct-11250	29	50	progesterone	progesterone	NOUN
ct-11250	29	51	and	and	CCONJ
ct-11250	29	52	estradiol-17β	estradiol-17β	PROPN
ct-11250	29	53	)	)	PUNCT
ct-11250	29	54	,	,	PUNCT
ct-11250	29	55	which	which	PRON
ct-11250	29	56	incorporate	incorporate	VERB
ct-11250	29	57	a	a	DET
ct-11250	29	58	single	single	ADJ
ct-11250	29	59	pgf2α	pgf2α	NOUN
ct-11250	29	60	treatment	treatment	NOUN
ct-11250	29	61	to	to	PART
ct-11250	29	62	eliminate	eliminate	VERB
ct-11250	29	63	endogenous	endogenous	ADJ
ct-11250	29	64	progesterone	progesterone	NOUN
ct-11250	29	65	secretion	secretion	NOUN
ct-11250	29	66	from	from	ADP
ct-11250	29	67	a	a	DET
ct-11250	29	68	cl	cl	NOUN
ct-11250	29	69	.	.	PUNCT
ct-11250	30	1	prostaglandin	prostaglandin	NOUN
ct-11250	30	2	f2α	f2α	PRON
ct-11250	30	3	is	be	AUX
ct-11250	30	4	also	also	ADV
ct-11250	30	5	used	use	VERB
ct-11250	30	6	in	in	ADP
ct-11250	30	7	nonpregnant	nonpregnant	ADJ
ct-11250	30	8	mares	mare	NOUN
ct-11250	30	9	for	for	ADP
ct-11250	30	10	its	its	PRON
ct-11250	30	11	ecbolic	ecbolic	ADJ
ct-11250	30	12	effect	effect	NOUN
ct-11250	30	13	to	to	PART
ct-11250	30	14	stimulate	stimulate	VERB
ct-11250	30	15	uterine	uterine	ADJ
ct-11250	30	16	contractile	contractile	NOUN
ct-11250	30	17	activity	activity	NOUN
ct-11250	30	18	for	for	ADP
ct-11250	30	19	the	the	DET
ct-11250	30	20	treatment	treatment	NOUN
ct-11250	30	21	of	of	ADP
ct-11250	30	22	uterine	uterine	ADJ
ct-11250	30	23	fluid	fluid	ADJ
ct-11250	30	24	accumulation	accumulation	NOUN
ct-11250	30	25	associated	associate	VERB
ct-11250	30	26	with	with	ADP
ct-11250	30	27	pathological	pathological	ADJ
ct-11250	30	28	processes	process	NOUN
ct-11250	30	29	such	such	ADJ
ct-11250	30	30	as	as	ADP
ct-11250	30	31	persistent	persistent	ADJ
ct-11250	30	32	mating	mating	NOUN
ct-11250	30	33	-	-	PUNCT
ct-11250	30	34	induced	induce	VERB
ct-11250	30	35	endometritis	endometritis	NOUN
ct-11250	30	36	.	.	PUNCT
ct-11250	31	1	exogenous	exogenous	ADJ
ct-11250	31	2	pgf2α	pgf2α	PROPN
ct-11250	31	3	will	will	AUX
ct-11250	31	4	stimulate	stimulate	VERB
ct-11250	31	5	uterine	uterine	ADJ
ct-11250	31	6	contractile	contractile	NOUN
ct-11250	31	7	activity	activity	NOUN
ct-11250	31	8	for	for	ADP
ct-11250	31	9	a	a	DET
ct-11250	31	10	duration	duration	NOUN
ct-11250	31	11	of	of	ADP
ct-11250	31	12	four	four	NUM
ct-11250	31	13	to	to	PART
ct-11250	31	14	five	five	NUM
ct-11250	31	15	hours	hour	NOUN
ct-11250	31	16	,	,	PUNCT
ct-11250	31	17	with	with	ADP
ct-11250	31	18	cloprostenol	cloprostenol	NOUN
ct-11250	31	19	inducing	induce	VERB
ct-11250	31	20	a	a	DET
ct-11250	31	21	more	more	ADV
ct-11250	31	22	consistent	consistent	ADJ
ct-11250	31	23	response	response	NOUN
ct-11250	31	24	than	than	ADP
ct-11250	31	25	native	native	ADJ
ct-11250	31	26	pgf2α	pgf2α	PROPN
ct-11250	31	27	,	,	PUNCT
ct-11250	31	28	so	so	SCONJ
ct-11250	31	29	it	it	PRON
ct-11250	31	30	is	be	AUX
ct-11250	31	31	the	the	DET
ct-11250	31	32	agent	agent	NOUN
ct-11250	31	33	of	of	ADP
ct-11250	31	34	choice	choice	NOUN
ct-11250	31	35	for	for	ADP
ct-11250	31	36	this	this	PRON
ct-11250	31	37	application.17	application.17	NOUN
ct-11250	31	38	it	it	PRON
ct-11250	31	39	is	be	AUX
ct-11250	31	40	important	important	ADJ
ct-11250	31	41	to	to	PART
ct-11250	31	42	note	note	VERB
ct-11250	31	43	,	,	PUNCT
ct-11250	31	44	that	that	SCONJ
ct-11250	31	45	although	although	SCONJ
ct-11250	31	46	historically	historically	ADV
ct-11250	31	47	the	the	DET
ct-11250	31	48	cl	cl	NOUN
ct-11250	31	49	has	have	AUX
ct-11250	31	50	been	be	AUX
ct-11250	31	51	considered	consider	VERB
ct-11250	31	52	to	to	PART
ct-11250	31	53	be	be	AUX
ct-11250	31	54	resistant	resistant	ADJ
ct-11250	31	55	to	to	ADP
ct-11250	31	56	the	the	DET
ct-11250	31	57	luteolytic	luteolytic	ADJ
ct-11250	31	58	effects	effect	NOUN
ct-11250	31	59	of	of	ADP
ct-11250	31	60	pgf2α	pgf2α	PROPN
ct-11250	31	61	until	until	ADP
ct-11250	31	62	day	day	NOUN
ct-11250	31	63	five	five	NUM
ct-11250	31	64	after	after	ADP
ct-11250	31	65	ovulation	ovulation	NOUN
ct-11250	31	66	,	,	PUNCT
ct-11250	31	67	it	it	PRON
ct-11250	31	68	has	have	AUX
ct-11250	31	69	been	be	AUX
ct-11250	31	70	demonstrated	demonstrate	VERB
ct-11250	31	71	that	that	SCONJ
ct-11250	31	72	cl	cl	NOUN
ct-11250	31	73	function	function	NOUN
ct-11250	31	74	is	be	AUX
ct-11250	31	75	altered	alter	VERB
ct-11250	31	76	following	follow	VERB
ct-11250	31	77	administration	administration	NOUN
ct-11250	31	78	of	of	ADP
ct-11250	31	79	pgf2α	pgf2α	PROPN
ct-11250	31	80	as	as	ADV
ct-11250	31	81	early	early	ADV
ct-11250	31	82	as	as	ADP
ct-11250	31	83	day	day	NOUN
ct-11250	31	84	two	two	NUM
ct-11250	31	85	after	after	ADP
ct-11250	31	86	ovulation.17	ovulation.17	PROPN
ct-11250	31	87	therefore	therefore	ADV
ct-11250	31	88	,	,	PUNCT
ct-11250	31	89	when	when	SCONJ
ct-11250	31	90	using	use	VERB
ct-11250	31	91	exogenous	exogenous	ADJ
ct-11250	31	92	pgf2α	pgf2α	PROPN
ct-11250	31	93	to	to	PART
ct-11250	31	94	treat	treat	VERB
ct-11250	31	95	mares	mare	NOUN
ct-11250	31	96	for	for	ADP
ct-11250	31	97	fluid	fluid	ADJ
ct-11250	31	98	accumulation	accumulation	NOUN
ct-11250	31	99	during	during	ADP
ct-11250	31	100	estrus	estrus	NOUN
ct-11250	31	101	,	,	PUNCT
ct-11250	31	102	treatment	treatment	NOUN
ct-11250	31	103	is	be	AUX
ct-11250	31	104	generally	generally	ADV
ct-11250	31	105	not	not	PART
ct-11250	31	106	continued	continue	VERB
ct-11250	31	107	beyond	beyond	ADP
ct-11250	31	108	the	the	DET
ct-11250	31	109	day	day	NOUN
ct-11250	31	110	of	of	ADP
ct-11250	31	111	ovulation	ovulation	NOUN
ct-11250	31	112	.	.	PUNCT
ct-11250	32	1	administration	administration	NOUN
ct-11250	32	2	of	of	ADP
ct-11250	32	3	pgf2α	pgf2α	PROPN
ct-11250	32	4	is	be	AUX
ct-11250	32	5	the	the	DET
ct-11250	32	6	preferred	preferred	ADJ
ct-11250	32	7	method	method	NOUN
ct-11250	32	8	of	of	ADP
ct-11250	32	9	terminating	terminate	VERB
ct-11250	32	10	pregnancy	pregnancy	NOUN
ct-11250	32	11	during	during	ADP
ct-11250	32	12	early	early	ADJ
ct-11250	32	13	gestation	gestation	NOUN
ct-11250	32	14	in	in	ADP
ct-11250	32	15	mares.17	mares.17	PROPN
ct-11250	32	16	prior	prior	ADV
ct-11250	32	17	to	to	ADP
ct-11250	32	18	approximately	approximately	ADV
ct-11250	32	19	30	30	NUM
ct-11250	32	20	to	to	PART
ct-11250	32	21	35	35	NUM
ct-11250	32	22	days	day	NOUN
ct-11250	32	23	of	of	ADP
ct-11250	32	24	gestation	gestation	NOUN
ct-11250	32	25	,	,	PUNCT
ct-11250	32	26	administration	administration	NOUN
ct-11250	32	27	of	of	ADP
ct-11250	32	28	a	a	DET
ct-11250	32	29	single	single	ADJ
ct-11250	32	30	dose	dose	NOUN
ct-11250	32	31	of	of	ADP
ct-11250	32	32	pgf2α	pgf2α	PROPN
ct-11250	32	33	is	be	AUX
ct-11250	32	34	reliably	reliably	ADV
ct-11250	32	35	abortifacient	abortifacient	ADJ
ct-11250	32	36	through	through	ADP
ct-11250	32	37	its	its	PRON
ct-11250	32	38	luteolytic	luteolytic	ADJ
ct-11250	32	39	effect	effect	NOUN
ct-11250	32	40	causing	cause	VERB
ct-11250	32	41	endogenous	endogenous	ADJ
ct-11250	32	42	progesterone	progesterone	NOUN
ct-11250	32	43	levels	level	NOUN
ct-11250	32	44	to	to	PART
ct-11250	32	45	fall	fall	VERB
ct-11250	32	46	below	below	ADP
ct-11250	32	47	the	the	DET
ct-11250	32	48	threshold	threshold	NOUN
ct-11250	32	49	necessary	necessary	ADJ
ct-11250	32	50	for	for	ADP
ct-11250	32	51	continued	continue	VERB
ct-11250	32	52	maintenance	maintenance	NOUN
ct-11250	32	53	of	of	ADP
ct-11250	32	54	pregnancy	pregnancy	NOUN
ct-11250	32	55	.	.	PUNCT
ct-11250	33	1	after	after	ADP
ct-11250	33	2	35	35	NUM
ct-11250	33	3	days	day	NOUN
ct-11250	33	4	of	of	ADP
ct-11250	33	5	gestation	gestation	NOUN
ct-11250	33	6	,	,	PUNCT
ct-11250	33	7	coincident	coincident	ADJ
ct-11250	33	8	with	with	ADP
ct-11250	33	9	formation	formation	NOUN
ct-11250	33	10	of	of	ADP
ct-11250	33	11	the	the	DET
ct-11250	33	12	endometrial	endometrial	ADJ
ct-11250	33	13	cups	cup	NOUN
ct-11250	33	14	and	and	CCONJ
ct-11250	33	15	secretion	secretion	NOUN
ct-11250	33	16	of	of	ADP
ct-11250	33	17	equine	equine	NOUN
ct-11250	33	18	chorionic	chorionic	ADJ
ct-11250	33	19	gonadotropin	gonadotropin	NOUN
ct-11250	33	20	(	(	PUNCT
ct-11250	33	21	ecg	ecg	PROPN
ct-11250	33	22	)	)	PUNCT
ct-11250	33	23	that	that	PRON
ct-11250	33	24	induces	induce	VERB
ct-11250	33	25	supplemental	supplemental	ADJ
ct-11250	33	26	cl	cl	NOUN
ct-11250	33	27	formation	formation	NOUN
ct-11250	33	28	,	,	PUNCT
ct-11250	33	29	multiple	multiple	ADJ
ct-11250	33	30	pgf2α	pgf2α	NOUN
ct-11250	33	31	treatments	treatment	NOUN
ct-11250	33	32	may	may	AUX
ct-11250	33	33	be	be	AUX
ct-11250	33	34	necessary	necessary	ADJ
ct-11250	33	35	to	to	PART
ct-11250	33	36	induce	induce	VERB
ct-11250	33	37	abortion	abortion	NOUN
ct-11250	33	38	.	.	PUNCT
ct-11250	34	1	after	after	SCONJ
ct-11250	34	2	fetal	fetal	ADJ
ct-11250	34	3	-	-	PUNCT
ct-11250	34	4	placental	placental	NOUN
ct-11250	34	5	production	production	NOUN
ct-11250	34	6	of	of	ADP
ct-11250	34	7	progesterone	progesterone	NOUN
ct-11250	34	8	/	/	SYM
ct-11250	34	9	progestins	progestin	NOUN
ct-11250	34	10	becomes	become	VERB
ct-11250	34	11	sufficient	sufficient	ADJ
ct-11250	34	12	to	to	PART
ct-11250	34	13	maintain	maintain	VERB
ct-11250	34	14	pregnancy	pregnancy	NOUN
ct-11250	34	15	without	without	ADP
ct-11250	34	16	an	an	DET
ct-11250	34	17	ovarian	ovarian	ADJ
ct-11250	34	18	/	/	SYM
ct-11250	34	19	cl	cl	NOUN
ct-11250	34	20	source	source	NOUN
ct-11250	34	21	of	of	ADP
ct-11250	34	22	progesterone	progesterone	NOUN
ct-11250	34	23	(	(	PUNCT
ct-11250	34	24	>	>	NOUN
ct-11250	34	25	100	100	NUM
ct-11250	34	26	days	day	NOUN
ct-11250	34	27	of	of	ADP
ct-11250	34	28	gestation	gestation	NOUN
ct-11250	34	29	)	)	PUNCT
ct-11250	34	30	,	,	PUNCT
ct-11250	34	31	pgf2α	pgf2α	PROPN
ct-11250	34	32	can	can	AUX
ct-11250	34	33	still	still	ADV
ct-11250	34	34	be	be	AUX
ct-11250	34	35	used	use	VERB
ct-11250	34	36	to	to	PART
ct-11250	34	37	induce	induce	VERB
ct-11250	34	38	abortion	abortion	NOUN
ct-11250	34	39	in	in	ADP
ct-11250	34	40	mares	mare	NOUN
ct-11250	34	41	,	,	PUNCT
ct-11250	34	42	however	however	ADV
ct-11250	34	43	multiple	multiple	ADJ
ct-11250	34	44	treatments	treatment	NOUN
ct-11250	34	45	will	will	AUX
ct-11250	34	46	be	be	AUX
ct-11250	34	47	required	require	VERB
ct-11250	34	48	over	over	ADP
ct-11250	34	49	the	the	DET
ct-11250	34	50	course	course	NOUN
ct-11250	34	51	of	of	ADP
ct-11250	34	52	several	several	ADJ
ct-11250	34	53	days	day	NOUN
ct-11250	34	54	.	.	PUNCT
ct-11250	35	1	although	although	SCONJ
ct-11250	35	2	they	they	PRON
ct-11250	35	3	are	be	AUX
ct-11250	35	4	not	not	PART
ct-11250	35	5	used	use	VERB
ct-11250	35	6	nearly	nearly	ADV
ct-11250	35	7	as	as	ADV
ct-11250	35	8	extensively	extensively	ADV
ct-11250	35	9	as	as	ADP
ct-11250	35	10	pgf2α	pgf2α	NOUN
ct-11250	35	11	,	,	PUNCT
ct-11250	35	12	prostaglandins	prostaglandin	NOUN
ct-11250	35	13	e1	e1	PROPN
ct-11250	35	14	(	(	PUNCT
ct-11250	35	15	pge1	pge1	PROPN
ct-11250	35	16	)	)	PUNCT
ct-11250	35	17	and	and	CCONJ
ct-11250	35	18	e2	e2	PROPN
ct-11250	35	19	(	(	PUNCT
ct-11250	35	20	pge2	pge2	PROPN
ct-11250	35	21	)	)	PUNCT
ct-11250	35	22	do	do	AUX
ct-11250	35	23	have	have	VERB
ct-11250	35	24	therapeutic	therapeutic	ADJ
ct-11250	35	25	applications	application	NOUN
ct-11250	35	26	in	in	ADP
ct-11250	35	27	nonpregnant	nonpregnant	NOUN
ct-11250	35	28	and	and	CCONJ
ct-11250	35	29	pregnant	pregnant	ADJ
ct-11250	35	30	mares	mare	NOUN
ct-11250	35	31	(	(	PUNCT
ct-11250	35	32	table	table	NOUN
ct-11250	35	33	1).17	1).17	NUM
ct-11250	35	34	topical	topical	ADJ
ct-11250	35	35	application	application	NOUN
ct-11250	35	36	of	of	ADP
ct-11250	35	37	1.0	1.0	NUM
ct-11250	35	38	mg	mg	PROPN
ct-11250	35	39	pge1	pge1	PROPN
ct-11250	35	40	cream	cream	NOUN
ct-11250	35	41	to	to	ADP
ct-11250	35	42	the	the	DET
ct-11250	35	43	caudal	caudal	NOUN
ct-11250	35	44	cervical	cervical	ADJ
ct-11250	35	45	os	os	NOUN
ct-11250	35	46	and	and	CCONJ
ct-11250	35	47	lumen	luman	NOUN
ct-11250	35	48	has	have	AUX
ct-11250	35	49	been	be	AUX
ct-11250	35	50	used	use	VERB
ct-11250	35	51	to	to	PART
ct-11250	35	52	induce	induce	VERB
ct-11250	35	53	cervical	cervical	ADJ
ct-11250	35	54	relaxation	relaxation	NOUN
ct-11250	35	55	to	to	PART
ct-11250	35	56	aid	aid	VERB
ct-11250	35	57	uterine	uterine	ADJ
ct-11250	35	58	fluid	fluid	NOUN
ct-11250	35	59	evacuation	evacuation	NOUN
ct-11250	35	60	after	after	ADP
ct-11250	35	61	breeding	breed	VERB
ct-11250	35	62	in	in	ADP
ct-11250	35	63	mares	mare	NOUN
ct-11250	35	64	in	in	ADP
ct-11250	35	65	which	which	PRON
ct-11250	35	66	the	the	DET
ct-11250	35	67	cervix	cervix	NOUN
ct-11250	35	68	fails	fail	VERB
ct-11250	35	69	to	to	PART
ct-11250	35	70	relax	relax	VERB
ct-11250	35	71	during	during	ADP
ct-11250	35	72	estrus.18	estrus.18	PROPN
ct-11250	35	73	similarly	similarly	ADV
ct-11250	35	74	,	,	PUNCT
ct-11250	35	75	local	local	ADJ
ct-11250	35	76	application	application	NOUN
ct-11250	35	77	of	of	ADP
ct-11250	35	78	2.0	2.0	NUM
ct-11250	35	79	to	to	PART
ct-11250	35	80	2.5	2.5	NUM
ct-11250	35	81	mg	mg	PROPN
ct-11250	35	82	pge2	pge2	NOUN
ct-11250	35	83	into	into	ADP
ct-11250	35	84	the	the	DET
ct-11250	35	85	cervical	cervical	ADJ
ct-11250	35	86	canal	canal	NOUN
ct-11250	35	87	has	have	AUX
ct-11250	35	88	been	be	AUX
ct-11250	35	89	performed	perform	VERB
ct-11250	35	90	to	to	PART
ct-11250	35	91	aid	aid	VERB
ct-11250	35	92	cervical	cervical	ADJ
ct-11250	35	93	relaxation	relaxation	NOUN
ct-11250	35	94	(	(	PUNCT
ct-11250	35	95	i.e.	i.e.	X
ct-11250	35	96	,	,	PUNCT
ct-11250	35	97	“	"	PUNCT
ct-11250	35	98	cervical	cervical	ADJ
ct-11250	35	99	ripening	ripening	NOUN
ct-11250	35	100	”	"	PUNCT
ct-11250	35	101	)	)	PUNCT
ct-11250	35	102	prior	prior	ADV
ct-11250	35	103	to	to	ADP
ct-11250	35	104	induction	induction	NOUN
ct-11250	35	105	of	of	ADP
ct-11250	35	106	parturition.19	parturition.19	NOUN
ct-11250	35	107	cervical	cervical	ADJ
ct-11250	35	108	ripening	ripening	NOUN
ct-11250	35	109	with	with	ADP
ct-11250	35	110	pge2	pge2	NOUN
ct-11250	35	111	appeared	appear	VERB
ct-11250	35	112	to	to	PART
ct-11250	35	113	favor	favor	VERB
ct-11250	35	114	shorter	short	ADJ
ct-11250	35	115	delivery	delivery	NOUN
ct-11250	35	116	times	time	NOUN
ct-11250	35	117	and	and	CCONJ
ct-11250	35	118	foal	foal	NOUN
ct-11250	35	119	vigor	vigor	NOUN
ct-11250	35	120	,	,	PUNCT
ct-11250	35	121	although	although	SCONJ
ct-11250	35	122	the	the	DET
ct-11250	35	123	number	number	NOUN
ct-11250	35	124	of	of	ADP
ct-11250	35	125	mares	mare	NOUN
ct-11250	35	126	in	in	ADP
ct-11250	35	127	the	the	DET
ct-11250	35	128	study	study	NOUN
ct-11250	35	129	was	be	AUX
ct-11250	35	130	small	small	ADJ
ct-11250	35	131	and	and	CCONJ
ct-11250	35	132	most	most	ADJ
ct-11250	35	133	of	of	ADP
ct-11250	35	134	the	the	DET
ct-11250	35	135	end	end	NOUN
ct-11250	35	136	points	point	NOUN
ct-11250	35	137	that	that	PRON
ct-11250	35	138	were	be	AUX
ct-11250	35	139	compared	compare	VERB
ct-11250	35	140	between	between	ADP
ct-11250	35	141	control	control	NOUN
ct-11250	35	142	and	and	CCONJ
ct-11250	35	143	pge2	pge2	NOUN
ct-11250	35	144	-	-	PUNCT
ct-11250	35	145	treated	treat	VERB
ct-11250	35	146	mares	mare	NOUN
ct-11250	35	147	were	be	AUX
ct-11250	35	148	not	not	PART
ct-11250	35	149	significantly	significantly	ADV
ct-11250	35	150	different	different	ADJ
ct-11250	35	151	.	.	PUNCT
ct-11250	36	1	intrauterine	intrauterine	ADJ
ct-11250	36	2	deposition	deposition	NOUN
ct-11250	36	3	of	of	ADP
ct-11250	36	4	pge2	pge2	NOUN
ct-11250	36	5	prior	prior	ADV
ct-11250	36	6	to	to	ADP
ct-11250	36	7	insemination	insemination	NOUN
ct-11250	36	8	has	have	AUX
ct-11250	36	9	been	be	AUX
ct-11250	36	10	performed	perform	VERB
ct-11250	36	11	in	in	ADP
ct-11250	36	12	an	an	DET
ct-11250	36	13	attempt	attempt	NOUN
ct-11250	36	14	to	to	PART
ct-11250	36	15	enhance	enhance	VERB
ct-11250	36	16	pregnancy	pregnancy	NOUN
ct-11250	36	17	rates	rate	NOUN
ct-11250	36	18	by	by	ADP
ct-11250	36	19	increasing	increase	VERB
ct-11250	36	20	colonization	colonization	NOUN
ct-11250	36	21	of	of	ADP
ct-11250	36	22	the	the	DET
ct-11250	36	23	oviduct	oviduct	NOUN
ct-11250	36	24	by	by	ADP
ct-11250	36	25	fertile	fertile	ADJ
ct-11250	36	26	spermatozoa	spermatozoon	NOUN
ct-11250	36	27	.	.	PUNCT
ct-11250	37	1	the	the	DET
ct-11250	37	2	primary	primary	ADJ
ct-11250	37	3	interest	interest	NOUN
ct-11250	37	4	in	in	ADP
ct-11250	37	5	this	this	DET
ct-11250	37	6	treatment	treatment	NOUN
ct-11250	37	7	modality	modality	NOUN
ct-11250	37	8	is	be	AUX
ct-11250	37	9	for	for	ADP
ct-11250	37	10	situations	situation	NOUN
ct-11250	37	11	involving	involve	VERB
ct-11250	37	12	“	"	PUNCT
ct-11250	37	13	low	low	ADJ
ct-11250	37	14	-	-	PUNCT
ct-11250	37	15	dose	dose	NOUN
ct-11250	37	16	”	"	PUNCT
ct-11250	37	17	insemination	insemination	NOUN
ct-11250	37	18	with	with	ADP
ct-11250	37	19	a	a	DET
ct-11250	37	20	sub	sub	ADJ
ct-11250	37	21	-	-	ADJ
ct-11250	37	22	optimal	optimal	ADJ
ct-11250	37	23	number	number	NOUN
ct-11250	37	24	of	of	ADP
ct-11250	37	25	spermatozoa	spermatozoon	NOUN
ct-11250	37	26	.	.	PUNCT
ct-11250	38	1	in	in	ADP
ct-11250	38	2	an	an	DET
ct-11250	38	3	initial	initial	ADJ
ct-11250	38	4	report,20	report,20	ADJ
ct-11250	38	5	intrauterine	intrauterine	ADJ
ct-11250	38	6	deposition	deposition	NOUN
ct-11250	38	7	of	of	ADP
ct-11250	38	8	0.25	0.25	NUM
ct-11250	38	9	mg	mg	PROPN
ct-11250	38	10	pge2	pge2	PROPN
ct-11250	38	11	two	two	NUM
ct-11250	38	12	hours	hour	NOUN
ct-11250	38	13	prior	prior	ADV
ct-11250	38	14	to	to	ADP
ct-11250	38	15	insemination	insemination	NOUN
ct-11250	38	16	improved	improve	VERB
ct-11250	38	17	pregnancy	pregnancy	NOUN
ct-11250	38	18	rates	rate	NOUN
ct-11250	38	19	in	in	ADP
ct-11250	38	20	mares	mare	NOUN
ct-11250	38	21	inseminated	inseminate	VERB
ct-11250	38	22	with	with	ADP
ct-11250	38	23	a	a	DET
ct-11250	38	24	suboptimal	suboptimal	ADJ
ct-11250	38	25	number	number	NOUN
ct-11250	38	26	of	of	ADP
ct-11250	38	27	spermatozoa	spermatozoa	NOUN
ct-11250	38	28	from	from	ADP
ct-11250	38	29	a	a	DET
ct-11250	38	30	stallion	stallion	NOUN
ct-11250	38	31	with	with	ADP
ct-11250	38	32	good	good	ADJ
ct-11250	38	33	semen	semen	NOUN
ct-11250	38	34	quality	quality	NOUN
ct-11250	38	35	,	,	PUNCT
ct-11250	38	36	but	but	CCONJ
ct-11250	38	37	the	the	DET
ct-11250	38	38	same	same	ADJ
ct-11250	38	39	treatment	treatment	NOUN
ct-11250	38	40	did	do	AUX
ct-11250	38	41	not	not	PART
ct-11250	38	42	improve	improve	VERB
ct-11250	38	43	pregnancy	pregnancy	NOUN
ct-11250	38	44	rates	rate	NOUN
ct-11250	38	45	in	in	ADP
ct-11250	38	46	mares	mare	NOUN
ct-11250	38	47	inseminated	inseminate	VERB
ct-11250	38	48	with	with	ADP
ct-11250	38	49	a	a	DET
ct-11250	38	50	suboptimal	suboptimal	ADJ
ct-11250	38	51	number	number	NOUN
ct-11250	38	52	of	of	ADP
ct-11250	38	53	spermatozoa	spermatozoa	NOUN
ct-11250	38	54	from	from	ADP
ct-11250	38	55	a	a	DET
ct-11250	38	56	stallion	stallion	NOUN
ct-11250	38	57	with	with	ADP
ct-11250	38	58	poor	poor	ADJ
ct-11250	38	59	semen	semen	NOUN
ct-11250	38	60	quality	quality	NOUN
ct-11250	38	61	;	;	PUNCT
ct-11250	38	62	therefore	therefore	ADV
ct-11250	38	63	,	,	PUNCT
ct-11250	38	64	further	further	ADJ
ct-11250	38	65	studies	study	NOUN
ct-11250	38	66	are	be	AUX
ct-11250	38	67	needed	need	VERB
ct-11250	38	68	to	to	PART
ct-11250	38	69	more	more	ADV
ct-11250	38	70	fully	fully	ADV
ct-11250	38	71	assess	assess	VERB
ct-11250	38	72	the	the	DET
ct-11250	38	73	benefit	benefit	NOUN
ct-11250	38	74	(	(	PUNCT
ct-11250	38	75	if	if	SCONJ
ct-11250	38	76	any	any	PRON
ct-11250	38	77	)	)	PUNCT
ct-11250	38	78	of	of	ADP
ct-11250	38	79	intrauterine	intrauterine	ADJ
ct-11250	38	80	administration	administration	NOUN
ct-11250	38	81	of	of	ADP
ct-11250	38	82	pge2	pge2	PROPN
ct-11250	38	83	prior	prior	ADV
ct-11250	38	84	to	to	ADP
ct-11250	38	85	insemination	insemination	NOUN
ct-11250	38	86	with	with	ADP
ct-11250	38	87	a	a	DET
ct-11250	38	88	suboptimal	suboptimal	ADJ
ct-11250	38	89	number	number	NOUN
ct-11250	38	90	of	of	ADP
ct-11250	38	91	spermatozoa	spermatozoon	NOUN
ct-11250	38	92	.	.	PUNCT
ct-11250	39	1	there	there	PRON
ct-11250	39	2	is	be	VERB
ct-11250	39	3	clinical	clinical	ADJ
ct-11250	39	4	theriogenology	theriogenology	NOUN
ct-11250	39	5	•	•	NOUN
ct-11250	39	6	volume	volume	NOUN
ct-11250	39	7	3	3	NUM
ct-11250	39	8	number	number	NOUN
ct-11250	39	9	4	4	NUM
ct-11250	39	10	•	•	NOUN
ct-11250	39	11	december	december	PROPN
ct-11250	39	12	2011clinical	2011clinical	ADJ
ct-11250	39	13	theriogenology	theriogenology	NOUN
ct-11250	39	14	•	•	NOUN
ct-11250	39	15	volume	volume	NOUN
ct-11250	39	16	4	4	NUM
ct-11250	39	17	number	number	NOUN
ct-11250	39	18	1	1	NUM
ct-11250	39	19	•	•	NUM
ct-11250	39	20	march	march	PROPN
ct-11250	39	21	201241	201241	NUM
ct-11250	39	22	clinical	clinical	ADJ
ct-11250	39	23	theriogenology	theriogenology	NOUN
ct-11250	39	24	•	•	NOUN
ct-11250	39	25	volume	volume	NOUN
ct-11250	39	26	4	4	NUM
ct-11250	39	27	number	number	NOUN
ct-11250	39	28	1	1	NUM
ct-11250	39	29	•	•	NUM
ct-11250	39	30	march	march	PROPN
ct-11250	39	31	2012	2012	NUM
ct-11250	39	32	increasing	increase	VERB
ct-11250	39	33	interest	interest	NOUN
ct-11250	39	34	in	in	ADP
ct-11250	39	35	the	the	DET
ct-11250	39	36	use	use	NOUN
ct-11250	39	37	of	of	ADP
ct-11250	39	38	pge2	pge2	NOUN
ct-11250	39	39	to	to	PART
ct-11250	39	40	reestablish	reestablish	VERB
ct-11250	39	41	oviductal	oviductal	ADJ
ct-11250	39	42	patency	patency	NOUN
ct-11250	39	43	in	in	ADP
ct-11250	39	44	infertile	infertile	ADJ
ct-11250	39	45	mares	mare	NOUN
ct-11250	39	46	,	,	PUNCT
ct-11250	39	47	which	which	PRON
ct-11250	39	48	is	be	AUX
ct-11250	39	49	based	base	VERB
ct-11250	39	50	on	on	ADP
ct-11250	39	51	work	work	NOUN
ct-11250	39	52	by	by	ADP
ct-11250	39	53	allen	allen	PROPN
ct-11250	39	54	et	et	PROPN
ct-11250	40	1	al21	al21	PROPN
ct-11250	40	2	who	who	PRON
ct-11250	40	3	described	describe	VERB
ct-11250	40	4	laparoscopic	laparoscopic	NOUN
ct-11250	40	5	delivery	delivery	NOUN
ct-11250	40	6	of	of	ADP
ct-11250	40	7	pge2	pge2	NOUN
ct-11250	40	8	onto	onto	ADP
ct-11250	40	9	the	the	DET
ct-11250	40	10	oviducts	oviduct	NOUN
ct-11250	40	11	of	of	ADP
ct-11250	40	12	15	15	NUM
ct-11250	40	13	chronically	chronically	ADV
ct-11250	40	14	infertile	infertile	ADJ
ct-11250	40	15	mares	mare	NOUN
ct-11250	40	16	.	.	PUNCT
ct-11250	41	1	the	the	DET
ct-11250	41	2	mares	mare	NOUN
ct-11250	41	3	were	be	AUX
ct-11250	41	4	ten	ten	NUM
ct-11250	41	5	to	to	PART
ct-11250	41	6	21	21	NUM
ct-11250	41	7	years	year	NOUN
ct-11250	41	8	old	old	ADJ
ct-11250	41	9	and	and	CCONJ
ct-11250	41	10	all	all	PRON
ct-11250	41	11	of	of	ADP
ct-11250	41	12	them	they	PRON
ct-11250	41	13	had	have	AUX
ct-11250	41	14	failed	fail	VERB
ct-11250	41	15	to	to	PART
ct-11250	41	16	become	become	VERB
ct-11250	41	17	pregnant	pregnant	ADJ
ct-11250	41	18	over	over	ADP
ct-11250	41	19	a	a	DET
ct-11250	41	20	period	period	NOUN
ct-11250	41	21	of	of	ADP
ct-11250	41	22	one	one	NUM
ct-11250	41	23	to	to	PART
ct-11250	41	24	four	four	NUM
ct-11250	41	25	years	year	NOUN
ct-11250	41	26	during	during	ADP
ct-11250	41	27	which	which	PRON
ct-11250	41	28	they	they	PRON
ct-11250	41	29	were	be	AUX
ct-11250	41	30	bred	breed	VERB
ct-11250	41	31	to	to	ADP
ct-11250	41	32	fertile	fertile	ADJ
ct-11250	41	33	stallions	stallion	NOUN
ct-11250	41	34	.	.	PUNCT
ct-11250	42	1	none	none	NOUN
ct-11250	42	2	of	of	ADP
ct-11250	42	3	the	the	DET
ct-11250	42	4	mares	mare	NOUN
ct-11250	42	5	had	have	VERB
ct-11250	42	6	any	any	DET
ct-11250	42	7	identifiable	identifiable	ADJ
ct-11250	42	8	reproductive	reproductive	ADJ
ct-11250	42	9	pathology	pathology	NOUN
ct-11250	42	10	that	that	PRON
ct-11250	42	11	would	would	AUX
ct-11250	42	12	explain	explain	VERB
ct-11250	42	13	their	their	PRON
ct-11250	42	14	infertility	infertility	NOUN
ct-11250	42	15	.	.	PUNCT
ct-11250	43	1	laparoscopic	laparoscopic	ADJ
ct-11250	43	2	application	application	NOUN
ct-11250	43	3	of	of	ADP
ct-11250	43	4	0.2	0.2	NUM
ct-11250	43	5	mg	mg	NOUN
ct-11250	43	6	of	of	ADP
ct-11250	43	7	pge2	pge2	NOUN
ct-11250	43	8	gel	gel	NOUN
ct-11250	43	9	onto	onto	ADP
ct-11250	43	10	the	the	DET
ct-11250	43	11	surface	surface	NOUN
ct-11250	43	12	of	of	ADP
ct-11250	43	13	the	the	DET
ct-11250	43	14	oviducts	oviduct	NOUN
ct-11250	43	15	was	be	AUX
ct-11250	43	16	performed	perform	VERB
ct-11250	43	17	,	,	PUNCT
ct-11250	43	18	and	and	CCONJ
ct-11250	43	19	after	after	ADP
ct-11250	43	20	treatment	treatment	NOUN
ct-11250	43	21	14	14	NUM
ct-11250	43	22	of	of	ADP
ct-11250	43	23	the	the	DET
ct-11250	43	24	15	15	NUM
ct-11250	43	25	mares	mare	NOUN
ct-11250	43	26	(	(	PUNCT
ct-11250	43	27	93	93	NUM
ct-11250	43	28	%	%	NOUN
ct-11250	43	29	)	)	PUNCT
ct-11250	43	30	became	become	VERB
ct-11250	43	31	pregnant	pregnant	ADJ
ct-11250	43	32	either	either	CCONJ
ct-11250	43	33	the	the	DET
ct-11250	43	34	same	same	ADJ
ct-11250	43	35	or	or	CCONJ
ct-11250	43	36	the	the	DET
ct-11250	43	37	following	following	ADJ
ct-11250	43	38	year	year	NOUN
ct-11250	43	39	.	.	PUNCT
ct-11250	44	1	the	the	DET
ct-11250	44	2	authors	author	NOUN
ct-11250	44	3	hypothesized	hypothesize	VERB
ct-11250	44	4	that	that	SCONJ
ct-11250	44	5	over	over	ADP
ct-11250	44	6	time	time	NOUN
ct-11250	44	7	the	the	DET
ct-11250	44	8	mares	mare	NOUN
ct-11250	44	9	developed	develop	VERB
ct-11250	44	10	blocked	block	VERB
ct-11250	44	11	oviducts	oviduct	NOUN
ct-11250	44	12	due	due	ADP
ct-11250	44	13	to	to	ADP
ct-11250	44	14	the	the	DET
ct-11250	44	15	accumulation	accumulation	NOUN
ct-11250	44	16	of	of	ADP
ct-11250	44	17	naturally	naturally	ADV
ct-11250	44	18	occurring	occur	VERB
ct-11250	44	19	collagenous	collagenous	ADJ
ct-11250	44	20	oviductal	oviductal	ADJ
ct-11250	44	21	masses	masse	NOUN
ct-11250	44	22	and	and	CCONJ
ct-11250	44	23	that	that	SCONJ
ct-11250	44	24	topical	topical	ADJ
ct-11250	44	25	application	application	NOUN
ct-11250	44	26	of	of	ADP
ct-11250	44	27	the	the	DET
ct-11250	44	28	pge2	pge2	NOUN
ct-11250	44	29	induced	induce	VERB
ct-11250	44	30	changes	change	NOUN
ct-11250	44	31	in	in	ADP
ct-11250	44	32	circular	circular	ADJ
ct-11250	44	33	and	and	CCONJ
ct-11250	44	34	longitudinal	longitudinal	ADJ
ct-11250	44	35	oviductal	oviductal	ADJ
ct-11250	44	36	smooth	smooth	ADJ
ct-11250	44	37	muscle	muscle	NOUN
ct-11250	44	38	contractility	contractility	NOUN
ct-11250	44	39	that	that	PRON
ct-11250	44	40	resulted	result	VERB
ct-11250	44	41	in	in	ADP
ct-11250	44	42	the	the	DET
ct-11250	44	43	cathartic	cathartic	ADJ
ct-11250	44	44	transport	transport	NOUN
ct-11250	44	45	of	of	ADP
ct-11250	44	46	the	the	DET
ct-11250	44	47	masses	masse	NOUN
ct-11250	44	48	out	out	ADP
ct-11250	44	49	of	of	ADP
ct-11250	44	50	the	the	DET
ct-11250	44	51	oviduct	oviduct	NOUN
ct-11250	44	52	into	into	ADP
ct-11250	44	53	the	the	DET
ct-11250	44	54	uterine	uterine	ADJ
ct-11250	44	55	lumen	luman	NOUN
ct-11250	44	56	restoring	restore	VERB
ct-11250	44	57	patency	patency	NOUN
ct-11250	44	58	.	.	PUNCT
ct-11250	45	1	although	although	SCONJ
ct-11250	45	2	the	the	DET
ct-11250	45	3	results	result	NOUN
ct-11250	45	4	are	be	AUX
ct-11250	45	5	encouraging	encouraging	ADJ
ct-11250	45	6	,	,	PUNCT
ct-11250	45	7	the	the	DET
ct-11250	45	8	absence	absence	NOUN
ct-11250	45	9	of	of	ADP
ct-11250	45	10	a	a	DET
ct-11250	45	11	group	group	NOUN
ct-11250	45	12	of	of	ADP
ct-11250	45	13	control	control	NOUN
ct-11250	45	14	mares	mare	NOUN
ct-11250	45	15	and	and	CCONJ
ct-11250	45	16	the	the	DET
ct-11250	45	17	lack	lack	NOUN
ct-11250	45	18	of	of	ADP
ct-11250	45	19	pretreatment	pretreatment	NOUN
ct-11250	45	20	evidence	evidence	NOUN
ct-11250	45	21	that	that	SCONJ
ct-11250	45	22	oviductal	oviductal	ADJ
ct-11250	45	23	blockage	blockage	NOUN
ct-11250	45	24	was	be	AUX
ct-11250	45	25	the	the	DET
ct-11250	45	26	underlying	underlying	ADJ
ct-11250	45	27	cause	cause	NOUN
ct-11250	45	28	of	of	ADP
ct-11250	45	29	infertility	infertility	NOUN
ct-11250	45	30	in	in	ADP
ct-11250	45	31	these	these	DET
ct-11250	45	32	mares	mare	NOUN
ct-11250	45	33	are	be	AUX
ct-11250	45	34	limitations	limitation	NOUN
ct-11250	45	35	of	of	ADP
ct-11250	45	36	the	the	DET
ct-11250	45	37	study	study	NOUN
ct-11250	45	38	;	;	PUNCT
ct-11250	45	39	therefore	therefore	ADV
ct-11250	45	40	,	,	PUNCT
ct-11250	45	41	further	further	ADJ
ct-11250	45	42	work	work	NOUN
ct-11250	45	43	is	be	AUX
ct-11250	45	44	needed	need	VERB
ct-11250	45	45	to	to	PART
ct-11250	45	46	more	more	ADV
ct-11250	45	47	fully	fully	ADV
ct-11250	45	48	understand	understand	VERB
ct-11250	45	49	the	the	DET
ct-11250	45	50	incidence	incidence	NOUN
ct-11250	45	51	of	of	ADP
ct-11250	45	52	infertility	infertility	NOUN
ct-11250	45	53	caused	cause	VERB
ct-11250	45	54	by	by	ADP
ct-11250	45	55	pathological	pathological	ADJ
ct-11250	45	56	oviductal	oviductal	ADJ
ct-11250	45	57	blockage	blockage	NOUN
ct-11250	45	58	in	in	ADP
ct-11250	45	59	mares	mare	NOUN
ct-11250	45	60	and	and	CCONJ
ct-11250	45	61	the	the	DET
ct-11250	45	62	suitability	suitability	NOUN
ct-11250	45	63	of	of	ADP
ct-11250	45	64	laparoscopic	laparoscopic	ADJ
ct-11250	45	65	application	application	NOUN
ct-11250	45	66	of	of	ADP
ct-11250	45	67	pge2	pge2	NOUN
ct-11250	45	68	for	for	ADP
ct-11250	45	69	its	its	PRON
ct-11250	45	70	treatment	treatment	NOUN
ct-11250	45	71	.	.	PUNCT
ct-11250	46	1	the	the	DET
ct-11250	46	2	use	use	NOUN
ct-11250	46	3	of	of	ADP
ct-11250	46	4	exogenous	exogenous	ADJ
ct-11250	46	5	oxytocin	oxytocin	NOUN
ct-11250	46	6	has	have	VERB
ct-11250	46	7	applications	application	NOUN
ct-11250	46	8	in	in	ADP
ct-11250	46	9	nonpregnant	nonpregnant	NOUN
ct-11250	46	10	,	,	PUNCT
ct-11250	46	11	pregnant	pregnant	ADJ
ct-11250	46	12	and	and	CCONJ
ct-11250	46	13	postpartum	postpartum	NOUN
ct-11250	46	14	mares	mare	NOUN
ct-11250	46	15	(	(	PUNCT
ct-11250	46	16	table	table	NOUN
ct-11250	46	17	1).22	1).22	NOUN
ct-11250	46	18	in	in	ADP
ct-11250	46	19	nonpregnant	nonpregnant	ADJ
ct-11250	46	20	mares	mare	NOUN
ct-11250	46	21	oxytocin	oxytocin	PROPN
ct-11250	46	22	has	have	AUX
ct-11250	46	23	revolutionized	revolutionize	VERB
ct-11250	46	24	the	the	DET
ct-11250	46	25	clinical	clinical	ADJ
ct-11250	46	26	management	management	NOUN
ct-11250	46	27	of	of	ADP
ct-11250	46	28	endometritis	endometritis	NOUN
ct-11250	46	29	,	,	PUNCT
ct-11250	46	30	both	both	PRON
ct-11250	46	31	persistent	persistent	ADJ
ct-11250	46	32	mating	mating	NOUN
ct-11250	46	33	-	-	PUNCT
ct-11250	46	34	induced	induce	VERB
ct-11250	46	35	endometritis	endometritis	NOUN
ct-11250	46	36	and	and	CCONJ
ct-11250	46	37	infectious	infectious	ADJ
ct-11250	46	38	endometritis	endometritis	NOUN
ct-11250	46	39	,	,	PUNCT
ct-11250	46	40	because	because	SCONJ
ct-11250	46	41	of	of	ADP
ct-11250	46	42	its	its	PRON
ct-11250	46	43	ability	ability	NOUN
ct-11250	46	44	to	to	PART
ct-11250	46	45	stimulate	stimulate	VERB
ct-11250	46	46	uterine	uterine	ADJ
ct-11250	46	47	contractile	contractile	NOUN
ct-11250	46	48	activity	activity	NOUN
ct-11250	46	49	and	and	CCONJ
ct-11250	46	50	enhance	enhance	VERB
ct-11250	46	51	clearance	clearance	NOUN
ct-11250	46	52	of	of	ADP
ct-11250	46	53	intraluminal	intraluminal	ADJ
ct-11250	46	54	fluid	fluid	NOUN
ct-11250	46	55	.	.	PUNCT
ct-11250	47	1	depending	depend	VERB
ct-11250	47	2	upon	upon	SCONJ
ct-11250	47	3	the	the	DET
ct-11250	47	4	clinical	clinical	ADJ
ct-11250	47	5	circumstances	circumstance	NOUN
ct-11250	47	6	,	,	PUNCT
ct-11250	47	7	oxytocin	oxytocin	PROPN
ct-11250	47	8	can	can	AUX
ct-11250	47	9	be	be	AUX
ct-11250	47	10	used	use	VERB
ct-11250	47	11	alone	alone	ADJ
ct-11250	47	12	for	for	ADP
ct-11250	47	13	its	its	PRON
ct-11250	47	14	ecbolic	ecbolic	ADJ
ct-11250	47	15	effect	effect	NOUN
ct-11250	47	16	or	or	CCONJ
ct-11250	47	17	it	it	PRON
ct-11250	47	18	can	can	AUX
ct-11250	47	19	be	be	AUX
ct-11250	47	20	combined	combine	VERB
ct-11250	47	21	with	with	ADP
ct-11250	47	22	large	large	ADJ
ct-11250	47	23	volume	volume	NOUN
ct-11250	47	24	uterine	uterine	ADJ
ct-11250	47	25	lavage	lavage	NOUN
ct-11250	47	26	to	to	PART
ct-11250	47	27	facilitate	facilitate	VERB
ct-11250	47	28	evacuation	evacuation	NOUN
ct-11250	47	29	of	of	ADP
ct-11250	47	30	uterine	uterine	ADJ
ct-11250	47	31	fluid	fluid	NOUN
ct-11250	47	32	.	.	PUNCT
ct-11250	48	1	oxytocin	oxytocin	PROPN
ct-11250	48	2	stimulates	stimulate	VERB
ct-11250	48	3	uterine	uterine	ADJ
ct-11250	48	4	contractile	contractile	NOUN
ct-11250	48	5	activity	activity	NOUN
ct-11250	48	6	for	for	ADP
ct-11250	48	7	approximately	approximately	ADV
ct-11250	48	8	30	30	NUM
ct-11250	48	9	to	to	PART
ct-11250	48	10	45	45	NUM
ct-11250	48	11	minutes	minute	NOUN
ct-11250	48	12	,	,	PUNCT
ct-11250	48	13	so	so	CCONJ
ct-11250	48	14	repetitive	repetitive	ADJ
ct-11250	48	15	doses	dose	NOUN
ct-11250	48	16	are	be	AUX
ct-11250	48	17	often	often	ADV
ct-11250	48	18	given	give	VERB
ct-11250	48	19	during	during	ADP
ct-11250	48	20	the	the	DET
ct-11250	48	21	day	day	NOUN
ct-11250	48	22	in	in	ADP
ct-11250	48	23	an	an	DET
ct-11250	48	24	effort	effort	NOUN
ct-11250	48	25	to	to	PART
ct-11250	48	26	maximize	maximize	VERB
ct-11250	48	27	uterine	uterine	ADJ
ct-11250	48	28	clearance.22	clearance.22	PROPN
ct-11250	48	29	a	a	DET
ct-11250	48	30	newly	newly	ADV
ct-11250	48	31	described	describe	VERB
ct-11250	48	32	use	use	NOUN
ct-11250	48	33	of	of	ADP
ct-11250	48	34	exogenous	exogenous	ADJ
ct-11250	48	35	oxytocin	oxytocin	NOUN
ct-11250	48	36	in	in	ADP
ct-11250	48	37	nonpregnant	nonpregnant	ADJ
ct-11250	48	38	mares	mare	NOUN
ct-11250	48	39	is	be	AUX
ct-11250	48	40	administration	administration	NOUN
ct-11250	48	41	during	during	ADP
ct-11250	48	42	diestrus	diestrus	NOUN
ct-11250	48	43	to	to	PART
ct-11250	48	44	disrupt	disrupt	VERB
ct-11250	48	45	luteolysis	luteolysis	NOUN
ct-11250	48	46	to	to	PART
ct-11250	48	47	prolong	prolong	VERB
ct-11250	48	48	cl	cl	NOUN
ct-11250	48	49	function	function	NOUN
ct-11250	48	50	as	as	ADP
ct-11250	48	51	a	a	DET
ct-11250	48	52	means	means	NOUN
ct-11250	48	53	of	of	ADP
ct-11250	48	54	estrus	estrus	NOUN
ct-11250	48	55	suppression	suppression	NOUN
ct-11250	48	56	in	in	ADP
ct-11250	48	57	performance	performance	NOUN
ct-11250	48	58	mares	mare	NOUN
ct-11250	48	59	.	.	PUNCT
ct-11250	49	1	in	in	ADP
ct-11250	49	2	the	the	DET
ct-11250	49	3	initial	initial	ADJ
ct-11250	49	4	report	report	NOUN
ct-11250	49	5	on	on	ADP
ct-11250	49	6	the	the	DET
ct-11250	49	7	use	use	NOUN
ct-11250	49	8	of	of	ADP
ct-11250	49	9	oxytocin	oxytocin	NOUN
ct-11250	49	10	for	for	ADP
ct-11250	49	11	this	this	DET
ct-11250	49	12	purpose	purpose	NOUN
ct-11250	49	13	,	,	PUNCT
ct-11250	49	14	administration	administration	NOUN
ct-11250	49	15	of	of	ADP
ct-11250	49	16	60	60	NUM
ct-11250	49	17	units	unit	NOUN
ct-11250	49	18	of	of	ADP
ct-11250	49	19	oxytocin	oxytocin	PROPN
ct-11250	49	20	i	i	PRON
ct-11250	49	21	m	m	VERB
ct-11250	49	22	on	on	ADP
ct-11250	49	23	days	day	NOUN
ct-11250	49	24	seven	seven	NUM
ct-11250	49	25	to	to	PART
ct-11250	49	26	14	14	NUM
ct-11250	49	27	after	after	SCONJ
ct-11250	49	28	ovulation	ovulation	NOUN
ct-11250	49	29	induced	induce	VERB
ct-11250	49	30	prolonged	prolonged	ADJ
ct-11250	49	31	cl	cl	NOUN
ct-11250	49	32	function	function	NOUN
ct-11250	49	33	through	through	ADP
ct-11250	49	34	day	day	NOUN
ct-11250	49	35	30	30	NUM
ct-11250	49	36	after	after	ADP
ct-11250	49	37	ovulation	ovulation	NOUN
ct-11250	49	38	in	in	ADP
ct-11250	49	39	all	all	DET
ct-11250	49	40	six	six	NUM
ct-11250	49	41	treated	treat	VERB
ct-11250	49	42	mares	mare	NOUN
ct-11250	49	43	whereas	whereas	SCONJ
ct-11250	49	44	six	six	NUM
ct-11250	49	45	saline	saline	NOUN
ct-11250	49	46	-	-	PUNCT
ct-11250	49	47	treated	treat	VERB
ct-11250	49	48	control	control	NOUN
ct-11250	49	49	mares	mare	NOUN
ct-11250	49	50	all	all	DET
ct-11250	49	51	underwent	underwent	ADJ
ct-11250	49	52	luteolysis	luteolysis	NOUN
ct-11250	49	53	by	by	ADP
ct-11250	49	54	day	day	NOUN
ct-11250	49	55	16	16	NUM
ct-11250	49	56	after	after	ADP
ct-11250	49	57	ovulation.23	ovulation.23	VERB
ct-11250	49	58	in	in	ADP
ct-11250	49	59	a	a	DET
ct-11250	49	60	subsequent	subsequent	ADJ
ct-11250	49	61	report	report	NOUN
ct-11250	49	62	,	,	PUNCT
ct-11250	49	63	once	once	ADV
ct-11250	49	64	daily	daily	ADJ
ct-11250	49	65	administration	administration	NOUN
ct-11250	49	66	of	of	ADP
ct-11250	49	67	oxytocin	oxytocin	PROPN
ct-11250	49	68	was	be	AUX
ct-11250	49	69	found	find	VERB
ct-11250	49	70	to	to	PART
ct-11250	49	71	be	be	AUX
ct-11250	49	72	as	as	ADV
ct-11250	49	73	effective	effective	ADJ
ct-11250	49	74	as	as	ADP
ct-11250	49	75	twice	twice	ADJ
ct-11250	49	76	daily	daily	ADJ
ct-11250	49	77	administration	administration	NOUN
ct-11250	49	78	for	for	ADP
ct-11250	49	79	prolonging	prolong	VERB
ct-11250	49	80	cl	cl	NOUN
ct-11250	49	81	function	function	NOUN
ct-11250	49	82	,	,	PUNCT
ct-11250	49	83	which	which	PRON
ct-11250	49	84	further	far	ADV
ct-11250	49	85	simplifies	simplify	VERB
ct-11250	49	86	the	the	DET
ct-11250	49	87	treatment	treatment	NOUN
ct-11250	49	88	protocol.24	protocol.24	NOUN
ct-11250	49	89	the	the	DET
ct-11250	49	90	primary	primary	ADJ
ct-11250	49	91	use	use	NOUN
ct-11250	49	92	of	of	ADP
ct-11250	49	93	oxytocin	oxytocin	NOUN
ct-11250	49	94	in	in	ADP
ct-11250	49	95	pregnant	pregnant	ADJ
ct-11250	49	96	mares	mare	NOUN
ct-11250	49	97	is	be	AUX
ct-11250	49	98	for	for	ADP
ct-11250	49	99	induction	induction	NOUN
ct-11250	49	100	of	of	ADP
ct-11250	49	101	parturition	parturition	NOUN
ct-11250	49	102	and	and	CCONJ
ct-11250	49	103	numerous	numerous	ADJ
ct-11250	49	104	protocols	protocol	NOUN
ct-11250	49	105	for	for	ADP
ct-11250	49	106	this	this	DET
ct-11250	49	107	purpose	purpose	NOUN
ct-11250	49	108	have	have	AUX
ct-11250	49	109	been	be	AUX
ct-11250	49	110	described.22	described.22	NOUN
ct-11250	49	111	in	in	ADP
ct-11250	49	112	postpartum	postpartum	NOUN
ct-11250	49	113	mares	mare	NOUN
ct-11250	49	114	oxytocin	oxytocin	PROPN
ct-11250	49	115	is	be	AUX
ct-11250	49	116	routinely	routinely	ADV
ct-11250	49	117	used	use	VERB
ct-11250	49	118	as	as	ADP
ct-11250	49	119	an	an	DET
ct-11250	49	120	aid	aid	NOUN
ct-11250	49	121	in	in	ADP
ct-11250	49	122	the	the	DET
ct-11250	49	123	treatment	treatment	NOUN
ct-11250	49	124	of	of	ADP
ct-11250	49	125	retained	retain	VERB
ct-11250	49	126	fetal	fetal	ADJ
ct-11250	49	127	membranes	membrane	NOUN
ct-11250	49	128	.	.	PUNCT
ct-11250	50	1	treatment	treatment	NOUN
ct-11250	50	2	is	be	AUX
ct-11250	50	3	generally	generally	ADV
ct-11250	50	4	initiated	initiate	VERB
ct-11250	50	5	if	if	SCONJ
ct-11250	50	6	the	the	DET
ct-11250	50	7	fetal	fetal	ADJ
ct-11250	50	8	membranes	membrane	NOUN
ct-11250	50	9	have	have	AUX
ct-11250	50	10	not	not	PART
ct-11250	50	11	been	be	AUX
ct-11250	50	12	passed	pass	VERB
ct-11250	50	13	within	within	ADP
ct-11250	50	14	three	three	NUM
ct-11250	50	15	hours	hour	NOUN
ct-11250	50	16	after	after	ADP
ct-11250	50	17	parturition	parturition	NOUN
ct-11250	50	18	,	,	PUNCT
ct-11250	50	19	and	and	CCONJ
ct-11250	50	20	typically	typically	ADV
ct-11250	50	21	consists	consist	VERB
ct-11250	50	22	of	of	ADP
ct-11250	50	23	administration	administration	NOUN
ct-11250	50	24	of	of	ADP
ct-11250	50	25	ten	ten	NUM
ct-11250	50	26	to	to	PART
ct-11250	50	27	40	40	NUM
ct-11250	50	28	units	unit	NOUN
ct-11250	50	29	of	of	ADP
ct-11250	50	30	oxytocin	oxytocin	NOUN
ct-11250	50	31	given	give	VERB
ct-11250	50	32	iv	iv	ADP
ct-11250	50	33	or	or	CCONJ
ct-11250	50	34	i	i	PRON
ct-11250	50	35	m	m	PROPN
ct-11250	50	36	,	,	PUNCT
ct-11250	50	37	which	which	PRON
ct-11250	50	38	may	may	AUX
ct-11250	50	39	be	be	AUX
ct-11250	50	40	repeated	repeat	VERB
ct-11250	50	41	every	every	DET
ct-11250	50	42	30	30	NUM
ct-11250	50	43	minutes	minute	NOUN
ct-11250	50	44	to	to	ADP
ct-11250	50	45	four	four	NUM
ct-11250	50	46	hours	hour	NOUN
ct-11250	50	47	or	or	CCONJ
ct-11250	50	48	alternatively	alternatively	ADV
ct-11250	50	49	given	give	VERB
ct-11250	50	50	as	as	ADP
ct-11250	50	51	a	a	DET
ct-11250	50	52	slow	slow	ADJ
ct-11250	50	53	iv	iv	NOUN
ct-11250	50	54	drip	drip	NOUN
ct-11250	50	55	diluted	dilute	VERB
ct-11250	50	56	in	in	ADP
ct-11250	50	57	physiological	physiological	ADJ
ct-11250	50	58	saline	saline	NOUN
ct-11250	50	59	.	.	PUNCT
ct-11250	51	1	for	for	ADP
ct-11250	51	2	refractory	refractory	NOUN
ct-11250	51	3	cases	case	NOUN
ct-11250	51	4	,	,	PUNCT
ct-11250	51	5	administration	administration	NOUN
ct-11250	51	6	of	of	ADP
ct-11250	51	7	one	one	NUM
ct-11250	51	8	liter	liter	NOUN
ct-11250	51	9	of	of	ADP
ct-11250	51	10	lactated	lactated	ADJ
ct-11250	51	11	ringer	ringer	NOUN
ct-11250	51	12	’s	’s	PART
ct-11250	51	13	solution	solution	NOUN
ct-11250	51	14	containing	contain	VERB
ct-11250	51	15	100	100	NUM
ct-11250	51	16	to	to	PART
ct-11250	51	17	150	150	NUM
ct-11250	51	18	ml	ml	NOUN
ct-11250	51	19	of	of	ADP
ct-11250	51	20	23	23	NUM
ct-11250	51	21	%	%	NOUN
ct-11250	51	22	calcium	calcium	NOUN
ct-11250	51	23	gluconate	gluconate	NOUN
ct-11250	51	24	followed	follow	VERB
ct-11250	51	25	by	by	ADP
ct-11250	51	26	20	20	NUM
ct-11250	51	27	units	unit	NOUN
ct-11250	51	28	of	of	ADP
ct-11250	51	29	oxytocin	oxytocin	NOUN
ct-11250	51	30	iv	iv	NUM
ct-11250	51	31	is	be	AUX
ct-11250	51	32	often	often	ADV
ct-11250	51	33	successful.22	successful.22	ADJ
ct-11250	51	34	personal	personal	ADJ
ct-11250	51	35	safety	safety	NOUN
ct-11250	51	36	given	give	VERB
ct-11250	51	37	the	the	DET
ct-11250	51	38	extensive	extensive	ADJ
ct-11250	51	39	selection	selection	NOUN
ct-11250	51	40	of	of	ADP
ct-11250	51	41	exogenous	exogenous	ADJ
ct-11250	51	42	hormones	hormone	NOUN
ct-11250	51	43	that	that	PRON
ct-11250	51	44	are	be	AUX
ct-11250	51	45	available	available	ADJ
ct-11250	51	46	and	and	CCONJ
ct-11250	51	47	their	their	PRON
ct-11250	51	48	numerous	numerous	ADJ
ct-11250	51	49	applications	application	NOUN
ct-11250	51	50	in	in	ADP
ct-11250	51	51	both	both	DET
ct-11250	51	52	mares	mare	NOUN
ct-11250	51	53	and	and	CCONJ
ct-11250	51	54	stallions	stallion	NOUN
ct-11250	51	55	it	it	PRON
ct-11250	51	56	is	be	AUX
ct-11250	51	57	clear	clear	ADJ
ct-11250	51	58	these	these	DET
ct-11250	51	59	products	product	NOUN
ct-11250	51	60	are	be	AUX
ct-11250	51	61	indispensable	indispensable	ADJ
ct-11250	51	62	for	for	ADP
ct-11250	51	63	the	the	DET
ct-11250	51	64	reproductive	reproductive	ADJ
ct-11250	51	65	management	management	NOUN
ct-11250	51	66	of	of	ADP
ct-11250	51	67	horses	horse	NOUN
ct-11250	51	68	.	.	PUNCT
ct-11250	52	1	therefore	therefore	ADV
ct-11250	52	2	,	,	PUNCT
ct-11250	52	3	it	it	PRON
ct-11250	52	4	seems	seem	VERB
ct-11250	52	5	inevitable	inevitable	ADJ
ct-11250	52	6	that	that	SCONJ
ct-11250	52	7	veterinarians	veterinarian	NOUN
ct-11250	52	8	and	and	CCONJ
ct-11250	52	9	other	other	ADJ
ct-11250	52	10	veterinary	veterinary	ADJ
ct-11250	52	11	healthcare	healthcare	NOUN
ct-11250	52	12	workers	worker	NOUN
ct-11250	52	13	will	will	AUX
ct-11250	52	14	handle	handle	VERB
ct-11250	52	15	and	and	CCONJ
ct-11250	52	16	administer	administer	VERB
ct-11250	52	17	many	many	ADJ
ct-11250	52	18	,	,	PUNCT
ct-11250	52	19	if	if	SCONJ
ct-11250	52	20	not	not	PART
ct-11250	52	21	all	all	PRON
ct-11250	52	22	,	,	PUNCT
ct-11250	52	23	of	of	ADP
ct-11250	52	24	these	these	DET
ct-11250	52	25	agents	agent	NOUN
ct-11250	52	26	on	on	ADP
ct-11250	52	27	a	a	DET
ct-11250	52	28	regular	regular	ADJ
ct-11250	52	29	basis	basis	NOUN
ct-11250	52	30	if	if	SCONJ
ct-11250	52	31	they	they	PRON
ct-11250	52	32	are	be	AUX
ct-11250	52	33	involved	involve	VERB
ct-11250	52	34	in	in	ADP
ct-11250	52	35	equine	equine	ADJ
ct-11250	52	36	reproductive	reproductive	ADJ
ct-11250	52	37	activities	activity	NOUN
ct-11250	52	38	.	.	PUNCT
ct-11250	53	1	in	in	ADP
ct-11250	53	2	addition	addition	NOUN
ct-11250	53	3	,	,	PUNCT
ct-11250	53	4	veterinarians	veterinarian	NOUN
ct-11250	53	5	will	will	AUX
ct-11250	53	6	likely	likely	ADV
ct-11250	53	7	dispense	dispense	VERB
ct-11250	53	8	or	or	CCONJ
ct-11250	53	9	provide	provide	VERB
ct-11250	53	10	prescriptions	prescription	NOUN
ct-11250	53	11	for	for	ADP
ct-11250	53	12	many	many	ADJ
ct-11250	53	13	of	of	ADP
ct-11250	53	14	these	these	DET
ct-11250	53	15	agents	agent	NOUN
ct-11250	53	16	to	to	PART
ct-11250	53	17	horse	horse	NOUN
ct-11250	53	18	owners	owner	NOUN
ct-11250	53	19	,	,	PUNCT
ct-11250	53	20	managers	manager	NOUN
ct-11250	53	21	or	or	CCONJ
ct-11250	53	22	other	other	ADJ
ct-11250	53	23	lay	lie	VERB
ct-11250	53	24	personnel	personnel	NOUN
ct-11250	53	25	further	far	ADV
ct-11250	53	26	increasing	increase	VERB
ct-11250	53	27	the	the	DET
ct-11250	53	28	number	number	NOUN
ct-11250	53	29	of	of	ADP
ct-11250	53	30	individuals	individual	NOUN
ct-11250	53	31	handling	handle	VERB
ct-11250	53	32	and	and	CCONJ
ct-11250	53	33	administering	administer	VERB
ct-11250	53	34	these	these	DET
ct-11250	53	35	products	product	NOUN
ct-11250	53	36	.	.	PUNCT
ct-11250	54	1	most	most	ADJ
ct-11250	54	2	,	,	PUNCT
ct-11250	54	3	but	but	CCONJ
ct-11250	54	4	not	not	PART
ct-11250	54	5	all	all	PRON
ct-11250	54	6	,	,	PUNCT
ct-11250	54	7	commercially	commercially	ADV
ct-11250	54	8	-	-	PUNCT
ct-11250	54	9	available	available	ADJ
ct-11250	54	10	hormone	hormone	NOUN
ct-11250	54	11	preparations	preparation	NOUN
ct-11250	54	12	provide	provide	VERB
ct-11250	54	13	specific	specific	ADJ
ct-11250	54	14	human	human	ADJ
ct-11250	54	15	safety	safety	NOUN
ct-11250	54	16	warnings	warning	NOUN
ct-11250	54	17	and	and	CCONJ
ct-11250	54	18	guidelines	guideline	NOUN
ct-11250	54	19	for	for	ADP
ct-11250	54	20	safe	safe	ADJ
ct-11250	54	21	handling	handling	NOUN
ct-11250	54	22	and	and	CCONJ
ct-11250	54	23	administration	administration	NOUN
ct-11250	54	24	(	(	PUNCT
ct-11250	54	25	table	table	NOUN
ct-11250	54	26	2	2	NUM
ct-11250	54	27	)	)	PUNCT
ct-11250	54	28	.	.	PUNCT
ct-11250	55	1	in	in	ADP
ct-11250	55	2	contrast	contrast	NOUN
ct-11250	55	3	,	,	PUNCT
ct-11250	55	4	compounded	compound	VERB
ct-11250	55	5	preparations	preparation	NOUN
ct-11250	55	6	are	be	AUX
ct-11250	55	7	generally	generally	ADV
ct-11250	55	8	not	not	PART
ct-11250	55	9	accompanied	accompany	VERB
ct-11250	55	10	with	with	ADP
ct-11250	55	11	this	this	DET
ct-11250	55	12	type	type	NOUN
ct-11250	55	13	of	of	ADP
ct-11250	55	14	human	human	ADJ
ct-11250	55	15	safety	safety	NOUN
ct-11250	55	16	information	information	NOUN
ct-11250	55	17	(	(	PUNCT
ct-11250	55	18	table	table	NOUN
ct-11250	55	19	2	2	NUM
ct-11250	55	20	)	)	PUNCT
ct-11250	55	21	.	.	PUNCT
ct-11250	56	1	most	most	ADJ
ct-11250	56	2	of	of	ADP
ct-11250	56	3	the	the	DET
ct-11250	56	4	safety	safety	NOUN
ct-11250	56	5	warnings	warning	NOUN
ct-11250	56	6	that	that	PRON
ct-11250	56	7	accompany	accompany	VERB
ct-11250	56	8	hormone	hormone	NOUN
ct-11250	56	9	products	product	NOUN
ct-11250	56	10	address	address	VERB
ct-11250	56	11	particular	particular	ADJ
ct-11250	56	12	concerns	concern	NOUN
ct-11250	56	13	for	for	ADP
ct-11250	56	14	women	woman	NOUN
ct-11250	56	15	,	,	PUNCT
ct-11250	56	16	specifically	specifically	ADV
ct-11250	56	17	pregnant	pregnant	ADJ
ct-11250	56	18	women	woman	NOUN
ct-11250	56	19	and	and	CCONJ
ct-11250	56	20	women	woman	NOUN
ct-11250	56	21	of	of	ADP
ct-11250	56	22	childbearing	childbeare	VERB
ct-11250	56	23	age	age	NOUN
ct-11250	56	24	.	.	PUNCT
ct-11250	57	1	for	for	ADP
ct-11250	57	2	example	example	NOUN
ct-11250	57	3	,	,	PUNCT
ct-11250	57	4	inadvertent	inadvertent	ADJ
ct-11250	57	5	exposure	exposure	NOUN
ct-11250	57	6	of	of	ADP
ct-11250	57	7	some	some	DET
ct-11250	57	8	drugs	drug	NOUN
ct-11250	57	9	(	(	PUNCT
ct-11250	57	10	e.g.	e.g.	ADV
ct-11250	57	11	,	,	PUNCT
ct-11250	57	12	gnrh	gnrh	NOUN
ct-11250	57	13	analogs	analog	NOUN
ct-11250	57	14	and	and	CCONJ
ct-11250	57	15	clinical	clinical	ADJ
ct-11250	57	16	theriogenology	theriogenology	NOUN
ct-11250	57	17	•	•	NOUN
ct-11250	57	18	volume	volume	NOUN
ct-11250	57	19	3	3	NUM
ct-11250	57	20	number	number	NOUN
ct-11250	57	21	4	4	NUM
ct-11250	57	22	•	•	NOUN
ct-11250	57	23	december	december	PROPN
ct-11250	57	24	2011clinical	2011clinical	ADJ
ct-11250	57	25	theriogenology	theriogenology	NOUN
ct-11250	57	26	•	•	NOUN
ct-11250	57	27	volume	volume	NOUN
ct-11250	57	28	4	4	NUM
ct-11250	57	29	number	number	NOUN
ct-11250	57	30	1	1	NUM
ct-11250	57	31	•	•	NUM
ct-11250	57	32	march	march	PROPN
ct-11250	57	33	2012	2012	NUM
ct-11250	57	34	42clinical	42clinical	NUM
ct-11250	57	35	theriogenology	theriogenology	NOUN
ct-11250	57	36	•	•	NOUN
ct-11250	57	37	volume	volume	NOUN
ct-11250	57	38	4	4	NUM
ct-11250	57	39	number	number	NOUN
ct-11250	57	40	1	1	NUM
ct-11250	57	41	•	•	NUM
ct-11250	57	42	march	march	PROPN
ct-11250	57	43	2012	2012	NUM
ct-11250	57	44	progesterone	progesterone	NOUN
ct-11250	57	45	/	/	SYM
ct-11250	57	46	progestins	progestin	NOUN
ct-11250	57	47	)	)	PUNCT
ct-11250	57	48	may	may	AUX
ct-11250	57	49	lead	lead	VERB
ct-11250	57	50	to	to	ADP
ct-11250	57	51	disruption	disruption	NOUN
ct-11250	57	52	of	of	ADP
ct-11250	57	53	the	the	DET
ct-11250	57	54	menstrual	menstrual	ADJ
ct-11250	57	55	cycle	cycle	NOUN
ct-11250	57	56	;	;	PUNCT
ct-11250	57	57	abdominal	abdominal	ADJ
ct-11250	57	58	cramping	cramping	NOUN
ct-11250	57	59	;	;	PUNCT
ct-11250	57	60	increased	increase	VERB
ct-11250	57	61	or	or	CCONJ
ct-11250	57	62	decreased	decrease	VERB
ct-11250	57	63	uterine	uterine	ADJ
ct-11250	57	64	bleeding	bleeding	NOUN
ct-11250	57	65	;	;	PUNCT
ct-11250	57	66	prolongation	prolongation	NOUN
ct-11250	57	67	of	of	ADP
ct-11250	57	68	pregnancy	pregnancy	NOUN
ct-11250	57	69	;	;	PUNCT
ct-11250	57	70	or	or	CCONJ
ct-11250	57	71	headaches	headache	NOUN
ct-11250	57	72	;	;	PUNCT
ct-11250	57	73	while	while	SCONJ
ct-11250	57	74	other	other	ADJ
ct-11250	57	75	drugs	drug	NOUN
ct-11250	57	76	(	(	PUNCT
ct-11250	57	77	e.g.	e.g.	ADV
ct-11250	57	78	,	,	PUNCT
ct-11250	57	79	pgf2α	pgf2α	PROPN
ct-11250	57	80	,	,	PUNCT
ct-11250	57	81	pge1	pge1	NOUN
ct-11250	57	82	,	,	PUNCT
ct-11250	57	83	pge2	pge2	NOUN
ct-11250	57	84	and	and	CCONJ
ct-11250	57	85	their	their	PRON
ct-11250	57	86	analogs	analog	NOUN
ct-11250	57	87	)	)	PUNCT
ct-11250	57	88	may	may	AUX
ct-11250	57	89	cause	cause	VERB
ct-11250	57	90	abortion	abortion	NOUN
ct-11250	57	91	(	(	PUNCT
ct-11250	57	92	table	table	NOUN
ct-11250	57	93	2	2	NUM
ct-11250	57	94	)	)	PUNCT
ct-11250	57	95	.	.	PUNCT
ct-11250	58	1	other	other	ADJ
ct-11250	58	2	safety	safety	NOUN
ct-11250	58	3	warnings	warning	NOUN
ct-11250	58	4	are	be	AUX
ct-11250	58	5	more	more	ADV
ct-11250	58	6	general	general	ADJ
ct-11250	58	7	and	and	CCONJ
ct-11250	58	8	are	be	AUX
ct-11250	58	9	relevant	relevant	ADJ
ct-11250	58	10	regardless	regardless	ADV
ct-11250	58	11	of	of	ADP
ct-11250	58	12	gender	gender	NOUN
ct-11250	58	13	.	.	PUNCT
ct-11250	59	1	for	for	ADP
ct-11250	59	2	example	example	NOUN
ct-11250	59	3	,	,	PUNCT
ct-11250	59	4	individuals	individual	NOUN
ct-11250	59	5	with	with	ADP
ct-11250	59	6	asthma	asthma	NOUN
ct-11250	59	7	or	or	CCONJ
ct-11250	59	8	other	other	ADJ
ct-11250	59	9	respiratory	respiratory	ADJ
ct-11250	59	10	conditions	condition	NOUN
ct-11250	59	11	,	,	PUNCT
ct-11250	59	12	regardless	regardless	ADV
ct-11250	59	13	of	of	ADP
ct-11250	59	14	gender	gender	NOUN
ct-11250	59	15	,	,	PUNCT
ct-11250	59	16	are	be	AUX
ct-11250	59	17	urged	urge	VERB
ct-11250	59	18	to	to	PART
ct-11250	59	19	use	use	VERB
ct-11250	59	20	caution	caution	NOUN
ct-11250	59	21	when	when	SCONJ
ct-11250	59	22	handling	handle	VERB
ct-11250	59	23	drugs	drug	NOUN
ct-11250	59	24	such	such	ADJ
ct-11250	59	25	as	as	ADP
ct-11250	59	26	pgf2α	pgf2α	PROPN
ct-11250	59	27	and	and	CCONJ
ct-11250	59	28	its	its	PRON
ct-11250	59	29	analogs	analog	NOUN
ct-11250	59	30	,	,	PUNCT
ct-11250	59	31	because	because	SCONJ
ct-11250	59	32	they	they	PRON
ct-11250	59	33	can	can	AUX
ct-11250	59	34	cause	cause	VERB
ct-11250	59	35	bronchiospasms	bronchiospasm	NOUN
ct-11250	59	36	(	(	PUNCT
ct-11250	59	37	table	table	NOUN
ct-11250	59	38	2	2	NUM
ct-11250	59	39	)	)	PUNCT
ct-11250	59	40	.	.	PUNCT
ct-11250	60	1	a	a	DET
ct-11250	60	2	primary	primary	ADJ
ct-11250	60	3	emphasis	emphasis	NOUN
ct-11250	60	4	in	in	ADP
ct-11250	60	5	most	most	ADJ
ct-11250	60	6	of	of	ADP
ct-11250	60	7	the	the	DET
ct-11250	60	8	manufacturer	manufacturer	NOUN
ct-11250	60	9	-	-	PUNCT
ct-11250	60	10	recommended	recommend	VERB
ct-11250	60	11	safety	safety	NOUN
ct-11250	60	12	warnings	warning	NOUN
ct-11250	60	13	is	be	AUX
ct-11250	60	14	to	to	PART
ct-11250	60	15	avoid	avoid	VERB
ct-11250	60	16	direct	direct	ADJ
ct-11250	60	17	skin	skin	NOUN
ct-11250	60	18	contact	contact	NOUN
ct-11250	60	19	since	since	SCONJ
ct-11250	60	20	many	many	ADJ
ct-11250	60	21	of	of	ADP
ct-11250	60	22	the	the	DET
ct-11250	60	23	hormones	hormone	NOUN
ct-11250	60	24	can	can	AUX
ct-11250	60	25	be	be	AUX
ct-11250	60	26	readily	readily	ADV
ct-11250	60	27	absorbed	absorb	VERB
ct-11250	60	28	through	through	ADP
ct-11250	60	29	unbroken	unbroken	ADJ
ct-11250	60	30	skin	skin	NOUN
ct-11250	60	31	.	.	PUNCT
ct-11250	61	1	because	because	SCONJ
ct-11250	61	2	of	of	ADP
ct-11250	61	3	that	that	DET
ct-11250	61	4	concern	concern	NOUN
ct-11250	61	5	,	,	PUNCT
ct-11250	61	6	most	most	ADJ
ct-11250	61	7	products	product	NOUN
ct-11250	61	8	list	list	VERB
ct-11250	61	9	specific	specific	ADJ
ct-11250	61	10	procedures	procedure	NOUN
ct-11250	61	11	to	to	PART
ct-11250	61	12	follow	follow	VERB
ct-11250	61	13	to	to	PART
ct-11250	61	14	avoid	avoid	VERB
ct-11250	61	15	direct	direct	ADJ
ct-11250	61	16	skin	skin	NOUN
ct-11250	61	17	contact	contact	NOUN
ct-11250	61	18	such	such	ADJ
ct-11250	61	19	as	as	ADP
ct-11250	61	20	wearing	wear	VERB
ct-11250	61	21	impervious	impervious	ADJ
ct-11250	61	22	gloves	glove	NOUN
ct-11250	61	23	during	during	ADP
ct-11250	61	24	drug	drug	NOUN
ct-11250	61	25	handling	handling	NOUN
ct-11250	61	26	and	and	CCONJ
ct-11250	61	27	appropriate	appropriate	ADJ
ct-11250	61	28	hand	hand	NOUN
ct-11250	61	29	washing	washing	NOUN
ct-11250	61	30	immediately	immediately	ADV
ct-11250	61	31	afterwards	afterwards	ADV
ct-11250	61	32	,	,	PUNCT
ct-11250	61	33	particularly	particularly	ADV
ct-11250	61	34	if	if	SCONJ
ct-11250	61	35	exposure	exposure	NOUN
ct-11250	61	36	is	be	AUX
ct-11250	61	37	known	know	VERB
ct-11250	61	38	to	to	PART
ct-11250	61	39	occur	occur	VERB
ct-11250	61	40	(	(	PUNCT
ct-11250	61	41	table	table	NOUN
ct-11250	61	42	2	2	NUM
ct-11250	61	43	)	)	PUNCT
ct-11250	61	44	.	.	PUNCT
ct-11250	62	1	in	in	ADP
ct-11250	62	2	the	the	DET
ct-11250	62	3	case	case	NOUN
ct-11250	62	4	of	of	ADP
ct-11250	62	5	accidental	accidental	ADJ
ct-11250	62	6	exposure	exposure	NOUN
ct-11250	62	7	through	through	ADP
ct-11250	62	8	other	other	ADJ
ct-11250	62	9	routes	route	NOUN
ct-11250	62	10	,	,	PUNCT
ct-11250	62	11	most	most	ADJ
ct-11250	62	12	manufacturers	manufacturer	NOUN
ct-11250	62	13	recommend	recommend	VERB
ct-11250	62	14	seeking	seek	VERB
ct-11250	62	15	medical	medical	ADJ
ct-11250	62	16	attention	attention	NOUN
ct-11250	62	17	or	or	CCONJ
ct-11250	62	18	consulting	consult	VERB
ct-11250	62	19	a	a	DET
ct-11250	62	20	physician	physician	NOUN
ct-11250	62	21	immediately	immediately	ADV
ct-11250	62	22	(	(	PUNCT
ct-11250	62	23	table	table	NOUN
ct-11250	62	24	2	2	NUM
ct-11250	62	25	)	)	PUNCT
ct-11250	62	26	.	.	PUNCT
ct-11250	63	1	although	although	SCONJ
ct-11250	63	2	safety	safety	NOUN
ct-11250	63	3	warnings	warning	NOUN
ct-11250	63	4	are	be	AUX
ct-11250	63	5	not	not	PART
ct-11250	63	6	usually	usually	ADV
ct-11250	63	7	provided	provide	VERB
ct-11250	63	8	with	with	ADP
ct-11250	63	9	compounded	compound	VERB
ct-11250	63	10	hormone	hormone	NOUN
ct-11250	63	11	products	product	NOUN
ct-11250	63	12	,	,	PUNCT
ct-11250	63	13	it	it	PRON
ct-11250	63	14	would	would	AUX
ct-11250	63	15	seem	seem	VERB
ct-11250	63	16	prudent	prudent	ADJ
ct-11250	63	17	to	to	PART
ct-11250	63	18	avoid	avoid	VERB
ct-11250	63	19	direct	direct	ADJ
ct-11250	63	20	contact	contact	NOUN
ct-11250	63	21	with	with	ADP
ct-11250	63	22	skin	skin	NOUN
ct-11250	63	23	by	by	ADP
ct-11250	63	24	wearing	wear	VERB
ct-11250	63	25	impervious	impervious	ADJ
ct-11250	63	26	gloves	glove	NOUN
ct-11250	63	27	and	and	CCONJ
ct-11250	63	28	if	if	SCONJ
ct-11250	63	29	contact	contact	NOUN
ct-11250	63	30	occurs	occur	VERB
ct-11250	63	31	to	to	PART
ct-11250	63	32	cleanse	cleanse	VERB
ct-11250	63	33	the	the	DET
ct-11250	63	34	affected	affected	ADJ
ct-11250	63	35	area	area	NOUN
ct-11250	63	36	appropriately	appropriately	ADV
ct-11250	63	37	,	,	PUNCT
ct-11250	63	38	and	and	CCONJ
ct-11250	63	39	for	for	ADP
ct-11250	63	40	other	other	ADJ
ct-11250	63	41	routes	route	NOUN
ct-11250	63	42	of	of	ADP
ct-11250	63	43	exposure	exposure	NOUN
ct-11250	63	44	to	to	PART
ct-11250	63	45	seek	seek	VERB
ct-11250	63	46	medical	medical	ADJ
ct-11250	63	47	attention	attention	NOUN
ct-11250	63	48	or	or	CCONJ
ct-11250	63	49	consult	consult	VERB
ct-11250	63	50	a	a	DET
ct-11250	63	51	physician	physician	NOUN
ct-11250	63	52	immediately	immediately	ADV
ct-11250	63	53	.	.	PUNCT
ct-11250	64	1	additional	additional	ADJ
ct-11250	64	2	information	information	NOUN
ct-11250	64	3	about	about	ADP
ct-11250	64	4	preventing	prevent	VERB
ct-11250	64	5	occupational	occupational	ADJ
ct-11250	64	6	exposure	exposure	NOUN
ct-11250	64	7	to	to	ADP
ct-11250	64	8	hazardous	hazardous	ADJ
ct-11250	64	9	drugs	drug	NOUN
ct-11250	64	10	is	be	AUX
ct-11250	64	11	available	available	ADJ
ct-11250	64	12	through	through	ADP
ct-11250	64	13	niosh.1,2	niosh.1,2	PROPN
ct-11250	64	14	in	in	ADP
ct-11250	64	15	summary	summary	NOUN
ct-11250	64	16	,	,	PUNCT
ct-11250	64	17	the	the	DET
ct-11250	64	18	use	use	NOUN
ct-11250	64	19	of	of	ADP
ct-11250	64	20	exogenous	exogenous	ADJ
ct-11250	64	21	reproductive	reproductive	ADJ
ct-11250	64	22	hormones	hormone	NOUN
ct-11250	64	23	and/or	and/or	CCONJ
ct-11250	64	24	hormone	hormone	NOUN
ct-11250	64	25	analogs	analog	NOUN
ct-11250	64	26	is	be	AUX
ct-11250	64	27	a	a	DET
ct-11250	64	28	mainstay	mainstay	NOUN
ct-11250	64	29	of	of	ADP
ct-11250	64	30	both	both	CCONJ
ct-11250	64	31	clinical	clinical	ADJ
ct-11250	64	32	practice	practice	NOUN
ct-11250	64	33	and	and	CCONJ
ct-11250	64	34	research	research	NOUN
ct-11250	64	35	activities	activity	NOUN
ct-11250	64	36	in	in	ADP
ct-11250	64	37	equine	equine	NOUN
ct-11250	64	38	reproduction	reproduction	NOUN
ct-11250	64	39	.	.	PUNCT
ct-11250	65	1	although	although	SCONJ
ct-11250	65	2	these	these	DET
ct-11250	65	3	agents	agent	NOUN
ct-11250	65	4	are	be	AUX
ct-11250	65	5	used	use	VERB
ct-11250	65	6	to	to	PART
ct-11250	65	7	regulate	regulate	VERB
ct-11250	65	8	reproductive	reproductive	ADJ
ct-11250	65	9	events	event	NOUN
ct-11250	65	10	in	in	ADP
ct-11250	65	11	horses	horse	NOUN
ct-11250	65	12	,	,	PUNCT
ct-11250	65	13	they	they	PRON
ct-11250	65	14	can	can	AUX
ct-11250	65	15	have	have	VERB
ct-11250	65	16	adverse	adverse	ADJ
ct-11250	65	17	effects	effect	NOUN
ct-11250	65	18	on	on	ADP
ct-11250	65	19	people	people	NOUN
ct-11250	65	20	,	,	PUNCT
ct-11250	65	21	particularly	particularly	ADV
ct-11250	65	22	women	woman	NOUN
ct-11250	65	23	,	,	PUNCT
ct-11250	65	24	who	who	PRON
ct-11250	65	25	handle	handle	VERB
ct-11250	65	26	and	and	CCONJ
ct-11250	65	27	administer	administer	VERB
ct-11250	65	28	them	they	PRON
ct-11250	65	29	if	if	SCONJ
ct-11250	65	30	appropriate	appropriate	ADJ
ct-11250	65	31	precautions	precaution	NOUN
ct-11250	65	32	are	be	AUX
ct-11250	65	33	not	not	PART
ct-11250	65	34	taken	take	VERB
ct-11250	65	35	.	.	PUNCT
ct-11250	66	1	for	for	ADP
ct-11250	66	2	hormone	hormone	NOUN
ct-11250	66	3	products	product	NOUN
ct-11250	66	4	that	that	PRON
ct-11250	66	5	are	be	AUX
ct-11250	66	6	provided	provide	VERB
ct-11250	66	7	with	with	ADP
ct-11250	66	8	them	they	PRON
ct-11250	66	9	,	,	PUNCT
ct-11250	66	10	manufacturer	manufacturer	NOUN
ct-11250	66	11	-	-	PUNCT
ct-11250	66	12	recommended	recommend	VERB
ct-11250	66	13	safety	safety	NOUN
ct-11250	66	14	warnings	warning	NOUN
ct-11250	66	15	should	should	AUX
ct-11250	66	16	be	be	AUX
ct-11250	66	17	noted	note	VERB
ct-11250	66	18	and	and	CCONJ
ct-11250	66	19	handling	handle	VERB
ct-11250	66	20	guidelines	guideline	NOUN
ct-11250	66	21	followed	follow	VERB
ct-11250	66	22	.	.	PUNCT
ct-11250	67	1	when	when	SCONJ
ct-11250	67	2	specific	specific	ADJ
ct-11250	67	3	warnings	warning	NOUN
ct-11250	67	4	and	and	CCONJ
ct-11250	67	5	guidelines	guideline	NOUN
ct-11250	67	6	are	be	AUX
ct-11250	67	7	not	not	PART
ct-11250	67	8	provided	provide	VERB
ct-11250	67	9	with	with	ADP
ct-11250	67	10	a	a	DET
ct-11250	67	11	product	product	NOUN
ct-11250	67	12	,	,	PUNCT
ct-11250	67	13	such	such	ADJ
ct-11250	67	14	as	as	ADP
ct-11250	67	15	compounded	compound	VERB
ct-11250	67	16	preparations	preparation	NOUN
ct-11250	67	17	,	,	PUNCT
ct-11250	67	18	heeding	heed	VERB
ct-11250	67	19	safety	safety	NOUN
ct-11250	67	20	warnings	warning	NOUN
ct-11250	67	21	and	and	CCONJ
ct-11250	67	22	handling	handle	VERB
ct-11250	67	23	guidelines	guideline	NOUN
ct-11250	67	24	such	such	ADJ
ct-11250	67	25	as	as	ADP
ct-11250	67	26	those	those	PRON
ct-11250	67	27	that	that	PRON
ct-11250	67	28	are	be	AUX
ct-11250	67	29	provided	provide	VERB
ct-11250	67	30	with	with	ADP
ct-11250	67	31	fda	fda	PROPN
ct-11250	67	32	-	-	PUNCT
ct-11250	67	33	approved	approve	VERB
ct-11250	67	34	products	product	NOUN
ct-11250	67	35	and/or	and/or	CCONJ
ct-11250	67	36	following	follow	VERB
ct-11250	67	37	niosh	niosh	PROPN
ct-11250	67	38	guidelines1,2	guidelines1,2	PROPN
ct-11250	67	39	would	would	AUX
ct-11250	67	40	be	be	AUX
ct-11250	67	41	a	a	DET
ct-11250	67	42	judicious	judicious	ADJ
ct-11250	67	43	course	course	NOUN
ct-11250	67	44	of	of	ADP
ct-11250	67	45	action	action	NOUN
ct-11250	67	46	.	.	PUNCT
ct-11250	68	1	references	reference	NOUN
ct-11250	68	2	1	1	NUM
ct-11250	68	3	.	.	PUNCT
ct-11250	69	1	niosh	niosh	PROPN
ct-11250	69	2	alert	alert	PROPN
ct-11250	69	3	:	:	PUNCT
ct-11250	69	4	preventing	prevent	VERB
ct-11250	69	5	occupational	occupational	ADJ
ct-11250	69	6	exposures	exposure	NOUN
ct-11250	69	7	to	to	ADP
ct-11250	69	8	antineoplastic	antineoplastic	ADJ
ct-11250	69	9	and	and	CCONJ
ct-11250	69	10	other	other	ADJ
ct-11250	69	11	hazardous	hazardous	ADJ
ct-11250	69	12	drugs	drug	NOUN
ct-11250	69	13	in	in	ADP
ct-11250	69	14	healthcare	healthcare	NOUN
ct-11250	69	15	settings	setting	NOUN
ct-11250	69	16	.	.	PUNCT
ct-11250	70	1	u.s	u.s	PROPN
ct-11250	70	2	.	.	PROPN
ct-11250	70	3	department	department	PROPN
ct-11250	70	4	of	of	ADP
ct-11250	70	5	health	health	PROPN
ct-11250	70	6	and	and	CCONJ
ct-11250	70	7	human	human	PROPN
ct-11250	70	8	services	service	NOUN
ct-11250	70	9	,	,	PUNCT
ct-11250	70	10	centers	center	NOUN
ct-11250	70	11	for	for	ADP
ct-11250	70	12	disease	disease	NOUN
ct-11250	70	13	control	control	NOUN
ct-11250	70	14	and	and	CCONJ
ct-11250	70	15	prevention	prevention	NOUN
ct-11250	70	16	,	,	PUNCT
ct-11250	70	17	national	national	PROPN
ct-11250	70	18	institute	institute	PROPN
ct-11250	70	19	for	for	ADP
ct-11250	70	20	occupational	occupational	ADJ
ct-11250	70	21	safety	safety	NOUN
ct-11250	70	22	and	and	CCONJ
ct-11250	70	23	health	health	NOUN
ct-11250	70	24	,	,	PUNCT
ct-11250	70	25	dhhs	dhhs	PROPN
ct-11250	70	26	(	(	PUNCT
ct-11250	70	27	niosh	niosh	PROPN
ct-11250	70	28	)	)	PUNCT
ct-11250	70	29	publication	publication	NOUN
ct-11250	70	30	no	no	INTJ
ct-11250	70	31	.	.	PUNCT
ct-11250	71	1	2004	2004	NUM
ct-11250	71	2	-	-	SYM
ct-11250	71	3	165	165	NUM
ct-11250	71	4	,	,	PUNCT
ct-11250	71	5	cincinnati	cincinnati	PROPN
ct-11250	71	6	,	,	PUNCT
ct-11250	71	7	oh	oh	INTJ
ct-11250	71	8	:	:	PUNCT
ct-11250	72	1	2004	2004	NUM
ct-11250	72	2	.	.	PUNCT
ct-11250	73	1	available	available	ADJ
ct-11250	73	2	on	on	ADP
ct-11250	73	3	-	-	PUNCT
ct-11250	73	4	line	line	NOUN
ct-11250	73	5	at	at	ADP
ct-11250	73	6	:	:	PUNCT
ct-11250	73	7	http://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf	http://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf	PROPN
ct-11250	73	8	.	.	PUNCT
ct-11250	74	1	2	2	X
ct-11250	74	2	.	.	X
ct-11250	74	3	niosh	niosh	PROPN
ct-11250	74	4	workplace	workplace	PROPN
ct-11250	74	5	solutions	solution	NOUN
ct-11250	74	6	:	:	PUNCT
ct-11250	74	7	safe	safe	ADJ
ct-11250	74	8	handling	handling	NOUN
ct-11250	74	9	of	of	ADP
ct-11250	74	10	hazardous	hazardous	ADJ
ct-11250	74	11	drugs	drug	NOUN
ct-11250	74	12	for	for	ADP
ct-11250	74	13	veterinary	veterinary	ADJ
ct-11250	74	14	healthcare	healthcare	NOUN
ct-11250	74	15	workers	worker	NOUN
ct-11250	74	16	.	.	PUNCT
ct-11250	75	1	u.s	u.s	PROPN
ct-11250	75	2	.	.	PROPN
ct-11250	75	3	department	department	PROPN
ct-11250	75	4	of	of	ADP
ct-11250	75	5	health	health	PROPN
ct-11250	75	6	and	and	CCONJ
ct-11250	75	7	human	human	PROPN
ct-11250	75	8	services	service	NOUN
ct-11250	75	9	,	,	PUNCT
ct-11250	75	10	centers	center	NOUN
ct-11250	75	11	for	for	ADP
ct-11250	75	12	disease	disease	NOUN
ct-11250	75	13	control	control	NOUN
ct-11250	75	14	and	and	CCONJ
ct-11250	75	15	prevention	prevention	NOUN
ct-11250	75	16	,	,	PUNCT
ct-11250	75	17	national	national	PROPN
ct-11250	75	18	institute	institute	PROPN
ct-11250	75	19	for	for	ADP
ct-11250	75	20	occupational	occupational	ADJ
ct-11250	75	21	safety	safety	NOUN
ct-11250	75	22	and	and	CCONJ
ct-11250	75	23	health	health	NOUN
ct-11250	75	24	,	,	PUNCT
ct-11250	75	25	dhhs	dhhs	PROPN
ct-11250	75	26	(	(	PUNCT
ct-11250	75	27	niosh	niosh	PROPN
ct-11250	75	28	)	)	PUNCT
ct-11250	75	29	publication	publication	NOUN
ct-11250	75	30	no	no	INTJ
ct-11250	75	31	.	.	PUNCT
ct-11250	76	1	2010	2010	NUM
ct-11250	76	2	-	-	SYM
ct-11250	76	3	150	150	NUM
ct-11250	76	4	,	,	PUNCT
ct-11250	76	5	cincinnati	cincinnati	PROPN
ct-11250	76	6	,	,	PUNCT
ct-11250	77	1	oh	oh	INTJ
ct-11250	77	2	:	:	PUNCT
ct-11250	77	3	2010	2010	NUM
ct-11250	77	4	.	.	PUNCT
ct-11250	78	1	available	available	ADJ
ct-11250	78	2	on	on	ADP
ct-11250	78	3	-	-	PUNCT
ct-11250	78	4	line	line	NOUN
ct-11250	78	5	at	at	ADP
ct-11250	78	6	:	:	PUNCT
ct-11250	78	7	http://www.cdc.gov/niosh/docs/wp-solutions/2010-150/pdfs/2010-150.pdf	http://www.cdc.gov/niosh/docs/wp-solutions/2010-150/pdfs/2010-150.pdf	PROPN
ct-11250	78	8	.	.	PUNCT
ct-11250	79	1	3	3	X
ct-11250	79	2	.	.	X
ct-11250	79	3	squires	squires	PROPN
ct-11250	79	4	el	el	PROPN
ct-11250	79	5	:	:	PUNCT
ct-11250	79	6	gonadotropin	gonadotropin	NOUN
ct-11250	79	7	-	-	PUNCT
ct-11250	79	8	releasing	release	VERB
ct-11250	79	9	hormones	hormone	NOUN
ct-11250	79	10	.	.	PUNCT
ct-11250	80	1	in	in	ADP
ct-11250	80	2	:	:	PUNCT
ct-11250	80	3	mckinnon	mckinnon	PROPN
ct-11250	80	4	ao	ao	PROPN
ct-11250	80	5	,	,	PUNCT
ct-11250	80	6	squires	squires	PROPN
ct-11250	80	7	el	el	PROPN
ct-11250	80	8	,	,	PUNCT
ct-11250	80	9	vaala	vaala	VERB
ct-11250	80	10	we	we	PRON
ct-11250	80	11	,	,	PUNCT
ct-11250	80	12	et	et	PROPN
ct-11250	80	13	al	al	PROPN
ct-11250	80	14	,	,	PUNCT
ct-11250	80	15	editors	editor	NOUN
ct-11250	80	16	.	.	PUNCT
ct-11250	81	1	equine	equine	NOUN
ct-11250	81	2	reproduction	reproduction	NOUN
ct-11250	81	3	.	.	PUNCT
ct-11250	82	1	2nd	2nd	ADJ
ct-11250	82	2	ed	ed	NOUN
ct-11250	82	3	.	.	PUNCT
ct-11250	83	1	oxford	oxford	PROPN
ct-11250	83	2	:	:	PUNCT
ct-11250	83	3	wiley	wiley	PROPN
ct-11250	83	4	-	-	PUNCT
ct-11250	83	5	blackwell	blackwell	PROPN
ct-11250	83	6	;	;	PUNCT
ct-11250	83	7	2011	2011	NUM
ct-11250	83	8	.	.	PUNCT
ct-11250	84	1	p.	p.	NOUN
ct-11250	84	2	1820	1820	NUM
ct-11250	84	3	-	-	SYM
ct-11250	84	4	1824	1824	NUM
ct-11250	84	5	.	.	PUNCT
ct-11250	85	1	4	4	X
ct-11250	85	2	.	.	X
ct-11250	85	3	mckinnon	mckinnon	PROPN
ct-11250	85	4	ao	ao	PROPN
ct-11250	85	5	,	,	PUNCT
ct-11250	85	6	mccue	mccue	PROPN
ct-11250	85	7	pm	pm	PROPN
ct-11250	85	8	:	:	PUNCT
ct-11250	85	9	induction	induction	NOUN
ct-11250	85	10	of	of	ADP
ct-11250	85	11	ovulation	ovulation	NOUN
ct-11250	85	12	.	.	PUNCT
ct-11250	86	1	in	in	ADP
ct-11250	86	2	:	:	PUNCT
ct-11250	86	3	mckinnon	mckinnon	PROPN
ct-11250	86	4	ao	ao	PROPN
ct-11250	86	5	,	,	PUNCT
ct-11250	86	6	squires	squires	PROPN
ct-11250	86	7	el	el	PROPN
ct-11250	86	8	,	,	PUNCT
ct-11250	86	9	vaala	vaala	VERB
ct-11250	86	10	we	we	PRON
ct-11250	86	11	,	,	PUNCT
ct-11250	86	12	et	et	PROPN
ct-11250	86	13	al	al	PROPN
ct-11250	86	14	,	,	PUNCT
ct-11250	86	15	editors	editor	NOUN
ct-11250	86	16	.	.	PUNCT
ct-11250	87	1	equine	equine	NOUN
ct-11250	87	2	reproduction	reproduction	NOUN
ct-11250	87	3	.	.	PUNCT
ct-11250	88	1	2nd	2nd	ADJ
ct-11250	88	2	ed	ed	NOUN
ct-11250	88	3	.	.	PUNCT
ct-11250	89	1	oxford	oxford	PROPN
ct-11250	89	2	:	:	PUNCT
ct-11250	89	3	wiley	wiley	PROPN
ct-11250	89	4	-	-	PUNCT
ct-11250	89	5	blackwell	blackwell	PROPN
ct-11250	89	6	;	;	PUNCT
ct-11250	89	7	2011	2011	NUM
ct-11250	89	8	.	.	PUNCT
ct-11250	90	1	p.	p.	NOUN
ct-11250	90	2	1858	1858	NUM
ct-11250	90	3	-	-	SYM
ct-11250	90	4	1869	1869	NUM
ct-11250	90	5	.	.	PUNCT
ct-11250	91	1	5	5	X
ct-11250	91	2	.	.	X
ct-11250	92	1	newcombe	newcombe	PROPN
ct-11250	92	2	jr	jr	PROPN
ct-11250	92	3	:	:	PUNCT
ct-11250	92	4	human	human	ADJ
ct-11250	92	5	chorionic	chorionic	ADJ
ct-11250	92	6	gonadotropin	gonadotropin	NOUN
ct-11250	92	7	.	.	PUNCT
ct-11250	93	1	in	in	ADP
ct-11250	93	2	:	:	PUNCT
ct-11250	93	3	mckinnon	mckinnon	PROPN
ct-11250	93	4	ao	ao	PROPN
ct-11250	93	5	,	,	PUNCT
ct-11250	93	6	squires	squires	PROPN
ct-11250	93	7	el	el	PROPN
ct-11250	93	8	,	,	PUNCT
ct-11250	93	9	vaala	vaala	VERB
ct-11250	93	10	we	we	PRON
ct-11250	93	11	,	,	PUNCT
ct-11250	93	12	et	et	PROPN
ct-11250	93	13	al	al	PROPN
ct-11250	93	14	,	,	PUNCT
ct-11250	93	15	editors	editor	NOUN
ct-11250	93	16	.	.	PUNCT
ct-11250	94	1	equine	equine	NOUN
ct-11250	94	2	reproduction	reproduction	NOUN
ct-11250	94	3	.	.	PUNCT
ct-11250	95	1	2nd	2nd	ADJ
ct-11250	95	2	ed	ed	NOUN
ct-11250	95	3	.	.	PUNCT
ct-11250	96	1	oxford	oxford	PROPN
ct-11250	96	2	:	:	PUNCT
ct-11250	96	3	wiley	wiley	PROPN
ct-11250	96	4	-	-	PUNCT
ct-11250	96	5	blackwell	blackwell	PROPN
ct-11250	96	6	;	;	PUNCT
ct-11250	96	7	2011	2011	NUM
ct-11250	96	8	.	.	PUNCT
ct-11250	97	1	p.	p.	NOUN
ct-11250	97	2	1804	1804	NUM
ct-11250	97	3	-	-	SYM
ct-11250	97	4	1810	1810	NUM
ct-11250	97	5	.	.	PUNCT
ct-11250	98	1	6	6	NUM
ct-11250	98	2	.	.	X
ct-11250	98	3	arighi	arighi	PROPN
ct-11250	98	4	m	m	PRON
ct-11250	98	5	:	:	PUNCT
ct-11250	98	6	testicular	testicular	ADJ
ct-11250	98	7	descent	descent	NOUN
ct-11250	98	8	.	.	PUNCT
ct-11250	99	1	in	in	ADP
ct-11250	99	2	:	:	PUNCT
ct-11250	99	3	mckinnon	mckinnon	PROPN
ct-11250	99	4	ao	ao	PROPN
ct-11250	99	5	,	,	PUNCT
ct-11250	99	6	squires	squires	PROPN
ct-11250	99	7	el	el	PROPN
ct-11250	99	8	,	,	PUNCT
ct-11250	99	9	vaala	vaala	VERB
ct-11250	99	10	we	we	PRON
ct-11250	99	11	,	,	PUNCT
ct-11250	99	12	et	et	PROPN
ct-11250	99	13	al	al	PROPN
ct-11250	99	14	,	,	PUNCT
ct-11250	99	15	editors	editor	NOUN
ct-11250	99	16	.	.	PUNCT
ct-11250	100	1	equine	equine	NOUN
ct-11250	100	2	reproduction	reproduction	NOUN
ct-11250	100	3	.	.	PUNCT
ct-11250	101	1	2nd	2nd	ADJ
ct-11250	101	2	ed	ed	NOUN
ct-11250	101	3	.	.	PUNCT
ct-11250	102	1	oxford	oxford	PROPN
ct-11250	102	2	:	:	PUNCT
ct-11250	102	3	wiley	wiley	PROPN
ct-11250	102	4	-	-	PUNCT
ct-11250	102	5	blackwell	blackwell	PROPN
ct-11250	102	6	;	;	PUNCT
ct-11250	102	7	2011	2011	NUM
ct-11250	102	8	.	.	PUNCT
ct-11250	103	1	p.	p.	NOUN
ct-11250	103	2	1099	1099	NUM
ct-11250	103	3	-	-	SYM
ct-11250	103	4	1106	1106	NUM
ct-11250	103	5	.	.	PUNCT
ct-11250	104	1	7	7	X
ct-11250	104	2	.	.	NUM
ct-11250	104	3	squires	squires	PROPN
ct-11250	104	4	el	el	PROPN
ct-11250	104	5	,	,	PUNCT
ct-11250	104	6	mccue	mccue	PROPN
ct-11250	104	7	pm	pm	PROPN
ct-11250	104	8	:	:	PUNCT
ct-11250	104	9	superovulation	superovulation	NOUN
ct-11250	104	10	.	.	PUNCT
ct-11250	105	1	in	in	ADP
ct-11250	105	2	:	:	PUNCT
ct-11250	105	3	mckinnon	mckinnon	PROPN
ct-11250	105	4	ao	ao	PROPN
ct-11250	105	5	,	,	PUNCT
ct-11250	105	6	squires	squires	PROPN
ct-11250	105	7	el	el	PROPN
ct-11250	105	8	,	,	PUNCT
ct-11250	105	9	vaala	vaala	VERB
ct-11250	105	10	we	we	PRON
ct-11250	105	11	,	,	PUNCT
ct-11250	105	12	et	et	PROPN
ct-11250	105	13	al	al	PROPN
ct-11250	105	14	,	,	PUNCT
ct-11250	105	15	editors	editor	NOUN
ct-11250	105	16	.	.	PUNCT
ct-11250	106	1	equine	equine	NOUN
ct-11250	106	2	reproduction	reproduction	NOUN
ct-11250	106	3	.	.	PUNCT
ct-11250	107	1	2nd	2nd	ADJ
ct-11250	107	2	ed	ed	NOUN
ct-11250	107	3	.	.	PUNCT
ct-11250	108	1	oxford	oxford	PROPN
ct-11250	108	2	:	:	PUNCT
ct-11250	108	3	wiley	wiley	PROPN
ct-11250	108	4	-	-	PUNCT
ct-11250	108	5	blackwell	blackwell	PROPN
ct-11250	108	6	;	;	PUNCT
ct-11250	108	7	2011	2011	NUM
ct-11250	108	8	.	.	PUNCT
ct-11250	109	1	p.	p.	NOUN
ct-11250	109	2	1836	1836	NUM
ct-11250	109	3	-	-	SYM
ct-11250	109	4	1844	1844	NUM
ct-11250	109	5	.	.	PUNCT
ct-11250	110	1	8	8	X
ct-11250	110	2	.	.	X
ct-11250	111	1	mccue	mccue	PROPN
ct-11250	111	2	pm	pm	PROPN
ct-11250	111	3	,	,	PUNCT
ct-11250	111	4	leblanc	leblanc	PROPN
ct-11250	111	5	mm	mm	PROPN
ct-11250	111	6	,	,	PUNCT
ct-11250	111	7	squires	squires	PROPN
ct-11250	111	8	el	el	PROPN
ct-11250	111	9	:	:	PUNCT
ct-11250	111	10	efsh	efsh	VERB
ct-11250	111	11	in	in	ADP
ct-11250	111	12	clinical	clinical	ADJ
ct-11250	111	13	equine	equine	NOUN
ct-11250	111	14	practice	practice	NOUN
ct-11250	111	15	.	.	PUNCT
ct-11250	112	1	theriogenology	theriogenology	NOUN
ct-11250	112	2	2007;68:429	2007;68:429	NUM
ct-11250	112	3	-	-	SYM
ct-11250	112	4	433	433	NUM
ct-11250	112	5	.	.	PUNCT
ct-11250	112	6	9	9	NUM
ct-11250	112	7	.	.	PUNCT
ct-11250	113	1	meyers	meyer	NOUN
ct-11250	113	2	-	-	PUNCT
ct-11250	113	3	brown	brown	PROPN
ct-11250	113	4	ga	ga	PROPN
ct-11250	113	5	,	,	PUNCT
ct-11250	113	6	mccue	mccue	PROPN
ct-11250	113	7	pm	pm	PROPN
ct-11250	113	8	,	,	PUNCT
ct-11250	113	9	niswender	niswender	NOUN
ct-11250	113	10	kd	kd	PROPN
ct-11250	113	11	,	,	PUNCT
ct-11250	113	12	et	et	PROPN
ct-11250	113	13	al	al	PROPN
ct-11250	113	14	:	:	PUNCT
ct-11250	113	15	superovulation	superovulation	NOUN
ct-11250	113	16	in	in	ADP
ct-11250	113	17	mares	mare	NOUN
ct-11250	113	18	using	use	VERB
ct-11250	113	19	recombinant	recombinant	ADJ
ct-11250	113	20	equine	equine	NOUN
ct-11250	113	21	follicle	follicle	NOUN
ct-11250	113	22	stimulating	stimulate	VERB
ct-11250	113	23	hormone	hormone	NOUN
ct-11250	113	24	:	:	PUNCT
ct-11250	113	25	ovulation	ovulation	NOUN
ct-11250	113	26	rates	rate	NOUN
ct-11250	113	27	,	,	PUNCT
ct-11250	113	28	embryo	embryo	NOUN
ct-11250	113	29	retrieval	retrieval	NOUN
ct-11250	113	30	,	,	PUNCT
ct-11250	113	31	and	and	CCONJ
ct-11250	113	32	hormone	hormone	NOUN
ct-11250	113	33	profiles	profile	NOUN
ct-11250	113	34	.	.	PUNCT
ct-11250	114	1	j	j	PROPN
ct-11250	114	2	equine	equine	PROPN
ct-11250	114	3	vet	vet	NOUN
ct-11250	114	4	sci	sci	PROPN
ct-11250	114	5	2010;30:560	2010;30:560	PROPN
ct-11250	114	6	-	-	PUNCT
ct-11250	114	7	568	568	NUM
ct-11250	114	8	.	.	PUNCT
ct-11250	114	9	10	10	NUM
ct-11250	114	10	.	.	PUNCT
ct-11250	115	1	tibary	tibary	PROPN
ct-11250	115	2	a	a	DET
ct-11250	115	3	:	:	PUNCT
ct-11250	115	4	estrogen	estrogen	NOUN
ct-11250	115	5	therapy	therapy	NOUN
ct-11250	115	6	.	.	PUNCT
ct-11250	116	1	in	in	ADP
ct-11250	116	2	:	:	PUNCT
ct-11250	116	3	mckinnon	mckinnon	PROPN
ct-11250	116	4	ao	ao	PROPN
ct-11250	116	5	,	,	PUNCT
ct-11250	116	6	squires	squires	PROPN
ct-11250	116	7	el	el	PROPN
ct-11250	116	8	,	,	PUNCT
ct-11250	116	9	vaala	vaala	VERB
ct-11250	116	10	we	we	PRON
ct-11250	116	11	,	,	PUNCT
ct-11250	116	12	et	et	PROPN
ct-11250	116	13	al	al	PROPN
ct-11250	116	14	,	,	PUNCT
ct-11250	116	15	editors	editor	NOUN
ct-11250	116	16	.	.	PUNCT
ct-11250	117	1	equine	equine	NOUN
ct-11250	117	2	reproduction	reproduction	NOUN
ct-11250	117	3	.	.	PUNCT
ct-11250	118	1	2nd	2nd	ADJ
ct-11250	118	2	ed	ed	NOUN
ct-11250	118	3	.	.	PUNCT
ct-11250	119	1	oxford	oxford	PROPN
ct-11250	119	2	:	:	PUNCT
ct-11250	119	3	wiley	wiley	PROPN
ct-11250	119	4	-	-	PUNCT
ct-11250	119	5	blackwell	blackwell	PROPN
ct-11250	119	6	;	;	PUNCT
ct-11250	119	7	2011	2011	NUM
ct-11250	119	8	.	.	PUNCT
ct-11250	120	1	p.	p.	NOUN
ct-11250	120	2	1825	1825	NUM
ct-11250	120	3	-	-	SYM
ct-11250	120	4	1829	1829	NUM
ct-11250	120	5	.	.	PUNCT
ct-11250	121	1	11	11	NUM
ct-11250	121	2	.	.	X
ct-11250	121	3	pinto	pinto	PROPN
ct-11250	121	4	crf	crf	PROPN
ct-11250	121	5	:	:	PUNCT
ct-11250	121	6	progestagens	progestagen	NOUN
ct-11250	121	7	and	and	CCONJ
ct-11250	121	8	progesterone	progesterone	NOUN
ct-11250	121	9	.	.	PUNCT
ct-11250	122	1	in	in	ADP
ct-11250	122	2	:	:	PUNCT
ct-11250	122	3	mckinnon	mckinnon	PROPN
ct-11250	122	4	ao	ao	PROPN
ct-11250	122	5	,	,	PUNCT
ct-11250	122	6	squires	squires	PROPN
ct-11250	122	7	el	el	PROPN
ct-11250	122	8	,	,	PUNCT
ct-11250	122	9	vaala	vaala	VERB
ct-11250	122	10	we	we	PRON
ct-11250	122	11	,	,	PUNCT
ct-11250	122	12	et	et	PROPN
ct-11250	122	13	al	al	PROPN
ct-11250	122	14	,	,	PUNCT
ct-11250	122	15	editors	editor	NOUN
ct-11250	122	16	.	.	PUNCT
ct-11250	123	1	equine	equine	NOUN
ct-11250	123	2	reproduction	reproduction	NOUN
ct-11250	123	3	.	.	PUNCT
ct-11250	124	1	2nd	2nd	ADJ
ct-11250	124	2	ed	ed	NOUN
ct-11250	124	3	.	.	PUNCT
ct-11250	125	1	oxford	oxford	PROPN
ct-11250	125	2	:	:	PUNCT
ct-11250	125	3	wiley	wiley	PROPN
ct-11250	125	4	-	-	PUNCT
ct-11250	125	5	blackwell	blackwell	PROPN
ct-11250	125	6	;	;	PUNCT
ct-11250	125	7	2011	2011	NUM
ct-11250	125	8	.	.	PUNCT
ct-11250	126	1	p.	p.	NOUN
ct-11250	126	2	1811	1811	NUM
ct-11250	126	3	-	-	SYM
ct-11250	126	4	1819	1819	NUM
ct-11250	126	5	.	.	PUNCT
ct-11250	127	1	12	12	NUM
ct-11250	127	2	.	.	PUNCT
ct-11250	128	1	squires	squires	PROPN
ct-11250	128	2	el	el	PROPN
ct-11250	128	3	,	,	PUNCT
ct-11250	128	4	badzinski	badzinski	ADJ
ct-11250	128	5	sl	sl	PROPN
ct-11250	128	6	,	,	PUNCT
ct-11250	128	7	amann	amann	PROPN
ct-11250	128	8	rp	rp	PROPN
ct-11250	128	9	,	,	PUNCT
ct-11250	128	10	et	et	PROPN
ct-11250	128	11	al	al	PROPN
ct-11250	128	12	:	:	PUNCT
ct-11250	128	13	effects	effect	NOUN
ct-11250	128	14	of	of	ADP
ct-11250	128	15	altrenogest	altrenogest	NOUN
ct-11250	128	16	on	on	ADP
ct-11250	128	17	total	total	ADJ
ct-11250	128	18	scrotal	scrotal	ADJ
ct-11250	128	19	width	width	NOUN
ct-11250	128	20	,	,	PUNCT
ct-11250	128	21	seminal	seminal	ADJ
ct-11250	128	22	characteristics	characteristic	NOUN
ct-11250	128	23	,	,	PUNCT
ct-11250	128	24	concentrations	concentration	NOUN
ct-11250	128	25	of	of	ADP
ct-11250	128	26	lh	lh	PROPN
ct-11250	128	27	and	and	CCONJ
ct-11250	128	28	testosterone	testosterone	NOUN
ct-11250	128	29	and	and	CCONJ
ct-11250	128	30	sexual	sexual	ADJ
ct-11250	128	31	behavior	behavior	NOUN
ct-11250	128	32	of	of	ADP
ct-11250	128	33	stallions	stallion	NOUN
ct-11250	128	34	.	.	PUNCT
ct-11250	129	1	theriogenology	theriogenology	NOUN
ct-11250	129	2	1997;48:313	1997;48:313	NUM
ct-11250	129	3	-	-	SYM
ct-11250	129	4	328	328	NUM
ct-11250	129	5	.	.	PUNCT
ct-11250	129	6	13	13	NUM
ct-11250	129	7	.	.	PUNCT
ct-11250	130	1	brady	brady	PROPN
ct-11250	130	2	ha	ha	PROPN
ct-11250	130	3	,	,	PUNCT
ct-11250	130	4	johnson	johnson	PROPN
ct-11250	130	5	nn	nn	PROPN
ct-11250	130	6	,	,	PUNCT
ct-11250	130	7	whisnant	whisnant	ADJ
ct-11250	130	8	cs	cs	PROPN
ct-11250	130	9	,	,	PUNCT
ct-11250	130	10	et	et	PROPN
ct-11250	130	11	al	al	PROPN
ct-11250	130	12	:	:	PUNCT
ct-11250	130	13	effects	effect	NOUN
ct-11250	130	14	of	of	ADP
ct-11250	130	15	oral	oral	ADJ
ct-11250	130	16	altrenogest	altrenogest	NOUN
ct-11250	130	17	on	on	ADP
ct-11250	130	18	testicular	testicular	ADJ
ct-11250	130	19	parameters	parameter	NOUN
ct-11250	130	20	,	,	PUNCT
ct-11250	130	21	steroidal	steroidal	NOUN
ct-11250	130	22	profiles	profile	NOUN
ct-11250	130	23	,	,	PUNCT
ct-11250	130	24	and	and	CCONJ
ct-11250	130	25	clinical	clinical	ADJ
ct-11250	130	26	theriogenology	theriogenology	NOUN
ct-11250	130	27	•	•	NOUN
ct-11250	130	28	volume	volume	NOUN
ct-11250	130	29	3	3	NUM
ct-11250	130	30	number	number	NOUN
ct-11250	130	31	4	4	NUM
ct-11250	130	32	•	•	NOUN
ct-11250	130	33	december	december	PROPN
ct-11250	130	34	2011clinical	2011clinical	ADJ
ct-11250	130	35	theriogenology	theriogenology	NOUN
ct-11250	130	36	•	•	NOUN
ct-11250	130	37	volume	volume	NOUN
ct-11250	130	38	4	4	NUM
ct-11250	130	39	number	number	NOUN
ct-11250	130	40	1	1	NUM
ct-11250	130	41	•	•	NUM
ct-11250	130	42	march	march	PROPN
ct-11250	130	43	201243	201243	NUM
ct-11250	130	44	clinical	clinical	ADJ
ct-11250	130	45	theriogenology	theriogenology	NOUN
ct-11250	130	46	•	•	NOUN
ct-11250	130	47	volume	volume	NOUN
ct-11250	130	48	4	4	NUM
ct-11250	130	49	number	number	NOUN
ct-11250	130	50	1	1	NUM
ct-11250	130	51	•	•	NUM
ct-11250	130	52	march	march	PROPN
ct-11250	130	53	2012	2012	NUM
ct-11250	130	54	seminal	seminal	ADJ
ct-11250	130	55	characteristics	characteristic	NOUN
ct-11250	130	56	in	in	ADP
ct-11250	130	57	young	young	ADJ
ct-11250	130	58	stallions	stallion	NOUN
ct-11250	130	59	.	.	PUNCT
ct-11250	131	1	proc	proc	PROPN
ct-11250	131	2	annu	annu	PROPN
ct-11250	131	3	conv	conv	PROPN
ct-11250	131	4	am	am	PROPN
ct-11250	131	5	assoc	assoc	PROPN
ct-11250	131	6	equine	equine	PROPN
ct-11250	131	7	pract	pract	PROPN
ct-11250	131	8	1997	1997	NUM
ct-11250	131	9	;	;	PUNCT
ct-11250	131	10	p.	p.	NOUN
ct-11250	131	11	195	195	NUM
ct-11250	131	12	-	-	SYM
ct-11250	131	13	196	196	NUM
ct-11250	131	14	.	.	PUNCT
ct-11250	132	1	14	14	NUM
ct-11250	132	2	.	.	PUNCT
ct-11250	133	1	miller	miller	PROPN
ct-11250	133	2	cd	cd	PROPN
ct-11250	133	3	,	,	PUNCT
ct-11250	133	4	varner	varner	PROPN
ct-11250	133	5	dd	dd	PROPN
ct-11250	133	6	,	,	PUNCT
ct-11250	133	7	blanchard	blanchard	PROPN
ct-11250	133	8	tl	tl	PROPN
ct-11250	133	9	,	,	PUNCT
ct-11250	133	10	et	et	PROPN
ct-11250	133	11	al	al	PROPN
ct-11250	133	12	:	:	PUNCT
ct-11250	133	13	effects	effect	NOUN
ct-11250	133	14	of	of	ADP
ct-11250	133	15	altrenogest	altrenogest	NOUN
ct-11250	133	16	on	on	ADP
ct-11250	133	17	behavior	behavior	NOUN
ct-11250	133	18	and	and	CCONJ
ct-11250	133	19	reproductive	reproductive	ADJ
ct-11250	133	20	function	function	NOUN
ct-11250	133	21	of	of	ADP
ct-11250	133	22	stallions	stallion	NOUN
ct-11250	133	23	.	.	PUNCT
ct-11250	134	1	proc	proc	PROPN
ct-11250	134	2	annu	annu	PROPN
ct-11250	134	3	conv	conv	PROPN
ct-11250	134	4	am	am	PROPN
ct-11250	134	5	assoc	assoc	PROPN
ct-11250	134	6	equine	equine	PROPN
ct-11250	134	7	pract	pract	PROPN
ct-11250	134	8	1997	1997	NUM
ct-11250	134	9	;	;	PUNCT
ct-11250	134	10	p.	p.	NOUN
ct-11250	134	11	197	197	NUM
ct-11250	134	12	-	-	SYM
ct-11250	134	13	198	198	NUM
ct-11250	134	14	.	.	PUNCT
ct-11250	134	15	15	15	NUM
ct-11250	134	16	.	.	PUNCT
ct-11250	135	1	mcdonnell	mcdonnell	PROPN
ct-11250	135	2	sm	sm	PROPN
ct-11250	135	3	:	:	PUNCT
ct-11250	135	4	practical	practical	ADJ
ct-11250	135	5	review	review	NOUN
ct-11250	135	6	of	of	ADP
ct-11250	135	7	self	self	NOUN
ct-11250	135	8	-	-	PUNCT
ct-11250	135	9	mutilation	mutilation	NOUN
ct-11250	135	10	in	in	ADP
ct-11250	135	11	horses	horse	NOUN
ct-11250	135	12	.	.	PUNCT
ct-11250	136	1	anim	anim	PROPN
ct-11250	136	2	reprod	reprod	PROPN
ct-11250	136	3	sci	sci	PROPN
ct-11250	136	4	2008;107:219	2008;107:219	NUM
ct-11250	136	5	-	-	SYM
ct-11250	136	6	228	228	NUM
ct-11250	136	7	.	.	PUNCT
ct-11250	136	8	16	16	NUM
ct-11250	136	9	.	.	PUNCT
ct-11250	137	1	mcdonnell	mcdonnell	PROPN
ct-11250	137	2	sm	sm	PROPN
ct-11250	137	3	:	:	PUNCT
ct-11250	137	4	pharmacological	pharmacological	ADJ
ct-11250	137	5	manipulation	manipulation	NOUN
ct-11250	137	6	of	of	ADP
ct-11250	137	7	stallion	stallion	NOUN
ct-11250	137	8	behavior	behavior	NOUN
ct-11250	137	9	.	.	PUNCT
ct-11250	138	1	in	in	ADP
ct-11250	138	2	:	:	PUNCT
ct-11250	138	3	mckinnon	mckinnon	PROPN
ct-11250	138	4	ao	ao	PROPN
ct-11250	138	5	,	,	PUNCT
ct-11250	138	6	squires	squires	PROPN
ct-11250	138	7	el	el	PROPN
ct-11250	138	8	,	,	PUNCT
ct-11250	138	9	vaala	vaala	VERB
ct-11250	138	10	we	we	PRON
ct-11250	138	11	,	,	PUNCT
ct-11250	138	12	et	et	PROPN
ct-11250	138	13	al	al	PROPN
ct-11250	138	14	,	,	PUNCT
ct-11250	138	15	editors	editor	NOUN
ct-11250	138	16	.	.	PUNCT
ct-11250	139	1	equine	equine	NOUN
ct-11250	139	2	reproduction	reproduction	NOUN
ct-11250	139	3	.	.	PUNCT
ct-11250	140	1	2nd	2nd	ADJ
ct-11250	140	2	ed	ed	NOUN
ct-11250	140	3	.	.	PUNCT
ct-11250	141	1	oxford	oxford	PROPN
ct-11250	141	2	:	:	PUNCT
ct-11250	141	3	wiley	wiley	PROPN
ct-11250	141	4	-	-	PUNCT
ct-11250	141	5	blackwell	blackwell	PROPN
ct-11250	141	6	;	;	PUNCT
ct-11250	141	7	2011	2011	NUM
ct-11250	141	8	.	.	PUNCT
ct-11250	142	1	p.	p.	NOUN
ct-11250	142	2	1415	1415	NUM
ct-11250	142	3	-	-	SYM
ct-11250	142	4	1418	1418	NUM
ct-11250	142	5	.	.	PUNCT
ct-11250	143	1	17	17	NUM
ct-11250	143	2	.	.	PUNCT
ct-11250	144	1	staempfli	staempfli	PROPN
ct-11250	144	2	sa	sa	PROPN
ct-11250	144	3	:	:	PUNCT
ct-11250	144	4	prostaglandins	prostaglandin	NOUN
ct-11250	144	5	.	.	PUNCT
ct-11250	145	1	in	in	ADP
ct-11250	145	2	:	:	PUNCT
ct-11250	145	3	mckinnon	mckinnon	PROPN
ct-11250	145	4	ao	ao	PROPN
ct-11250	145	5	,	,	PUNCT
ct-11250	145	6	squires	squires	PROPN
ct-11250	145	7	el	el	PROPN
ct-11250	145	8	,	,	PUNCT
ct-11250	145	9	vaala	vaala	VERB
ct-11250	145	10	we	we	PRON
ct-11250	145	11	,	,	PUNCT
ct-11250	145	12	et	et	PROPN
ct-11250	145	13	al	al	PROPN
ct-11250	145	14	,	,	PUNCT
ct-11250	145	15	editors	editor	NOUN
ct-11250	145	16	.	.	PUNCT
ct-11250	146	1	equine	equine	NOUN
ct-11250	146	2	reproduction	reproduction	NOUN
ct-11250	146	3	.	.	PUNCT
ct-11250	147	1	2nd	2nd	ADJ
ct-11250	147	2	ed	ed	NOUN
ct-11250	147	3	.	.	PUNCT
ct-11250	148	1	oxford	oxford	PROPN
ct-11250	148	2	:	:	PUNCT
ct-11250	148	3	wiley	wiley	PROPN
ct-11250	148	4	-	-	PUNCT
ct-11250	148	5	blackwell	blackwell	PROPN
ct-11250	148	6	;	;	PUNCT
ct-11250	148	7	2011	2011	NUM
ct-11250	148	8	.	.	PUNCT
ct-11250	149	1	p.	p.	NOUN
ct-11250	149	2	1797	1797	NUM
ct-11250	149	3	-	-	SYM
ct-11250	149	4	1803	1803	NUM
ct-11250	149	5	.	.	PUNCT
ct-11250	150	1	18	18	NUM
ct-11250	150	2	.	.	PUNCT
ct-11250	150	3	nie	nie	PROPN
ct-11250	150	4	gj	gj	PROPN
ct-11250	150	5	,	,	PUNCT
ct-11250	150	6	barnes	barnes	PROPN
ct-11250	150	7	aj	aj	PROPN
ct-11250	150	8	:	:	PUNCT
ct-11250	150	9	use	use	NOUN
ct-11250	150	10	of	of	ADP
ct-11250	150	11	prostaglandin	prostaglandin	NOUN
ct-11250	150	12	e1	e1	NOUN
ct-11250	150	13	to	to	PART
ct-11250	150	14	induce	induce	VERB
ct-11250	150	15	cervical	cervical	ADJ
ct-11250	150	16	relaxation	relaxation	NOUN
ct-11250	150	17	in	in	ADP
ct-11250	150	18	a	a	DET
ct-11250	150	19	maiden	maiden	ADJ
ct-11250	150	20	mare	mare	NOUN
ct-11250	150	21	with	with	ADP
ct-11250	150	22	post	post	NOUN
ct-11250	150	23	breeding	breeding	NOUN
ct-11250	150	24	endometritis	endometritis	NOUN
ct-11250	150	25	.	.	PUNCT
ct-11250	151	1	equine	equine	NOUN
ct-11250	151	2	vet	vet	NOUN
ct-11250	151	3	educ	educ	VERB
ct-11250	151	4	2003;5:221	2003;5:221	NOUN
ct-11250	151	5	-	-	SYM
ct-11250	151	6	224	224	NUM
ct-11250	151	7	.	.	PUNCT
ct-11250	152	1	19	19	NUM
ct-11250	152	2	.	.	PUNCT
ct-11250	152	3	rigby	rigby	PROPN
ct-11250	152	4	s	s	PROPN
ct-11250	152	5	,	,	PUNCT
ct-11250	152	6	love	love	NOUN
ct-11250	152	7	c	c	NOUN
ct-11250	152	8	,	,	PUNCT
ct-11250	152	9	carpenter	carpenter	PROPN
ct-11250	152	10	k	k	PROPN
ct-11250	152	11	,	,	PUNCT
ct-11250	152	12	et	et	PROPN
ct-11250	152	13	al	al	PROPN
ct-11250	152	14	:	:	PUNCT
ct-11250	152	15	use	use	NOUN
ct-11250	152	16	of	of	ADP
ct-11250	152	17	prostaglandin	prostaglandin	NOUN
ct-11250	152	18	e2	e2	PROPN
ct-11250	152	19	to	to	PART
ct-11250	152	20	ripen	ripen	VERB
ct-11250	152	21	the	the	DET
ct-11250	152	22	cervix	cervix	NOUN
ct-11250	152	23	of	of	ADP
ct-11250	152	24	the	the	DET
ct-11250	152	25	mare	mare	NOUN
ct-11250	152	26	prior	prior	ADV
ct-11250	152	27	to	to	ADP
ct-11250	152	28	induction	induction	NOUN
ct-11250	152	29	of	of	ADP
ct-11250	152	30	parturition	parturition	NOUN
ct-11250	152	31	.	.	PUNCT
ct-11250	153	1	theriogenology	theriogenology	NOUN
ct-11250	153	2	1998;50:897	1998;50:897	PROPN
ct-11250	153	3	-	-	SYM
ct-11250	153	4	904	904	NUM
ct-11250	153	5	.	.	PUNCT
ct-11250	153	6	20	20	NUM
ct-11250	153	7	.	.	PUNCT
ct-11250	154	1	woods	woods	PROPN
ct-11250	154	2	j	j	PROPN
ct-11250	154	3	,	,	PUNCT
ct-11250	154	4	rigby	rigby	PROPN
ct-11250	154	5	s	s	PROPN
ct-11250	154	6	,	,	PUNCT
ct-11250	154	7	brinsko	brinsko	PROPN
ct-11250	154	8	s	s	PART
ct-11250	154	9	,	,	PUNCT
ct-11250	154	10	et	et	PROPN
ct-11250	154	11	al	al	PROPN
ct-11250	154	12	:	:	PUNCT
ct-11250	154	13	effect	effect	NOUN
ct-11250	154	14	of	of	ADP
ct-11250	154	15	intrauterine	intrauterine	ADJ
ct-11250	154	16	treatment	treatment	NOUN
ct-11250	154	17	with	with	ADP
ct-11250	154	18	prostaglandin	prostaglandin	NOUN
ct-11250	154	19	e2	e2	NOUN
ct-11250	154	20	prior	prior	ADV
ct-11250	154	21	to	to	ADP
ct-11250	154	22	insemination	insemination	NOUN
ct-11250	154	23	of	of	ADP
ct-11250	154	24	mares	mare	NOUN
ct-11250	154	25	in	in	ADP
ct-11250	154	26	the	the	DET
ct-11250	154	27	uterine	uterine	ADJ
ct-11250	154	28	horn	horn	NOUN
ct-11250	154	29	or	or	CCONJ
ct-11250	154	30	body	body	NOUN
ct-11250	154	31	.	.	PUNCT
ct-11250	155	1	theriogenology	theriogenology	NOUN
ct-11250	155	2	2000;53:1827	2000;53:1827	PROPN
ct-11250	155	3	-	-	SYM
ct-11250	155	4	1836	1836	NUM
ct-11250	155	5	.	.	PUNCT
ct-11250	156	1	21	21	NUM
ct-11250	156	2	.	.	PUNCT
ct-11250	157	1	allen	allen	PROPN
ct-11250	157	2	wr	wr	PROPN
ct-11250	157	3	,	,	PUNCT
ct-11250	157	4	wilsher	wilsher	PROPN
ct-11250	157	5	s	s	PROPN
ct-11250	157	6	,	,	PUNCT
ct-11250	157	7	morris	morris	PROPN
ct-11250	157	8	l	l	PROPN
ct-11250	157	9	,	,	PUNCT
ct-11250	157	10	et	et	PROPN
ct-11250	157	11	al	al	PROPN
ct-11250	157	12	:	:	PUNCT
ct-11250	157	13	laparoscopic	laparoscopic	ADJ
ct-11250	157	14	application	application	NOUN
ct-11250	157	15	of	of	ADP
ct-11250	157	16	pge2	pge2	NOUN
ct-11250	157	17	to	to	PART
ct-11250	157	18	re	re	VERB
ct-11250	157	19	-	-	VERB
ct-11250	157	20	establish	establish	VERB
ct-11250	157	21	oviducal	oviducal	ADJ
ct-11250	157	22	patency	patency	NOUN
ct-11250	157	23	and	and	CCONJ
ct-11250	157	24	fertility	fertility	NOUN
ct-11250	157	25	in	in	ADP
ct-11250	157	26	infertile	infertile	ADJ
ct-11250	157	27	mares	mare	NOUN
ct-11250	157	28	:	:	PUNCT
ct-11250	157	29	a	a	DET
ct-11250	157	30	preliminary	preliminary	ADJ
ct-11250	157	31	study	study	NOUN
ct-11250	157	32	.	.	PUNCT
ct-11250	158	1	equine	equine	NOUN
ct-11250	158	2	vet	vet	NOUN
ct-11250	158	3	j	j	PROPN
ct-11250	158	4	2006;38:454	2006;38:454	PROPN
ct-11250	158	5	-	-	SYM
ct-11250	158	6	459	459	NUM
ct-11250	158	7	.	.	PUNCT
ct-11250	159	1	22	22	NUM
ct-11250	159	2	.	.	PUNCT
ct-11250	160	1	leblanc	leblanc	PROPN
ct-11250	160	2	mm	mm	PROPN
ct-11250	160	3	:	:	PUNCT
ct-11250	160	4	oxytocin	oxytocin	PROPN
ct-11250	160	5	.	.	PUNCT
ct-11250	161	1	in	in	ADP
ct-11250	161	2	:	:	PUNCT
ct-11250	161	3	mckinnon	mckinnon	PROPN
ct-11250	161	4	ao	ao	PROPN
ct-11250	161	5	,	,	PUNCT
ct-11250	161	6	squires	squires	PROPN
ct-11250	161	7	el	el	PROPN
ct-11250	161	8	,	,	PUNCT
ct-11250	161	9	vaala	vaala	VERB
ct-11250	161	10	we	we	PRON
ct-11250	161	11	,	,	PUNCT
ct-11250	161	12	et	et	PROPN
ct-11250	161	13	al	al	PROPN
ct-11250	161	14	,	,	PUNCT
ct-11250	161	15	editors	editor	NOUN
ct-11250	161	16	.	.	PUNCT
ct-11250	162	1	equine	equine	NOUN
ct-11250	162	2	reproduction	reproduction	NOUN
ct-11250	162	3	.	.	PUNCT
ct-11250	163	1	2nd	2nd	ADJ
ct-11250	163	2	ed	ed	NOUN
ct-11250	163	3	.	.	PUNCT
ct-11250	164	1	oxford	oxford	PROPN
ct-11250	164	2	:	:	PUNCT
ct-11250	164	3	wiley	wiley	PROPN
ct-11250	164	4	-	-	PUNCT
ct-11250	164	5	blackwell	blackwell	PROPN
ct-11250	164	6	;	;	PUNCT
ct-11250	164	7	2011	2011	NUM
ct-11250	164	8	.	.	PUNCT
ct-11250	165	1	p.	p.	NOUN
ct-11250	165	2	1830	1830	NUM
ct-11250	166	1	-	-	SYM
ct-11250	166	2	1835	1835	NUM
ct-11250	166	3	.	.	PUNCT
ct-11250	167	1	23	23	NUM
ct-11250	167	2	.	.	PUNCT
ct-11250	168	1	vanderwall	vanderwall	PROPN
ct-11250	168	2	dk	dk	PROPN
ct-11250	168	3	,	,	PUNCT
ct-11250	168	4	rasmussen	rasmussen	PROPN
ct-11250	168	5	dm	dm	PROPN
ct-11250	168	6	,	,	PUNCT
ct-11250	168	7	woods	woods	PROPN
ct-11250	168	8	gl	gl	NOUN
ct-11250	168	9	:	:	PUNCT
ct-11250	168	10	effect	effect	NOUN
ct-11250	168	11	of	of	ADP
ct-11250	168	12	repeated	repeat	VERB
ct-11250	168	13	administration	administration	NOUN
ct-11250	168	14	of	of	ADP
ct-11250	168	15	oxytocin	oxytocin	PROPN
ct-11250	168	16	during	during	ADP
ct-11250	168	17	diestrus	diestrus	NOUN
ct-11250	168	18	on	on	ADP
ct-11250	168	19	duration	duration	NOUN
ct-11250	168	20	of	of	ADP
ct-11250	168	21	function	function	NOUN
ct-11250	168	22	of	of	ADP
ct-11250	168	23	corpora	corpora	ADJ
ct-11250	168	24	lutea	lutea	NOUN
ct-11250	168	25	in	in	ADP
ct-11250	168	26	mares	mare	NOUN
ct-11250	168	27	.	.	PUNCT
ct-11250	169	1	j	j	PROPN
ct-11250	169	2	am	be	AUX
ct-11250	169	3	vet	vet	NOUN
ct-11250	169	4	med	med	ADJ
ct-11250	169	5	assoc	assoc	PROPN
ct-11250	169	6	2007;231:1864	2007;231:1864	NUM
ct-11250	169	7	-	-	SYM
ct-11250	169	8	1867	1867	NUM
ct-11250	169	9	.	.	PUNCT
ct-11250	170	1	24	24	NUM
ct-11250	170	2	.	.	PUNCT
ct-11250	171	1	vanderwall	vanderwall	PROPN
ct-11250	171	2	dk	dk	PROPN
ct-11250	171	3	,	,	PUNCT
ct-11250	171	4	rasmussen	rasmussen	PROPN
ct-11250	171	5	dm	dm	PROPN
ct-11250	171	6	,	,	PUNCT
ct-11250	171	7	carnahan	carnahan	PROPN
ct-11250	171	8	kg	kg	PROPN
ct-11250	171	9	,	,	PUNCT
ct-11250	171	10	et	et	PROPN
ct-11250	171	11	al	al	PROPN
ct-11250	171	12	:	:	PUNCT
ct-11250	171	13	effect	effect	NOUN
ct-11250	171	14	of	of	ADP
ct-11250	171	15	administration	administration	NOUN
ct-11250	171	16	of	of	ADP
ct-11250	171	17	oxytocin	oxytocin	PROPN
ct-11250	171	18	during	during	ADP
ct-11250	171	19	diestrus	diestrus	NOUN
ct-11250	171	20	on	on	ADP
ct-11250	171	21	corpus	corpus	PROPN
ct-11250	171	22	luteum	luteum	NOUN
ct-11250	171	23	function	function	NOUN
ct-11250	171	24	and	and	CCONJ
ct-11250	171	25	endometrial	endometrial	ADJ
ct-11250	171	26	oxytocin	oxytocin	NOUN
ct-11250	171	27	receptor	receptor	NOUN
ct-11250	171	28	concentration	concentration	NOUN
ct-11250	171	29	in	in	ADP
ct-11250	171	30	cycling	cycling	NOUN
ct-11250	171	31	mares	mare	NOUN
ct-11250	171	32	.	.	PUNCT
ct-11250	172	1	j	j	PROPN
ct-11250	172	2	equine	equine	PROPN
ct-11250	172	3	vet	vet	NOUN
ct-11250	172	4	sci	sci	PROPN
ct-11250	172	5	2012	2012	NUM
ct-11250	172	6	(	(	PUNCT
ct-11250	172	7	in	in	ADP
ct-11250	172	8	press	press	NOUN
ct-11250	172	9	)	)	PUNCT
ct-11250	172	10	.	.	PUNCT
ct-11250	173	1	clinical	clinical	ADJ
ct-11250	173	2	theriogenology	theriogenology	NOUN
ct-11250	173	3	•	•	NOUN
ct-11250	173	4	volume	volume	NOUN
ct-11250	173	5	3	3	NUM
ct-11250	173	6	number	number	NOUN
ct-11250	173	7	4	4	NUM
ct-11250	173	8	•	•	NOUN
ct-11250	173	9	december	december	PROPN
ct-11250	173	10	2011clinical	2011clinical	ADJ
ct-11250	173	11	theriogenology	theriogenology	NOUN
ct-11250	173	12	•	•	NOUN
ct-11250	173	13	volume	volume	NOUN
ct-11250	173	14	4	4	NUM
ct-11250	173	15	number	number	NOUN
ct-11250	173	16	1	1	NUM
ct-11250	173	17	•	•	NUM
ct-11250	173	18	march	march	PROPN
ct-11250	173	19	2012	2012	NUM
ct-11250	173	20	44clinical	44clinical	ADJ
ct-11250	173	21	theriogenology	theriogenology	NOUN
ct-11250	173	22	•	•	NOUN
ct-11250	173	23	volume	volume	NOUN
ct-11250	173	24	4	4	NUM
ct-11250	173	25	number	number	NOUN
ct-11250	173	26	1	1	NUM
ct-11250	173	27	•	•	NUM
ct-11250	173	28	march	march	PROPN
ct-11250	173	29	2012	2012	NUM
ct-11250	173	30	table	table	NOUN
ct-11250	173	31	1	1	NUM
ct-11250	173	32	.	.	PUNCT
ct-11250	173	33	exogenous	exogenous	ADJ
ct-11250	173	34	hormone	hormone	NOUN
ct-11250	173	35	preparations	preparation	NOUN
ct-11250	173	36	available	available	ADJ
ct-11250	173	37	for	for	ADP
ct-11250	173	38	equine	equine	NOUN
ct-11250	173	39	reproductive	reproductive	ADJ
ct-11250	173	40	management	management	NOUN
ct-11250	173	41	.	.	PUNCT
ct-11250	174	1	hormone	hormone	NOUN
ct-11250	174	2	product	product	NOUN
ct-11250	174	3	(	(	PUNCT
ct-11250	174	4	supplier	supplier	NOUN
ct-11250	174	5	)	)	PUNCT
ct-11250	174	6	dose	dose	NOUN
ct-11250	174	7	and	and	CCONJ
ct-11250	174	8	route(s	route(s	NOUN
ct-11250	174	9	)	)	PUNCT
ct-11250	174	10	of	of	ADP
ct-11250	174	11	administration	administration	NOUN
ct-11250	174	12	to	to	ADP
ct-11250	174	13	horses	horse	NOUN
ct-11250	174	14	primary	primary	ADJ
ct-11250	174	15	use(s	use(s	PROPN
ct-11250	174	16	)	)	PUNCT
ct-11250	174	17	in	in	ADP
ct-11250	174	18	horses	horse	NOUN
ct-11250	174	19	deslorelin	deslorelin	NOUN
ct-11250	174	20	acetate	acetate	NOUN
ct-11250	174	21	(	(	PUNCT
ct-11250	174	22	gnrh	gnrh	NOUN
ct-11250	174	23	analog	analog	NOUN
ct-11250	174	24	)	)	PUNCT
ct-11250	174	25	sucromate	sucromate	VERB
ct-11250	174	26	™	™	ADJ
ct-11250	174	27	equine	equine	NOUN
ct-11250	174	28	(	(	PUNCT
ct-11250	174	29	thorn	thorn	PROPN
ct-11250	174	30	bioscience	bioscience	PROPN
ct-11250	174	31	llc	llc	PROPN
ct-11250	174	32	,	,	PUNCT
ct-11250	174	33	louisville	louisville	PROPN
ct-11250	174	34	,	,	PUNCT
ct-11250	174	35	ky	ky	PROPN
ct-11250	174	36	)	)	PUNCT
ct-11250	174	37	1.8	1.8	NUM
ct-11250	174	38	mg	mg	NOUN
ct-11250	175	1	i	i	PRON
ct-11250	175	2	m	m	VERB
ct-11250	175	3	induction	induction	NOUN
ct-11250	175	4	of	of	ADP
ct-11250	175	5	ovulation	ovulation	NOUN
ct-11250	175	6	.	.	PUNCT
ct-11250	176	1	human	human	ADJ
ct-11250	176	2	chorionic	chorionic	ADJ
ct-11250	176	3	gonadotropin	gonadotropin	NOUN
ct-11250	176	4	(	(	PUNCT
ct-11250	176	5	lh	lh	NOUN
ct-11250	176	6	activity	activity	NOUN
ct-11250	176	7	)	)	PUNCT
ct-11250	176	8	chorulon	chorulon	NOUN
ct-11250	176	9	®	®	NOUN
ct-11250	176	10	(	(	PUNCT
ct-11250	176	11	intervet/	intervet/	NUM
ct-11250	176	12	schering	schering	NOUN
ct-11250	176	13	-	-	PUNCT
ct-11250	176	14	plough	plough	NOUN
ct-11250	176	15	animal	animal	NOUN
ct-11250	176	16	health	health	NOUN
ct-11250	176	17	,	,	PUNCT
ct-11250	176	18	summit	summit	NOUN
ct-11250	176	19	,	,	PUNCT
ct-11250	176	20	nj	nj	PROPN
ct-11250	176	21	)	)	PUNCT
ct-11250	176	22	mares	mare	NOUN
ct-11250	176	23	:	:	PUNCT
ct-11250	176	24	3	3	NUM
ct-11250	176	25	to	to	PART
ct-11250	176	26	5	5	NUM
ct-11250	176	27	units	unit	NOUN
ct-11250	176	28	/	/	SYM
ct-11250	176	29	kg	kg	NOUN
ct-11250	176	30	iv	iv	ADP
ct-11250	176	31	or	or	CCONJ
ct-11250	176	32	i	i	PRON
ct-11250	176	33	m	m	PROPN
ct-11250	176	34	stallions	stallion	NOUN
ct-11250	176	35	:	:	PUNCT
ct-11250	176	36	6,000	6,000	NUM
ct-11250	176	37	to	to	PART
ct-11250	176	38	12,000	12,000	NUM
ct-11250	176	39	units	unit	NOUN
ct-11250	176	40	iv	iv	NUM
ct-11250	176	41	mares	mare	NOUN
ct-11250	176	42	:	:	PUNCT
ct-11250	176	43	induction	induction	NOUN
ct-11250	176	44	of	of	ADP
ct-11250	176	45	ovulation	ovulation	NOUN
ct-11250	176	46	.	.	PUNCT
ct-11250	177	1	stallions	stallion	NOUN
ct-11250	177	2	:	:	PUNCT
ct-11250	177	3	diagnostic	diagnostic	ADJ
ct-11250	177	4	evaluation	evaluation	NOUN
ct-11250	177	5	for	for	ADP
ct-11250	177	6	testicular	testicular	ADJ
ct-11250	177	7	tissue	tissue	NOUN
ct-11250	177	8	(	(	PUNCT
ct-11250	177	9	i.e.	i.e.	X
ct-11250	177	10	,	,	PUNCT
ct-11250	177	11	cryptorchid	cryptorchid	NOUN
ct-11250	177	12	stallions	stallion	NOUN
ct-11250	177	13	)	)	PUNCT
ct-11250	177	14	.	.	PUNCT
ct-11250	178	1	equine	equine	NOUN
ct-11250	178	2	follicle	follicle	NOUN
ct-11250	178	3	stimulating	stimulate	VERB
ct-11250	178	4	hormone	hormone	NOUN
ct-11250	178	5	(	(	PUNCT
ct-11250	178	6	efsh	efsh	NOUN
ct-11250	178	7	)	)	PUNCT
ct-11250	178	8	commercial	commercial	ADJ
ct-11250	178	9	product	product	NOUN
ct-11250	178	10	not	not	PART
ct-11250	178	11	currently	currently	ADV
ct-11250	178	12	available	available	ADJ
ct-11250	178	13	na	na	ADP
ct-11250	178	14	when	when	SCONJ
ct-11250	178	15	a	a	DET
ct-11250	178	16	product	product	NOUN
ct-11250	178	17	was	be	AUX
ct-11250	178	18	available	available	ADJ
ct-11250	178	19	it	it	PRON
ct-11250	178	20	was	be	AUX
ct-11250	178	21	primarily	primarily	ADV
ct-11250	178	22	used	use	VERB
ct-11250	178	23	for	for	ADP
ct-11250	178	24	superovulation	superovulation	NOUN
ct-11250	178	25	in	in	ADP
ct-11250	178	26	embryo	embryo	NOUN
ct-11250	178	27	donor	donor	NOUN
ct-11250	178	28	mares	mare	NOUN
ct-11250	178	29	.	.	PUNCT
ct-11250	179	1	estradiol-17β	estradiol-17β	PROPN
ct-11250	179	2	and	and	CCONJ
ct-11250	179	3	conjugated	conjugate	VERB
ct-11250	179	4	estrogens	estrogen	NOUN
ct-11250	179	5	(	(	PUNCT
ct-11250	179	6	e.g.	e.g.	ADV
ct-11250	179	7	,	,	PUNCT
ct-11250	179	8	estradiol	estradiol	PROPN
ct-11250	179	9	cypionate	cypionate	PROPN
ct-11250	179	10	and	and	CCONJ
ct-11250	179	11	estradiol	estradiol	PROPN
ct-11250	179	12	benzoate	benzoate	PROPN
ct-11250	179	13	)	)	PUNCT
ct-11250	179	14	compounded	compound	VERB
ct-11250	179	15	formulations	formulation	NOUN
ct-11250	179	16	see	see	VERB
ct-11250	179	17	reference	reference	NOUN
ct-11250	179	18	#	#	SYM
ct-11250	179	19	10	10	NUM
ct-11250	179	20	1	1	NUM
ct-11250	179	21	)	)	PUNCT
ct-11250	179	22	induction	induction	NOUN
ct-11250	179	23	of	of	ADP
ct-11250	179	24	estrus	estrus	NOUN
ct-11250	179	25	behavior	behavior	NOUN
ct-11250	179	26	in	in	ADP
ct-11250	179	27	ovariectomized	ovariectomize	VERB
ct-11250	179	28	mares	mare	NOUN
ct-11250	179	29	.	.	PUNCT
ct-11250	180	1	2	2	X
ct-11250	180	2	)	)	PUNCT
ct-11250	180	3	pretreatment	pretreatment	NOUN
ct-11250	180	4	of	of	ADP
ct-11250	180	5	non	non	ADJ
ct-11250	180	6	-	-	ADJ
ct-11250	180	7	ovulating	ovulating	ADJ
ct-11250	180	8	(	(	PUNCT
ct-11250	180	9	or	or	CCONJ
ct-11250	180	10	ovariectomized	ovariectomized	ADJ
ct-11250	180	11	)	)	PUNCT
ct-11250	180	12	oocyte	oocyte	NOUN
ct-11250	180	13	or	or	CCONJ
ct-11250	180	14	embryo	embryo	NOUN
ct-11250	180	15	recipient	recipient	NOUN
ct-11250	180	16	mares	mare	NOUN
ct-11250	180	17	.	.	PUNCT
ct-11250	181	1	3	3	X
ct-11250	181	2	)	)	PUNCT
ct-11250	181	3	pretreatment	pretreatment	NOUN
ct-11250	181	4	of	of	ADP
ct-11250	181	5	spring	spring	NOUN
ct-11250	181	6	“	"	PUNCT
ct-11250	181	7	transitional	transitional	ADJ
ct-11250	181	8	”	"	PUNCT
ct-11250	181	9	mares	mare	NOUN
ct-11250	181	10	prior	prior	ADV
ct-11250	181	11	to	to	ADP
ct-11250	181	12	administration	administration	NOUN
ct-11250	181	13	of	of	ADP
ct-11250	181	14	dopamine	dopamine	NOUN
ct-11250	181	15	antagonists	antagonist	NOUN
ct-11250	181	16	(	(	PUNCT
ct-11250	181	17	e.g.	e.g.	ADV
ct-11250	181	18	,	,	PUNCT
ct-11250	181	19	sulpiride	sulpiride	ADV
ct-11250	181	20	)	)	PUNCT
ct-11250	181	21	to	to	PART
ct-11250	181	22	hasten	hasten	VERB
ct-11250	181	23	onset	onset	NOUN
ct-11250	181	24	of	of	ADP
ct-11250	181	25	ovulation	ovulation	NOUN
ct-11250	181	26	.	.	PUNCT
ct-11250	182	1	4	4	X
ct-11250	182	2	)	)	PUNCT
ct-11250	182	3	high	high	ADJ
ct-11250	182	4	-	-	PUNCT
ct-11250	182	5	risk	risk	NOUN
ct-11250	182	6	pregnant	pregnant	ADJ
ct-11250	182	7	mares	mare	NOUN
ct-11250	182	8	(	(	PUNCT
ct-11250	182	9	e.g.	e.g.	ADV
ct-11250	182	10	,	,	PUNCT
ct-11250	182	11	placentitis	placentitis	PROPN
ct-11250	182	12	)	)	PUNCT
ct-11250	182	13	.	.	PUNCT
ct-11250	183	1	progesterone	progesterone	NOUN
ct-11250	183	2	compounded	compound	VERB
ct-11250	183	3	formulations	formulation	NOUN
ct-11250	183	4	100	100	NUM
ct-11250	183	5	to	to	PART
ct-11250	183	6	300	300	NUM
ct-11250	183	7	mg	mg	NOUN
ct-11250	183	8	in	in	ADP
ct-11250	183	9	oil	oil	NOUN
ct-11250	183	10	once	once	ADV
ct-11250	183	11	daily	daily	ADV
ct-11250	183	12	i	i	PRON
ct-11250	183	13	m	m	VERB
ct-11250	183	14	or	or	CCONJ
ct-11250	183	15	1.5	1.5	NUM
ct-11250	183	16	to	to	ADP
ct-11250	183	17	2.0	2.0	NUM
ct-11250	183	18	grams	gram	NOUN
ct-11250	183	19	once	once	ADV
ct-11250	183	20	every	every	DET
ct-11250	183	21	7	7	NUM
ct-11250	183	22	to	to	PART
ct-11250	183	23	10	10	NUM
ct-11250	183	24	days	day	NOUN
ct-11250	183	25	for	for	ADP
ct-11250	183	26	long	long	ADV
ct-11250	183	27	-	-	PUNCT
ct-11250	183	28	acting	act	VERB
ct-11250	183	29	formulations	formulation	NOUN
ct-11250	183	30	1	1	NUM
ct-11250	183	31	)	)	PUNCT
ct-11250	183	32	hasten	hasten	VERB
ct-11250	183	33	onset	onset	NOUN
ct-11250	183	34	of	of	ADP
ct-11250	183	35	ovulation	ovulation	NOUN
ct-11250	183	36	in	in	ADP
ct-11250	183	37	spring	spring	NOUN
ct-11250	183	38	“	"	PUNCT
ct-11250	183	39	transition	transition	NOUN
ct-11250	183	40	”	"	PUNCT
ct-11250	183	41	mares	mare	NOUN
ct-11250	183	42	.	.	PUNCT
ct-11250	184	1	2	2	X
ct-11250	184	2	)	)	PUNCT
ct-11250	184	3	estrus	estrus	NOUN
ct-11250	184	4	suppression	suppression	NOUN
ct-11250	184	5	.	.	PUNCT
ct-11250	185	1	3	3	X
ct-11250	185	2	)	)	PUNCT
ct-11250	185	3	supplementation	supplementation	NOUN
ct-11250	185	4	of	of	ADP
ct-11250	185	5	endogenous	endogenous	ADJ
ct-11250	185	6	progesterone	progesterone	NOUN
ct-11250	185	7	in	in	ADP
ct-11250	185	8	pregnant	pregnant	ADJ
ct-11250	185	9	mares	mare	NOUN
ct-11250	185	10	.	.	PUNCT
ct-11250	186	1	4	4	X
ct-11250	186	2	)	)	PUNCT
ct-11250	186	3	maintenance	maintenance	NOUN
ct-11250	186	4	of	of	ADP
ct-11250	186	5	pregnancy	pregnancy	NOUN
ct-11250	186	6	in	in	ADP
ct-11250	186	7	non	non	ADJ
ct-11250	186	8	-	-	ADJ
ct-11250	186	9	ovulating	ovulating	ADJ
ct-11250	186	10	(	(	PUNCT
ct-11250	186	11	or	or	CCONJ
ct-11250	186	12	ovariectomized	ovariectomized	ADJ
ct-11250	186	13	)	)	PUNCT
ct-11250	186	14	oocyte	oocyte	NOUN
ct-11250	186	15	or	or	CCONJ
ct-11250	186	16	embryo	embryo	NOUN
ct-11250	186	17	recipient	recipient	NOUN
ct-11250	186	18	mares	mare	NOUN
ct-11250	186	19	.	.	PUNCT
ct-11250	187	1	5	5	X
ct-11250	187	2	)	)	PUNCT
ct-11250	187	3	high	high	ADJ
ct-11250	187	4	-	-	PUNCT
ct-11250	187	5	risk	risk	NOUN
ct-11250	187	6	pregnant	pregnant	ADJ
ct-11250	187	7	mares	mare	NOUN
ct-11250	187	8	(	(	PUNCT
ct-11250	187	9	e.g.	e.g.	ADV
ct-11250	187	10	,	,	PUNCT
ct-11250	187	11	placentitis	placentitis	PROPN
ct-11250	187	12	)	)	PUNCT
ct-11250	187	13	or	or	CCONJ
ct-11250	187	14	mares	mare	NOUN
ct-11250	187	15	with	with	ADP
ct-11250	187	16	severe	severe	ADJ
ct-11250	187	17	systemic	systemic	ADJ
ct-11250	187	18	illness	illness	NOUN
ct-11250	187	19	(	(	PUNCT
ct-11250	187	20	e.g.	e.g.	ADV
ct-11250	187	21	,	,	PUNCT
ct-11250	187	22	colic	colic	NOUN
ct-11250	187	23	/	/	SYM
ct-11250	187	24	endotoxemia	endotoxemia	NOUN
ct-11250	187	25	,	,	PUNCT
ct-11250	187	26	etc	etc	X
ct-11250	187	27	.	.	X
ct-11250	187	28	)	)	PUNCT
ct-11250	187	29	.	.	PUNCT
ct-11250	188	1	altrenogest	altrenog	ADJ
ct-11250	188	2	(	(	PUNCT
ct-11250	188	3	synthetic	synthetic	ADJ
ct-11250	188	4	progestin	progestin	NOUN
ct-11250	188	5	)	)	PUNCT
ct-11250	188	6	regumate	regumate	NOUN
ct-11250	188	7	®	®	NOUN
ct-11250	188	8	solution	solution	NOUN
ct-11250	188	9	0.22	0.22	NUM
ct-11250	188	10	%	%	NOUN
ct-11250	188	11	(	(	PUNCT
ct-11250	188	12	intervet/	intervet/	NUM
ct-11250	188	13	schering	schering	NOUN
ct-11250	188	14	-	-	PUNCT
ct-11250	188	15	plough	plough	NOUN
ct-11250	188	16	animal	animal	NOUN
ct-11250	188	17	health	health	NOUN
ct-11250	188	18	,	,	PUNCT
ct-11250	188	19	summit	summit	NOUN
ct-11250	188	20	,	,	PUNCT
ct-11250	188	21	nj	nj	PROPN
ct-11250	188	22	)	)	PUNCT
ct-11250	188	23	0.044	0.044	NUM
ct-11250	188	24	mg	mg	PROPN
ct-11250	188	25	/	/	SYM
ct-11250	188	26	kg	kg	PROPN
ct-11250	188	27	orally	orally	ADV
ct-11250	188	28	(	(	PUNCT
ct-11250	188	29	0.088	0.088	NUM
ct-11250	188	30	mg	mg	PROPN
ct-11250	188	31	/	/	SYM
ct-11250	188	32	kg	kg	PROPN
ct-11250	188	33	in	in	ADP
ct-11250	188	34	high	high	ADJ
ct-11250	188	35	-	-	PUNCT
ct-11250	188	36	risk	risk	NOUN
ct-11250	188	37	pregnant	pregnant	ADJ
ct-11250	188	38	mares	mare	NOUN
ct-11250	188	39	or	or	CCONJ
ct-11250	188	40	those	those	PRON
ct-11250	188	41	with	with	ADP
ct-11250	188	42	severe	severe	ADJ
ct-11250	188	43	systemic	systemic	ADJ
ct-11250	188	44	disease	disease	NOUN
ct-11250	188	45	)	)	PUNCT
ct-11250	188	46	1	1	NUM
ct-11250	188	47	)	)	PUNCT
ct-11250	188	48	hasten	hasten	VERB
ct-11250	188	49	onset	onset	NOUN
ct-11250	188	50	of	of	ADP
ct-11250	188	51	ovulation	ovulation	NOUN
ct-11250	188	52	in	in	ADP
ct-11250	188	53	spring	spring	NOUN
ct-11250	188	54	“	"	PUNCT
ct-11250	188	55	transition	transition	NOUN
ct-11250	188	56	”	"	PUNCT
ct-11250	188	57	mares	mare	NOUN
ct-11250	188	58	.	.	PUNCT
ct-11250	189	1	2	2	X
ct-11250	189	2	)	)	PUNCT
ct-11250	189	3	estrus	estrus	NOUN
ct-11250	189	4	suppression	suppression	NOUN
ct-11250	189	5	.	.	PUNCT
ct-11250	190	1	3	3	X
ct-11250	190	2	)	)	PUNCT
ct-11250	190	3	supplementation	supplementation	NOUN
ct-11250	190	4	of	of	ADP
ct-11250	190	5	endogenous	endogenous	ADJ
ct-11250	190	6	progesterone	progesterone	NOUN
ct-11250	190	7	in	in	ADP
ct-11250	190	8	pregnant	pregnant	ADJ
ct-11250	190	9	mares	mare	NOUN
ct-11250	190	10	.	.	PUNCT
ct-11250	191	1	4	4	X
ct-11250	191	2	)	)	PUNCT
ct-11250	191	3	maintenance	maintenance	NOUN
ct-11250	191	4	of	of	ADP
ct-11250	191	5	pregnancy	pregnancy	NOUN
ct-11250	191	6	in	in	ADP
ct-11250	191	7	non	non	ADJ
ct-11250	191	8	-	-	ADJ
ct-11250	191	9	ovulating	ovulating	ADJ
ct-11250	191	10	(	(	PUNCT
ct-11250	191	11	or	or	CCONJ
ct-11250	191	12	ovariectomized	ovariectomized	ADJ
ct-11250	191	13	)	)	PUNCT
ct-11250	191	14	oocyte	oocyte	NOUN
ct-11250	191	15	or	or	CCONJ
ct-11250	191	16	embryo	embryo	NOUN
ct-11250	191	17	recipient	recipient	NOUN
ct-11250	191	18	mares	mare	NOUN
ct-11250	191	19	.	.	PUNCT
ct-11250	192	1	5	5	X
ct-11250	192	2	)	)	PUNCT
ct-11250	192	3	high	high	ADJ
ct-11250	192	4	-	-	PUNCT
ct-11250	192	5	risk	risk	NOUN
ct-11250	192	6	pregnant	pregnant	ADJ
ct-11250	192	7	mares	mare	NOUN
ct-11250	192	8	(	(	PUNCT
ct-11250	192	9	e.g.	e.g.	ADV
ct-11250	192	10	,	,	PUNCT
ct-11250	192	11	placentitis	placentitis	PROPN
ct-11250	192	12	)	)	PUNCT
ct-11250	192	13	or	or	CCONJ
ct-11250	192	14	mares	mare	NOUN
ct-11250	192	15	with	with	ADP
ct-11250	192	16	severe	severe	ADJ
ct-11250	192	17	systemic	systemic	ADJ
ct-11250	192	18	illness	illness	NOUN
ct-11250	192	19	(	(	PUNCT
ct-11250	192	20	e.g.	e.g.	ADV
ct-11250	192	21	,	,	PUNCT
ct-11250	192	22	colic	colic	NOUN
ct-11250	192	23	/	/	SYM
ct-11250	192	24	endotoxemia	endotoxemia	NOUN
ct-11250	192	25	,	,	PUNCT
ct-11250	192	26	etc	etc	X
ct-11250	192	27	.	.	X
ct-11250	192	28	)	)	PUNCT
ct-11250	192	29	.	.	PUNCT
ct-11250	193	1	6	6	NUM
ct-11250	193	2	)	)	PUNCT
ct-11250	193	3	suppression	suppression	NOUN
ct-11250	193	4	of	of	ADP
ct-11250	193	5	sexual	sexual	ADJ
ct-11250	193	6	and	and	CCONJ
ct-11250	193	7	aggressive	aggressive	ADJ
ct-11250	193	8	behavior	behavior	NOUN
ct-11250	193	9	in	in	ADP
ct-11250	193	10	stallions	stallion	NOUN
ct-11250	193	11	.	.	PUNCT
ct-11250	194	1	7	7	X
ct-11250	194	2	)	)	PUNCT
ct-11250	194	3	treatment	treatment	NOUN
ct-11250	194	4	for	for	ADP
ct-11250	194	5	self	self	NOUN
ct-11250	194	6	-	-	PUNCT
ct-11250	194	7	mutilation	mutilation	NOUN
ct-11250	194	8	in	in	ADP
ct-11250	194	9	stallions	stallion	NOUN
ct-11250	194	10	and	and	CCONJ
ct-11250	194	11	geldings	gelding	NOUN
ct-11250	194	12	.	.	PUNCT
ct-11250	195	1	progesterone	progesterone	NOUN
ct-11250	195	2	and	and	CCONJ
ct-11250	195	3	estrogen	estrogen	NOUN
ct-11250	195	4	combination	combination	NOUN
ct-11250	195	5	compounded	compound	VERB
ct-11250	195	6	formulations	formulation	NOUN
ct-11250	195	7	150	150	NUM
ct-11250	195	8	mg	mg	NOUN
ct-11250	195	9	progesterone	progesterone	NOUN
ct-11250	195	10	and	and	CCONJ
ct-11250	195	11	10	10	NUM
ct-11250	195	12	mg	mg	PROPN
ct-11250	195	13	estradiol17β	estradiol17β	PROPN
ct-11250	195	14	/	/	SYM
ct-11250	195	15	day	day	NOUN
ct-11250	195	16	i	i	PRON
ct-11250	195	17	m	m	VERB
ct-11250	195	18	1	1	NUM
ct-11250	195	19	)	)	PUNCT
ct-11250	195	20	synchronization	synchronization	NOUN
ct-11250	195	21	of	of	ADP
ct-11250	195	22	estrus	estrus	PROPN
ct-11250	195	23	/	/	SYM
ct-11250	195	24	ovulation	ovulation	NOUN
ct-11250	195	25	.	.	PUNCT
ct-11250	196	1	2	2	X
ct-11250	196	2	)	)	PUNCT
ct-11250	196	3	delaying	delay	VERB
ct-11250	196	4	postpartum	postpartum	NOUN
ct-11250	196	5	estrus	estrus	NOUN
ct-11250	196	6	/	/	SYM
ct-11250	196	7	ovulation	ovulation	NOUN
ct-11250	196	8	.	.	PUNCT
ct-11250	197	1	clinical	clinical	ADJ
ct-11250	197	2	theriogenology	theriogenology	NOUN
ct-11250	197	3	•	•	NOUN
ct-11250	197	4	volume	volume	NOUN
ct-11250	197	5	3	3	NUM
ct-11250	197	6	number	number	NOUN
ct-11250	197	7	4	4	NUM
ct-11250	197	8	•	•	NOUN
ct-11250	197	9	december	december	PROPN
ct-11250	197	10	2011clinical	2011clinical	ADJ
ct-11250	197	11	theriogenology	theriogenology	NOUN
ct-11250	197	12	•	•	NOUN
ct-11250	197	13	volume	volume	NOUN
ct-11250	197	14	4	4	NUM
ct-11250	197	15	number	number	NOUN
ct-11250	197	16	1	1	NUM
ct-11250	197	17	•	•	NUM
ct-11250	197	18	march	march	PROPN
ct-11250	197	19	201245	201245	NUM
ct-11250	197	20	clinical	clinical	ADJ
ct-11250	197	21	theriogenology	theriogenology	NOUN
ct-11250	197	22	•	•	NOUN
ct-11250	197	23	volume	volume	NOUN
ct-11250	197	24	4	4	NUM
ct-11250	197	25	number	number	NOUN
ct-11250	197	26	1	1	NUM
ct-11250	197	27	•	•	NUM
ct-11250	197	28	march	march	PROPN
ct-11250	197	29	2012	2012	NUM
ct-11250	197	30	testosterone	testosterone	NOUN
ct-11250	197	31	compounded	compound	VERB
ct-11250	197	32	formulations	formulation	NOUN
ct-11250	197	33	80	80	NUM
ct-11250	197	34	to	to	PART
ct-11250	197	35	100	100	NUM
ct-11250	197	36	mg	mg	PROPN
ct-11250	197	37	testosterone	testosterone	NOUN
ct-11250	197	38	in	in	ADP
ct-11250	197	39	oil	oil	NOUN
ct-11250	197	40	every	every	DET
ct-11250	197	41	-	-	PUNCT
ct-11250	197	42	other	other	ADJ
ct-11250	197	43	-	-	PUNCT
ct-11250	197	44	day	day	NOUN
ct-11250	197	45	i	i	PRON
ct-11250	197	46	m	m	VERB
ct-11250	197	47	or	or	CCONJ
ct-11250	197	48	once	once	ADV
ct-11250	197	49	or	or	CCONJ
ct-11250	197	50	twice	twice	ADV
ct-11250	197	51	daily	daily	ADJ
ct-11250	197	52	trans	trans	ADJ
ct-11250	197	53	-	-	ADJ
ct-11250	197	54	dermal	dermal	ADJ
ct-11250	197	55	application	application	NOUN
ct-11250	197	56	enhancement	enhancement	NOUN
ct-11250	197	57	of	of	ADP
ct-11250	197	58	libido	libido	NOUN
ct-11250	197	59	in	in	ADP
ct-11250	197	60	stallions	stallion	NOUN
ct-11250	197	61	.	.	PUNCT
ct-11250	198	1	prostaglandin	prostaglandin	VERB
ct-11250	198	2	f2α	f2α	PROPN
ct-11250	198	3	(	(	PUNCT
ct-11250	198	4	dinoprost	dinoprost	PROPN
ct-11250	198	5	tromethamine	tromethamine	PROPN
ct-11250	198	6	)	)	PUNCT
ct-11250	198	7	lutalyse	lutalyse	PROPN
ct-11250	198	8	®	®	PROPN
ct-11250	198	9	(	(	PUNCT
ct-11250	198	10	pfizer	pfizer	NOUN
ct-11250	198	11	animal	animal	NOUN
ct-11250	198	12	health	health	NOUN
ct-11250	198	13	,	,	PUNCT
ct-11250	198	14	new	new	PROPN
ct-11250	198	15	york	york	PROPN
ct-11250	198	16	,	,	PUNCT
ct-11250	198	17	ny	ny	PROPN
ct-11250	198	18	)	)	PUNCT
ct-11250	198	19	0.01	0.01	NUM
ct-11250	198	20	to	to	PART
ct-11250	198	21	0.02	0.02	NUM
ct-11250	198	22	mg	mg	NUM
ct-11250	198	23	/	/	SYM
ct-11250	198	24	kg	kg	NOUN
ct-11250	198	25	i	i	NOUN
ct-11250	198	26	m	m	VERB
ct-11250	198	27	1	1	NUM
ct-11250	198	28	)	)	PUNCT
ct-11250	198	29	induction	induction	NOUN
ct-11250	198	30	of	of	ADP
ct-11250	198	31	luteolysis	luteolysis	NOUN
ct-11250	198	32	.	.	PUNCT
ct-11250	199	1	2	2	X
ct-11250	199	2	)	)	PUNCT
ct-11250	199	3	termination	termination	NOUN
ct-11250	199	4	of	of	ADP
ct-11250	199	5	pregnancy	pregnancy	NOUN
ct-11250	199	6	.	.	PUNCT
ct-11250	200	1	cloprostenol	cloprostenol	NOUN
ct-11250	200	2	(	(	PUNCT
ct-11250	200	3	pgf2α	pgf2α	NOUN
ct-11250	200	4	analog	analog	NOUN
ct-11250	200	5	)	)	PUNCT
ct-11250	200	6	estrumate	estrumate	ADJ
ct-11250	200	7	®	®	NOUN
ct-11250	200	8	(	(	PUNCT
ct-11250	200	9	intervet/	intervet/	NUM
ct-11250	200	10	schering	schering	NOUN
ct-11250	200	11	-	-	PUNCT
ct-11250	200	12	plough	plough	NOUN
ct-11250	200	13	animal	animal	NOUN
ct-11250	200	14	health	health	NOUN
ct-11250	200	15	,	,	PUNCT
ct-11250	200	16	summit	summit	NOUN
ct-11250	200	17	,	,	PUNCT
ct-11250	200	18	nj	nj	PROPN
ct-11250	200	19	)	)	PUNCT
ct-11250	200	20	0.5	0.5	NUM
ct-11250	200	21	μg	μg	PROPN
ct-11250	200	22	/	/	SYM
ct-11250	200	23	kg	kg	PROPN
ct-11250	200	24	i	i	NOUN
ct-11250	200	25	m	m	VERB
ct-11250	200	26	1	1	NUM
ct-11250	200	27	)	)	PUNCT
ct-11250	200	28	induction	induction	NOUN
ct-11250	200	29	of	of	ADP
ct-11250	200	30	luteolysis	luteolysis	NOUN
ct-11250	200	31	.	.	PUNCT
ct-11250	201	1	2	2	X
ct-11250	201	2	)	)	PUNCT
ct-11250	201	3	termination	termination	NOUN
ct-11250	201	4	of	of	ADP
ct-11250	201	5	pregnancy	pregnancy	NOUN
ct-11250	201	6	.	.	PUNCT
ct-11250	202	1	3	3	X
ct-11250	202	2	)	)	PUNCT
ct-11250	202	3	ecbolic	ecbolic	ADJ
ct-11250	202	4	for	for	ADP
ct-11250	202	5	uterine	uterine	ADJ
ct-11250	202	6	fluid	fluid	ADJ
ct-11250	202	7	evacuation	evacuation	NOUN
ct-11250	202	8	and/or	and/or	CCONJ
ct-11250	202	9	expulsion	expulsion	NOUN
ct-11250	202	10	of	of	ADP
ct-11250	202	11	retained	retain	VERB
ct-11250	202	12	fetal	fetal	ADJ
ct-11250	202	13	membranes	membrane	NOUN
ct-11250	202	14	.	.	PUNCT
ct-11250	203	1	misoprostol	misoprostol	NOUN
ct-11250	203	2	(	(	PUNCT
ct-11250	203	3	pge1	pge1	NOUN
ct-11250	203	4	analog	analog	NOUN
ct-11250	203	5	)	)	PUNCT
ct-11250	203	6	cytotec	cytotec	NOUN
ct-11250	203	7	®	®	NOUN
ct-11250	203	8	(	(	PUNCT
ct-11250	203	9	pfizer	pfizer	PROPN
ct-11250	203	10	inc	inc	PROPN
ct-11250	203	11	.	.	PROPN
ct-11250	203	12	,	,	PUNCT
ct-11250	203	13	new	new	PROPN
ct-11250	203	14	york	york	PROPN
ct-11250	203	15	,	,	PUNCT
ct-11250	203	16	ny	ny	PROPN
ct-11250	203	17	)	)	PUNCT
ct-11250	203	18	1.0	1.0	NUM
ct-11250	203	19	mg	mg	NOUN
ct-11250	203	20	topically	topically	ADV
ct-11250	203	21	to	to	AUX
ct-11250	203	22	cervix	cervix	VERB
ct-11250	203	23	cervical	cervical	ADJ
ct-11250	203	24	relaxation	relaxation	NOUN
ct-11250	203	25	in	in	ADP
ct-11250	203	26	nonpregnant	nonpregnant	ADJ
ct-11250	203	27	mares	mare	NOUN
ct-11250	203	28	.	.	PUNCT
ct-11250	204	1	prostaglandin	prostaglandin	PROPN
ct-11250	204	2	e2	e2	PROPN
ct-11250	204	3	(	(	PUNCT
ct-11250	204	4	dinoprostone	dinoprostone	NOUN
ct-11250	204	5	)	)	PUNCT
ct-11250	204	6	compounded	compound	VERB
ct-11250	204	7	formulations	formulation	NOUN
ct-11250	204	8	2.0	2.0	NUM
ct-11250	204	9	to	to	PART
ct-11250	204	10	2.5	2.5	NUM
ct-11250	204	11	mg	mg	NOUN
ct-11250	204	12	topically	topically	ADV
ct-11250	204	13	to	to	ADP
ct-11250	204	14	cervix	cervix	NOUN
ct-11250	204	15	or	or	CCONJ
ct-11250	204	16	0.25	0.25	NUM
ct-11250	204	17	mg	mg	NOUN
ct-11250	204	18	intrauterine	intrauterine	ADJ
ct-11250	204	19	1	1	NUM
ct-11250	204	20	)	)	PUNCT
ct-11250	204	21	cervical	cervical	ADJ
ct-11250	204	22	“	"	PUNCT
ct-11250	204	23	ripening	ripening	NOUN
ct-11250	204	24	”	"	PUNCT
ct-11250	204	25	prior	prior	ADV
ct-11250	204	26	to	to	ADP
ct-11250	204	27	induction	induction	NOUN
ct-11250	204	28	of	of	ADP
ct-11250	204	29	parturition	parturition	NOUN
ct-11250	204	30	.	.	PUNCT
ct-11250	205	1	2	2	X
ct-11250	205	2	)	)	PUNCT
ct-11250	205	3	enhanced	enhance	VERB
ct-11250	205	4	transport	transport	NOUN
ct-11250	205	5	of	of	ADP
ct-11250	205	6	spermatozoa	spermatozoon	NOUN
ct-11250	205	7	into	into	ADP
ct-11250	205	8	the	the	DET
ct-11250	205	9	oviduct	oviduct	NOUN
ct-11250	205	10	after	after	ADP
ct-11250	205	11	insemination	insemination	NOUN
ct-11250	205	12	.	.	PUNCT
ct-11250	206	1	prostaglandin	prostaglandin	PROPN
ct-11250	206	2	e2	e2	PROPN
ct-11250	206	3	(	(	PUNCT
ct-11250	206	4	dinoprostone	dinoprostone	NOUN
ct-11250	206	5	)	)	PUNCT
ct-11250	206	6	prepidil	prepidil	PROPN
ct-11250	206	7	®	®	NOUN
ct-11250	206	8	gel	gel	NOUN
ct-11250	206	9	(	(	PUNCT
ct-11250	206	10	pfizer	pfizer	PROPN
ct-11250	206	11	inc	inc	PROPN
ct-11250	206	12	.	.	PROPN
ct-11250	206	13	,	,	PUNCT
ct-11250	206	14	new	new	PROPN
ct-11250	206	15	york	york	PROPN
ct-11250	206	16	,	,	PUNCT
ct-11250	206	17	ny	ny	PROPN
ct-11250	206	18	)	)	PUNCT
ct-11250	206	19	0.2	0.2	NUM
ct-11250	206	20	mg	mg	NOUN
ct-11250	206	21	topically	topically	ADV
ct-11250	206	22	onto	onto	ADP
ct-11250	206	23	oviduct	oviduct	NOUN
ct-11250	206	24	restoration	restoration	NOUN
ct-11250	206	25	of	of	ADP
ct-11250	206	26	oviductal	oviductal	ADJ
ct-11250	206	27	patency	patency	NOUN
ct-11250	206	28	.	.	PUNCT
ct-11250	207	1	oxytocin	oxytocin	NOUN
ct-11250	207	2	many	many	ADJ
ct-11250	207	3	generic	generic	ADJ
ct-11250	207	4	formulations	formulation	NOUN
ct-11250	207	5	see	see	VERB
ct-11250	207	6	reference	reference	NOUN
ct-11250	207	7	#	#	SYM
ct-11250	207	8	22	22	NUM
ct-11250	207	9	1	1	NUM
ct-11250	207	10	)	)	PUNCT
ct-11250	207	11	ecbolic	ecbolic	ADJ
ct-11250	207	12	for	for	ADP
ct-11250	207	13	uterine	uterine	ADJ
ct-11250	207	14	fluid	fluid	ADJ
ct-11250	207	15	evacuation	evacuation	NOUN
ct-11250	207	16	.	.	PUNCT
ct-11250	208	1	2	2	X
ct-11250	208	2	)	)	PUNCT
ct-11250	208	3	disruption	disruption	NOUN
ct-11250	208	4	of	of	ADP
ct-11250	208	5	luteolysis	luteolysis	NOUN
ct-11250	208	6	to	to	PART
ct-11250	208	7	prolong	prolong	VERB
ct-11250	208	8	cl	cl	NOUN
ct-11250	208	9	function	function	NOUN
ct-11250	208	10	.	.	PUNCT
ct-11250	209	1	3	3	X
ct-11250	209	2	)	)	PUNCT
ct-11250	209	3	induction	induction	NOUN
ct-11250	209	4	of	of	ADP
ct-11250	209	5	parturition	parturition	NOUN
ct-11250	209	6	.	.	PUNCT
ct-11250	210	1	4	4	X
ct-11250	210	2	)	)	PUNCT
ct-11250	210	3	treatment	treatment	NOUN
ct-11250	210	4	of	of	ADP
ct-11250	210	5	retained	retain	VERB
ct-11250	210	6	fetal	fetal	ADJ
ct-11250	210	7	membranes	membrane	NOUN
ct-11250	210	8	.	.	PUNCT
ct-11250	211	1	clinical	clinical	ADJ
ct-11250	211	2	theriogenology	theriogenology	NOUN
ct-11250	211	3	•	•	NOUN
ct-11250	211	4	volume	volume	NOUN
ct-11250	211	5	3	3	NUM
ct-11250	211	6	number	number	NOUN
ct-11250	211	7	4	4	NUM
ct-11250	211	8	•	•	NOUN
ct-11250	211	9	december	december	PROPN
ct-11250	211	10	2011clinical	2011clinical	ADJ
ct-11250	211	11	theriogenology	theriogenology	NOUN
ct-11250	211	12	•	•	NOUN
ct-11250	211	13	volume	volume	NOUN
ct-11250	211	14	4	4	NUM
ct-11250	211	15	number	number	NOUN
ct-11250	211	16	1	1	NUM
ct-11250	211	17	•	•	NUM
ct-11250	211	18	march	march	PROPN
ct-11250	211	19	2012	2012	NUM
ct-11250	211	20	46clinical	46clinical	PROPN
ct-11250	211	21	theriogenology	theriogenology	NOUN
ct-11250	211	22	•	•	NOUN
ct-11250	211	23	volume	volume	NOUN
ct-11250	211	24	4	4	NUM
ct-11250	211	25	number	number	NOUN
ct-11250	211	26	1	1	NUM
ct-11250	211	27	•	•	NUM
ct-11250	211	28	march	march	PROPN
ct-11250	211	29	2012	2012	NUM
ct-11250	211	30	table	table	NOUN
ct-11250	211	31	2	2	NUM
ct-11250	211	32	.	.	PUNCT
ct-11250	211	33	exogenous	exogenous	ADJ
ct-11250	211	34	hormone	hormone	NOUN
ct-11250	211	35	preparations	preparation	NOUN
ct-11250	211	36	available	available	ADJ
ct-11250	211	37	for	for	ADP
ct-11250	211	38	equine	equine	NOUN
ct-11250	211	39	reproductive	reproductive	ADJ
ct-11250	211	40	management	management	NOUN
ct-11250	211	41	and	and	CCONJ
ct-11250	211	42	their	their	PRON
ct-11250	211	43	associated	associated	ADJ
ct-11250	211	44	safety	safety	NOUN
ct-11250	211	45	warnings	warning	NOUN
ct-11250	211	46	regarding	regard	VERB
ct-11250	211	47	inadvertent	inadvertent	ADJ
ct-11250	211	48	human	human	ADJ
ct-11250	211	49	exposure	exposure	NOUN
ct-11250	211	50	.	.	PUNCT
ct-11250	212	1	hormone	hormone	NOUN
ct-11250	212	2	product	product	NOUN
ct-11250	212	3	(	(	PUNCT
ct-11250	212	4	supplier	supplier	NOUN
ct-11250	212	5	)	)	PUNCT
ct-11250	212	6	safety	safety	NOUN
ct-11250	212	7	warning	warn	VERB
ct-11250	212	8	on	on	ADP
ct-11250	212	9	product	product	NOUN
ct-11250	212	10	label	label	NOUN
ct-11250	212	11	and/or	and/or	CCONJ
ct-11250	212	12	package	package	NOUN
ct-11250	212	13	insert	insert	NOUN
ct-11250	212	14	*	*	PUNCT
ct-11250	212	15	deslorelin	deslorelin	NOUN
ct-11250	212	16	acetate	acetate	NOUN
ct-11250	212	17	(	(	PUNCT
ct-11250	212	18	gnrh	gnrh	NOUN
ct-11250	212	19	analog	analog	NOUN
ct-11250	212	20	)	)	PUNCT
ct-11250	212	21	sucromate	sucromate	VERB
ct-11250	212	22	™	™	ADJ
ct-11250	212	23	equine	equine	NOUN
ct-11250	212	24	(	(	PUNCT
ct-11250	212	25	thorn	thorn	PROPN
ct-11250	212	26	bioscience	bioscience	PROPN
ct-11250	212	27	llc	llc	PROPN
ct-11250	212	28	,	,	PUNCT
ct-11250	212	29	louisville	louisville	PROPN
ct-11250	212	30	,	,	PUNCT
ct-11250	212	31	ky	ky	PROPN
ct-11250	212	32	)	)	PUNCT
ct-11250	212	33	pregnant	pregnant	ADJ
ct-11250	212	34	women	woman	NOUN
ct-11250	212	35	and	and	CCONJ
ct-11250	212	36	women	woman	NOUN
ct-11250	212	37	of	of	ADP
ct-11250	212	38	childbearing	childbeare	VERB
ct-11250	212	39	age	age	NOUN
ct-11250	212	40	should	should	AUX
ct-11250	212	41	exercise	exercise	VERB
ct-11250	212	42	caution	caution	NOUN
ct-11250	212	43	when	when	SCONJ
ct-11250	212	44	handling	handle	VERB
ct-11250	212	45	this	this	DET
ct-11250	212	46	product	product	NOUN
ct-11250	212	47	.	.	PUNCT
ct-11250	213	1	accidental	accidental	PROPN
ct-11250	213	2	administration	administration	PROPN
ct-11250	213	3	may	may	AUX
ct-11250	213	4	lead	lead	VERB
ct-11250	213	5	to	to	ADP
ct-11250	213	6	disruption	disruption	NOUN
ct-11250	213	7	of	of	ADP
ct-11250	213	8	the	the	DET
ct-11250	213	9	menstrual	menstrual	ADJ
ct-11250	213	10	cycle	cycle	NOUN
ct-11250	213	11	.	.	PUNCT
ct-11250	214	1	direct	direct	ADJ
ct-11250	214	2	contact	contact	NOUN
ct-11250	214	3	with	with	ADP
ct-11250	214	4	skin	skin	NOUN
ct-11250	214	5	should	should	AUX
ct-11250	214	6	be	be	AUX
ct-11250	214	7	avoided	avoid	VERB
ct-11250	214	8	.	.	PUNCT
ct-11250	215	1	insoluble	insoluble	ADJ
ct-11250	215	2	in	in	ADP
ct-11250	215	3	water	water	NOUN
ct-11250	215	4	:	:	PUNCT
ct-11250	215	5	if	if	SCONJ
ct-11250	215	6	direct	direct	ADJ
ct-11250	215	7	contact	contact	NOUN
ct-11250	215	8	with	with	ADP
ct-11250	215	9	skin	skin	NOUN
ct-11250	215	10	occurs	occur	VERB
ct-11250	215	11	,	,	PUNCT
ct-11250	215	12	first	first	ADV
ct-11250	215	13	wash	wash	VERB
ct-11250	215	14	with	with	ADP
ct-11250	215	15	alcohol	alcohol	NOUN
ct-11250	215	16	,	,	PUNCT
ct-11250	215	17	then	then	ADV
ct-11250	215	18	soap	soap	NOUN
ct-11250	215	19	and	and	CCONJ
ct-11250	215	20	water	water	NOUN
ct-11250	215	21	.	.	PUNCT
ct-11250	216	1	in	in	ADP
ct-11250	216	2	case	case	NOUN
ct-11250	216	3	of	of	ADP
ct-11250	216	4	accidental	accidental	ADJ
ct-11250	216	5	human	human	ADJ
ct-11250	216	6	injection	injection	NOUN
ct-11250	216	7	,	,	PUNCT
ct-11250	216	8	consult	consult	VERB
ct-11250	216	9	a	a	DET
ct-11250	216	10	physician	physician	NOUN
ct-11250	216	11	immediately	immediately	ADV
ct-11250	216	12	.	.	PUNCT
ct-11250	217	1	human	human	ADJ
ct-11250	217	2	chorionic	chorionic	ADJ
ct-11250	217	3	gonadotropin	gonadotropin	NOUN
ct-11250	217	4	(	(	PUNCT
ct-11250	217	5	lh	lh	NOUN
ct-11250	217	6	activity	activity	NOUN
ct-11250	217	7	)	)	PUNCT
ct-11250	217	8	chorulon	chorulon	NOUN
ct-11250	217	9	®	®	NOUN
ct-11250	217	10	(	(	PUNCT
ct-11250	217	11	intervet/	intervet/	NUM
ct-11250	217	12	schering	schering	NOUN
ct-11250	217	13	-	-	PUNCT
ct-11250	217	14	plough	plough	NOUN
ct-11250	217	15	animal	animal	NOUN
ct-11250	217	16	health	health	NOUN
ct-11250	217	17	,	,	PUNCT
ct-11250	217	18	summit	summit	NOUN
ct-11250	217	19	,	,	PUNCT
ct-11250	217	20	nj	nj	PROPN
ct-11250	217	21	)	)	PUNCT
ct-11250	217	22	no	no	DET
ct-11250	217	23	specific	specific	ADJ
ct-11250	217	24	safety	safety	NOUN
ct-11250	217	25	warning	warning	NOUN
ct-11250	217	26	regarding	regard	VERB
ct-11250	217	27	human	human	ADJ
ct-11250	217	28	exposure	exposure	NOUN
ct-11250	217	29	provided	provide	VERB
ct-11250	217	30	with	with	ADP
ct-11250	217	31	product	product	NOUN
ct-11250	217	32	.	.	PUNCT
ct-11250	218	1	*	*	PUNCT
ct-11250	219	1	*	*	PUNCT
ct-11250	219	2	equine	equine	NOUN
ct-11250	219	3	follicle	follicle	NOUN
ct-11250	219	4	stimulating	stimulate	VERB
ct-11250	219	5	hormone	hormone	NOUN
ct-11250	219	6	(	(	PUNCT
ct-11250	219	7	efsh	efsh	NOUN
ct-11250	219	8	)	)	PUNCT
ct-11250	219	9	commercial	commercial	ADJ
ct-11250	219	10	product	product	NOUN
ct-11250	219	11	not	not	PART
ct-11250	219	12	currently	currently	ADV
ct-11250	219	13	available	available	ADJ
ct-11250	219	14	na	na	ADP
ct-11250	219	15	estrogen	estrogen	NOUN
ct-11250	219	16	(	(	PUNCT
ct-11250	219	17	estradiol	estradiol	PROPN
ct-11250	219	18	17β	17β	NUM
ct-11250	219	19	or	or	CCONJ
ct-11250	219	20	conjugated	conjugate	VERB
ct-11250	219	21	estrogens	estrogen	NOUN
ct-11250	219	22	such	such	ADJ
ct-11250	219	23	as	as	ADP
ct-11250	219	24	estradiol	estradiol	PROPN
ct-11250	219	25	cypionate	cypionate	PROPN
ct-11250	219	26	)	)	PUNCT
ct-11250	219	27	compounded	compound	VERB
ct-11250	219	28	formulations	formulation	NOUN
ct-11250	219	29	no	no	DET
ct-11250	219	30	specific	specific	ADJ
ct-11250	219	31	safety	safety	NOUN
ct-11250	219	32	warning	warning	NOUN
ct-11250	219	33	regarding	regard	VERB
ct-11250	219	34	human	human	ADJ
ct-11250	219	35	exposure	exposure	NOUN
ct-11250	219	36	provided	provide	VERB
ct-11250	219	37	with	with	ADP
ct-11250	219	38	product	product	NOUN
ct-11250	219	39	.	.	PUNCT
ct-11250	220	1	*	*	PUNCT
ct-11250	220	2	*	*	PUNCT
ct-11250	220	3	progesterone	progesterone	NOUN
ct-11250	220	4	compounded	compound	VERB
ct-11250	220	5	formulations	formulation	NOUN
ct-11250	220	6	no	no	DET
ct-11250	220	7	specific	specific	ADJ
ct-11250	220	8	safety	safety	NOUN
ct-11250	220	9	warning	warning	NOUN
ct-11250	220	10	regarding	regard	VERB
ct-11250	220	11	human	human	ADJ
ct-11250	220	12	exposure	exposure	NOUN
ct-11250	220	13	provided	provide	VERB
ct-11250	220	14	with	with	ADP
ct-11250	220	15	product	product	NOUN
ct-11250	220	16	.	.	PUNCT
ct-11250	221	1	*	*	PUNCT
ct-11250	221	2	*	*	AUX
ct-11250	221	3	altrenogest	altrenog	ADJ
ct-11250	221	4	(	(	PUNCT
ct-11250	221	5	synthetic	synthetic	ADJ
ct-11250	221	6	progestin	progestin	NOUN
ct-11250	221	7	)	)	PUNCT
ct-11250	221	8	regumate	regumate	NOUN
ct-11250	221	9	®	®	NOUN
ct-11250	221	10	solution	solution	NOUN
ct-11250	221	11	0.22	0.22	NUM
ct-11250	221	12	%	%	NOUN
ct-11250	221	13	(	(	PUNCT
ct-11250	221	14	intervet/	intervet/	NUM
ct-11250	221	15	schering	schering	NOUN
ct-11250	221	16	-	-	PUNCT
ct-11250	221	17	plough	plough	NOUN
ct-11250	221	18	animal	animal	NOUN
ct-11250	221	19	health	health	NOUN
ct-11250	221	20	,	,	PUNCT
ct-11250	221	21	summit	summit	NOUN
ct-11250	221	22	,	,	PUNCT
ct-11250	221	23	nj	nj	PROPN
ct-11250	221	24	)	)	PUNCT
ct-11250	221	25	women	woman	NOUN
ct-11250	221	26	of	of	ADP
ct-11250	221	27	childbearing	childbeare	VERB
ct-11250	221	28	age	age	NOUN
ct-11250	221	29	should	should	AUX
ct-11250	221	30	exercise	exercise	VERB
ct-11250	221	31	extreme	extreme	ADJ
ct-11250	221	32	caution	caution	NOUN
ct-11250	221	33	when	when	SCONJ
ct-11250	221	34	handling	handle	VERB
ct-11250	221	35	this	this	DET
ct-11250	221	36	product	product	NOUN
ct-11250	221	37	.	.	PUNCT
ct-11250	222	1	regumate	regumate	NOUN
ct-11250	222	2	is	be	AUX
ct-11250	222	3	readily	readily	ADV
ct-11250	222	4	absorbed	absorb	VERB
ct-11250	222	5	through	through	ADP
ct-11250	222	6	unbroken	unbroken	ADJ
ct-11250	222	7	skin	skin	NOUN
ct-11250	222	8	.	.	PUNCT
ct-11250	223	1	impervious	impervious	ADJ
ct-11250	223	2	rubber	rubber	NOUN
ct-11250	223	3	or	or	CCONJ
ct-11250	223	4	vinyl	vinyl	NOUN
ct-11250	223	5	gloves	glove	NOUN
ct-11250	223	6	must	must	AUX
ct-11250	223	7	be	be	AUX
ct-11250	223	8	worn	wear	VERB
ct-11250	223	9	when	when	SCONJ
ct-11250	223	10	handling	handle	VERB
ct-11250	223	11	regumate	regumate	NOUN
ct-11250	223	12	.	.	PUNCT
ct-11250	224	1	accidental	accidental	ADJ
ct-11250	224	2	absorption	absorption	NOUN
ct-11250	224	3	could	could	AUX
ct-11250	224	4	lead	lead	VERB
ct-11250	224	5	to	to	ADP
ct-11250	224	6	disruption	disruption	NOUN
ct-11250	224	7	of	of	ADP
ct-11250	224	8	the	the	DET
ct-11250	224	9	menstrual	menstrual	ADJ
ct-11250	224	10	cycle	cycle	NOUN
ct-11250	224	11	,	,	PUNCT
ct-11250	224	12	abdominal	abdominal	ADJ
ct-11250	224	13	cramping	cramping	NOUN
ct-11250	224	14	,	,	PUNCT
ct-11250	224	15	increased	increase	VERB
ct-11250	224	16	or	or	CCONJ
ct-11250	224	17	decreased	decrease	VERB
ct-11250	224	18	uterine	uterine	ADJ
ct-11250	224	19	bleeding	bleeding	NOUN
ct-11250	224	20	,	,	PUNCT
ct-11250	224	21	prolongation	prolongation	NOUN
ct-11250	224	22	of	of	ADP
ct-11250	224	23	pregnancy	pregnancy	NOUN
ct-11250	224	24	or	or	CCONJ
ct-11250	224	25	headaches	headache	NOUN
ct-11250	224	26	.	.	PUNCT
ct-11250	225	1	if	if	SCONJ
ct-11250	225	2	direct	direct	ADJ
ct-11250	225	3	contact	contact	NOUN
ct-11250	225	4	with	with	ADP
ct-11250	225	5	skin	skin	NOUN
ct-11250	225	6	occurs	occur	VERB
ct-11250	225	7	wash	wash	VERB
ct-11250	225	8	immediately	immediately	ADV
ct-11250	225	9	with	with	ADP
ct-11250	225	10	soap	soap	NOUN
ct-11250	225	11	and	and	CCONJ
ct-11250	225	12	water	water	NOUN
ct-11250	225	13	.	.	PUNCT
ct-11250	226	1	for	for	ADP
ct-11250	226	2	eye	eye	NOUN
ct-11250	226	3	exposure	exposure	NOUN
ct-11250	226	4	flush	flush	ADJ
ct-11250	226	5	with	with	ADP
ct-11250	226	6	plenty	plenty	NOUN
ct-11250	226	7	of	of	ADP
ct-11250	226	8	water	water	NOUN
ct-11250	226	9	for	for	ADP
ct-11250	226	10	15	15	NUM
ct-11250	226	11	minutes	minute	NOUN
ct-11250	226	12	and	and	CCONJ
ct-11250	226	13	get	get	VERB
ct-11250	226	14	medical	medical	ADJ
ct-11250	226	15	attention	attention	NOUN
ct-11250	226	16	.	.	PUNCT
ct-11250	227	1	if	if	SCONJ
ct-11250	227	2	swallowed	swallow	VERB
ct-11250	227	3	do	do	AUX
ct-11250	227	4	not	not	PART
ct-11250	227	5	induce	induce	VERB
ct-11250	227	6	vomiting	vomiting	NOUN
ct-11250	227	7	,	,	PUNCT
ct-11250	227	8	call	call	VERB
ct-11250	227	9	a	a	DET
ct-11250	227	10	physician	physician	NOUN
ct-11250	227	11	.	.	PUNCT
ct-11250	228	1	combinations	combination	NOUN
ct-11250	228	2	of	of	ADP
ct-11250	228	3	progesterone	progesterone	NOUN
ct-11250	228	4	and	and	CCONJ
ct-11250	228	5	estrogen	estrogen	NOUN
ct-11250	228	6	compounded	compound	VERB
ct-11250	228	7	formulations	formulation	NOUN
ct-11250	228	8	no	no	DET
ct-11250	228	9	specific	specific	ADJ
ct-11250	228	10	safety	safety	NOUN
ct-11250	228	11	warning	warning	NOUN
ct-11250	228	12	regarding	regard	VERB
ct-11250	228	13	human	human	ADJ
ct-11250	228	14	exposure	exposure	NOUN
ct-11250	228	15	provided	provide	VERB
ct-11250	228	16	with	with	ADP
ct-11250	228	17	product	product	NOUN
ct-11250	228	18	.	.	PUNCT
ct-11250	229	1	*	*	PUNCT
ct-11250	229	2	*	*	PUNCT
ct-11250	229	3	testosterone	testosterone	NOUN
ct-11250	229	4	compounded	compound	VERB
ct-11250	229	5	formulations	formulation	NOUN
ct-11250	229	6	no	no	DET
ct-11250	229	7	specific	specific	ADJ
ct-11250	229	8	safety	safety	NOUN
ct-11250	229	9	warning	warning	NOUN
ct-11250	229	10	regarding	regard	VERB
ct-11250	229	11	human	human	ADJ
ct-11250	229	12	exposure	exposure	NOUN
ct-11250	229	13	provided	provide	VERB
ct-11250	229	14	with	with	ADP
ct-11250	229	15	product	product	NOUN
ct-11250	229	16	.	.	PUNCT
ct-11250	230	1	*	*	PUNCT
ct-11250	230	2	*	*	PUNCT
ct-11250	230	3	prostaglandin	prostaglandin	VERB
ct-11250	230	4	f2α	f2α	PROPN
ct-11250	230	5	(	(	PUNCT
ct-11250	230	6	dinoprost	dinoprost	PROPN
ct-11250	230	7	tromethamine	tromethamine	PROPN
ct-11250	230	8	)	)	PUNCT
ct-11250	230	9	lutalyse	lutalyse	PROPN
ct-11250	230	10	®	®	PROPN
ct-11250	230	11	(	(	PUNCT
ct-11250	230	12	pfizer	pfizer	NOUN
ct-11250	230	13	animal	animal	NOUN
ct-11250	230	14	health	health	NOUN
ct-11250	230	15	,	,	PUNCT
ct-11250	230	16	new	new	PROPN
ct-11250	230	17	york	york	PROPN
ct-11250	230	18	,	,	PUNCT
ct-11250	230	19	ny	ny	PROPN
ct-11250	230	20	)	)	PUNCT
ct-11250	230	21	women	woman	NOUN
ct-11250	230	22	of	of	ADP
ct-11250	230	23	childbearing	childbeare	VERB
ct-11250	230	24	age	age	NOUN
ct-11250	230	25	,	,	PUNCT
ct-11250	230	26	asthmatics	asthmatic	NOUN
ct-11250	230	27	,	,	PUNCT
ct-11250	230	28	and	and	CCONJ
ct-11250	230	29	persons	person	NOUN
ct-11250	230	30	with	with	ADP
ct-11250	230	31	bronchial	bronchial	ADJ
ct-11250	230	32	or	or	CCONJ
ct-11250	230	33	other	other	ADJ
ct-11250	230	34	respiratory	respiratory	ADJ
ct-11250	230	35	problems	problem	NOUN
ct-11250	230	36	should	should	AUX
ct-11250	230	37	exercise	exercise	VERB
ct-11250	230	38	extreme	extreme	ADJ
ct-11250	230	39	caution	caution	NOUN
ct-11250	230	40	when	when	SCONJ
ct-11250	230	41	handling	handle	VERB
ct-11250	230	42	this	this	DET
ct-11250	230	43	product	product	NOUN
ct-11250	230	44	.	.	PUNCT
ct-11250	231	1	lutalyse	lutalyse	PROPN
ct-11250	231	2	is	be	AUX
ct-11250	231	3	readily	readily	ADV
ct-11250	231	4	absorbed	absorb	VERB
ct-11250	231	5	through	through	ADP
ct-11250	231	6	the	the	DET
ct-11250	231	7	skin	skin	NOUN
ct-11250	231	8	and	and	CCONJ
ct-11250	231	9	may	may	AUX
ct-11250	231	10	cause	cause	VERB
ct-11250	231	11	abortion	abortion	NOUN
ct-11250	231	12	.	.	PUNCT
ct-11250	232	1	if	if	SCONJ
ct-11250	232	2	direct	direct	ADJ
ct-11250	232	3	contact	contact	NOUN
ct-11250	232	4	with	with	ADP
ct-11250	232	5	skin	skin	NOUN
ct-11250	232	6	occurs	occur	VERB
ct-11250	232	7	wash	wash	VERB
ct-11250	232	8	with	with	ADP
ct-11250	232	9	soap	soap	NOUN
ct-11250	232	10	and	and	CCONJ
ct-11250	232	11	water	water	NOUN
ct-11250	232	12	.	.	PUNCT
ct-11250	233	1	[	[	X
ct-11250	233	2	note	note	NOUN
ct-11250	233	3	:	:	PUNCT
ct-11250	233	4	because	because	SCONJ
ct-11250	233	5	of	of	ADP
ct-11250	233	6	its	its	PRON
ct-11250	233	7	known	know	VERB
ct-11250	233	8	side	side	NOUN
ct-11250	233	9	effects	effect	NOUN
ct-11250	233	10	,	,	PUNCT
ct-11250	233	11	it	it	PRON
ct-11250	233	12	would	would	AUX
ct-11250	233	13	seem	seem	VERB
ct-11250	233	14	prudent	prudent	ADJ
ct-11250	233	15	that	that	SCONJ
ct-11250	233	16	pregnant	pregnant	ADJ
ct-11250	233	17	women	woman	NOUN
ct-11250	233	18	use	use	VERB
ct-11250	233	19	extreme	extreme	ADJ
ct-11250	233	20	caution	caution	NOUN
ct-11250	233	21	and/or	and/or	CCONJ
ct-11250	233	22	avoid	avoid	VERB
ct-11250	233	23	handling	handle	VERB
ct-11250	233	24	this	this	DET
ct-11250	233	25	product	product	NOUN
ct-11250	233	26	for	for	ADP
ct-11250	233	27	veterinary	veterinary	ADJ
ct-11250	233	28	use	use	NOUN
ct-11250	233	29	]	]	PUNCT
ct-11250	233	30	.	.	PUNCT
ct-11250	234	1	clinical	clinical	ADJ
ct-11250	234	2	theriogenology	theriogenology	NOUN
ct-11250	234	3	•	•	NOUN
ct-11250	234	4	volume	volume	NOUN
ct-11250	234	5	3	3	NUM
ct-11250	234	6	number	number	NOUN
ct-11250	234	7	4	4	NUM
ct-11250	234	8	•	•	NOUN
ct-11250	234	9	december	december	PROPN
ct-11250	234	10	2011clinical	2011clinical	ADJ
ct-11250	234	11	theriogenology	theriogenology	NOUN
ct-11250	234	12	•	•	NOUN
ct-11250	234	13	volume	volume	NOUN
ct-11250	234	14	4	4	NUM
ct-11250	234	15	number	number	NOUN
ct-11250	234	16	1	1	NUM
ct-11250	234	17	•	•	NUM
ct-11250	234	18	march	march	PROPN
ct-11250	234	19	201247	201247	NUM
ct-11250	234	20	clinical	clinical	ADJ
ct-11250	234	21	theriogenology	theriogenology	NOUN
ct-11250	234	22	•	•	NOUN
ct-11250	234	23	volume	volume	NOUN
ct-11250	234	24	4	4	NUM
ct-11250	234	25	number	number	NOUN
ct-11250	234	26	1	1	NUM
ct-11250	234	27	•	•	NUM
ct-11250	234	28	march	march	PROPN
ct-11250	234	29	2012	2012	NUM
ct-11250	234	30	cloprostenol	cloprostenol	NOUN
ct-11250	234	31	(	(	PUNCT
ct-11250	234	32	pgf2α	pgf2α	NOUN
ct-11250	234	33	analog	analog	NOUN
ct-11250	234	34	)	)	PUNCT
ct-11250	234	35	estrumate	estrumate	ADJ
ct-11250	234	36	®	®	NOUN
ct-11250	234	37	(	(	PUNCT
ct-11250	234	38	intervet/	intervet/	NUM
ct-11250	234	39	schering	schering	NOUN
ct-11250	234	40	-	-	PUNCT
ct-11250	234	41	plough	plough	NOUN
ct-11250	234	42	animal	animal	NOUN
ct-11250	234	43	health	health	NOUN
ct-11250	234	44	,	,	PUNCT
ct-11250	234	45	summit	summit	NOUN
ct-11250	234	46	,	,	PUNCT
ct-11250	234	47	nj	nj	PROPN
ct-11250	234	48	)	)	PUNCT
ct-11250	234	49	women	woman	NOUN
ct-11250	234	50	of	of	ADP
ct-11250	234	51	childbearing	childbeare	VERB
ct-11250	234	52	age	age	NOUN
ct-11250	234	53	,	,	PUNCT
ct-11250	234	54	asthmatics	asthmatic	NOUN
ct-11250	234	55	,	,	PUNCT
ct-11250	234	56	and	and	CCONJ
ct-11250	234	57	persons	person	NOUN
ct-11250	234	58	with	with	ADP
ct-11250	234	59	bronchial	bronchial	ADJ
ct-11250	234	60	or	or	CCONJ
ct-11250	234	61	other	other	ADJ
ct-11250	234	62	respiratory	respiratory	ADJ
ct-11250	234	63	problems	problem	NOUN
ct-11250	234	64	should	should	AUX
ct-11250	234	65	exercise	exercise	VERB
ct-11250	234	66	extreme	extreme	ADJ
ct-11250	234	67	caution	caution	NOUN
ct-11250	234	68	when	when	SCONJ
ct-11250	234	69	handling	handle	VERB
ct-11250	234	70	this	this	DET
ct-11250	234	71	product	product	NOUN
ct-11250	234	72	.	.	PUNCT
ct-11250	235	1	estrumate	estrumate	PROPN
ct-11250	235	2	is	be	AUX
ct-11250	235	3	readily	readily	ADV
ct-11250	235	4	absorbed	absorb	VERB
ct-11250	235	5	through	through	ADP
ct-11250	235	6	the	the	DET
ct-11250	235	7	skin	skin	NOUN
ct-11250	235	8	and	and	CCONJ
ct-11250	235	9	may	may	AUX
ct-11250	235	10	cause	cause	VERB
ct-11250	235	11	abortion	abortion	NOUN
ct-11250	235	12	and/or	and/or	CCONJ
ct-11250	235	13	bronchiospasms	bronchiospasm	NOUN
ct-11250	235	14	.	.	PUNCT
ct-11250	236	1	if	if	SCONJ
ct-11250	236	2	direct	direct	ADJ
ct-11250	236	3	contact	contact	NOUN
ct-11250	236	4	with	with	ADP
ct-11250	236	5	skin	skin	NOUN
ct-11250	236	6	occurs	occur	VERB
ct-11250	236	7	wash	wash	VERB
ct-11250	236	8	with	with	ADP
ct-11250	236	9	soap	soap	NOUN
ct-11250	236	10	and	and	CCONJ
ct-11250	236	11	water	water	NOUN
ct-11250	236	12	.	.	PUNCT
ct-11250	237	1	[	[	X
ct-11250	237	2	note	note	NOUN
ct-11250	237	3	:	:	PUNCT
ct-11250	237	4	because	because	SCONJ
ct-11250	237	5	of	of	ADP
ct-11250	237	6	its	its	PRON
ct-11250	237	7	known	know	VERB
ct-11250	237	8	side	side	NOUN
ct-11250	237	9	effects	effect	NOUN
ct-11250	237	10	,	,	PUNCT
ct-11250	237	11	it	it	PRON
ct-11250	237	12	would	would	AUX
ct-11250	237	13	seem	seem	VERB
ct-11250	237	14	prudent	prudent	ADJ
ct-11250	237	15	that	that	SCONJ
ct-11250	237	16	pregnant	pregnant	ADJ
ct-11250	237	17	women	woman	NOUN
ct-11250	237	18	use	use	VERB
ct-11250	237	19	extreme	extreme	ADJ
ct-11250	237	20	caution	caution	NOUN
ct-11250	237	21	and/or	and/or	CCONJ
ct-11250	237	22	avoid	avoid	VERB
ct-11250	237	23	handling	handle	VERB
ct-11250	237	24	this	this	DET
ct-11250	237	25	product	product	NOUN
ct-11250	237	26	for	for	ADP
ct-11250	237	27	veterinary	veterinary	ADJ
ct-11250	237	28	use	use	NOUN
ct-11250	237	29	]	]	PUNCT
ct-11250	237	30	.	.	PUNCT
ct-11250	238	1	misoprostol	misoprostol	NOUN
ct-11250	238	2	(	(	PUNCT
ct-11250	238	3	pge1	pge1	NOUN
ct-11250	238	4	analog	analog	NOUN
ct-11250	238	5	)	)	PUNCT
ct-11250	238	6	cytotec	cytotec	NOUN
ct-11250	238	7	®	®	NOUN
ct-11250	238	8	(	(	PUNCT
ct-11250	238	9	pfizer	pfizer	PROPN
ct-11250	238	10	inc	inc	PROPN
ct-11250	238	11	.	.	PROPN
ct-11250	238	12	,	,	PUNCT
ct-11250	238	13	new	new	PROPN
ct-11250	238	14	york	york	PROPN
ct-11250	238	15	,	,	PUNCT
ct-11250	238	16	ny	ny	PROPN
ct-11250	238	17	)	)	PUNCT
ct-11250	238	18	may	may	AUX
ct-11250	238	19	cause	cause	VERB
ct-11250	238	20	abortion	abortion	NOUN
ct-11250	238	21	,	,	PUNCT
ct-11250	238	22	pre	pre	ADJ
ct-11250	238	23	-	-	ADJ
ct-11250	238	24	term	term	ADJ
ct-11250	238	25	labor	labor	NOUN
ct-11250	238	26	or	or	CCONJ
ct-11250	238	27	birth	birth	NOUN
ct-11250	238	28	defects	defect	NOUN
ct-11250	238	29	.	.	PUNCT
ct-11250	239	1	no	no	DET
ct-11250	239	2	specific	specific	ADJ
ct-11250	239	3	handling	handling	NOUN
ct-11250	239	4	recommendations	recommendation	NOUN
ct-11250	239	5	provided	provide	VERB
ct-11250	239	6	with	with	ADP
ct-11250	239	7	product	product	NOUN
ct-11250	239	8	.	.	PUNCT
ct-11250	240	1	*	*	PUNCT
ct-11250	240	2	*	*	PUNCT
ct-11250	241	1	[	[	X
ct-11250	241	2	note	note	NOUN
ct-11250	241	3	:	:	PUNCT
ct-11250	241	4	because	because	SCONJ
ct-11250	241	5	of	of	ADP
ct-11250	241	6	its	its	PRON
ct-11250	241	7	known	know	VERB
ct-11250	241	8	side	side	NOUN
ct-11250	241	9	effects	effect	NOUN
ct-11250	241	10	,	,	PUNCT
ct-11250	241	11	it	it	PRON
ct-11250	241	12	would	would	AUX
ct-11250	241	13	seem	seem	VERB
ct-11250	241	14	prudent	prudent	ADJ
ct-11250	241	15	that	that	SCONJ
ct-11250	241	16	pregnant	pregnant	ADJ
ct-11250	241	17	women	woman	NOUN
ct-11250	241	18	use	use	VERB
ct-11250	241	19	extreme	extreme	ADJ
ct-11250	241	20	caution	caution	NOUN
ct-11250	241	21	and/or	and/or	CCONJ
ct-11250	241	22	avoid	avoid	VERB
ct-11250	241	23	handling	handle	VERB
ct-11250	241	24	this	this	DET
ct-11250	241	25	product	product	NOUN
ct-11250	241	26	for	for	ADP
ct-11250	241	27	veterinary	veterinary	ADJ
ct-11250	241	28	use	use	NOUN
ct-11250	241	29	]	]	PUNCT
ct-11250	241	30	.	.	PUNCT
ct-11250	242	1	prostaglandin	prostaglandin	PROPN
ct-11250	242	2	e2	e2	PROPN
ct-11250	242	3	(	(	PUNCT
ct-11250	242	4	dinoprostone	dinoprostone	NOUN
ct-11250	242	5	)	)	PUNCT
ct-11250	242	6	compounded	compound	VERB
ct-11250	242	7	formulations	formulation	NOUN
ct-11250	242	8	no	no	DET
ct-11250	242	9	specific	specific	ADJ
ct-11250	242	10	safety	safety	NOUN
ct-11250	242	11	warning	warning	NOUN
ct-11250	242	12	regarding	regard	VERB
ct-11250	242	13	human	human	ADJ
ct-11250	242	14	exposure	exposure	NOUN
ct-11250	242	15	provided	provide	VERB
ct-11250	242	16	with	with	ADP
ct-11250	242	17	product	product	NOUN
ct-11250	242	18	.	.	PUNCT
ct-11250	243	1	*	*	PUNCT
ct-11250	243	2	*	*	PUNCT
ct-11250	244	1	[	[	X
ct-11250	244	2	see	see	VERB
ct-11250	244	3	note	note	NOUN
ct-11250	244	4	below	below	ADV
ct-11250	244	5	for	for	ADP
ct-11250	244	6	prepidil	prepidil	ADJ
ct-11250	244	7	®	®	NOUN
ct-11250	244	8	gel	gel	NOUN
ct-11250	244	9	formulation	formulation	NOUN
ct-11250	244	10	of	of	ADP
ct-11250	244	11	pge2	pge2	NOUN
ct-11250	244	12	]	]	PUNCT
ct-11250	244	13	.	.	PUNCT
ct-11250	245	1	prostaglandin	prostaglandin	PROPN
ct-11250	245	2	e2	e2	PROPN
ct-11250	245	3	(	(	PUNCT
ct-11250	245	4	dinoprostone	dinoprostone	NOUN
ct-11250	245	5	)	)	PUNCT
ct-11250	245	6	prepidil	prepidil	PROPN
ct-11250	245	7	®	®	NOUN
ct-11250	245	8	gel	gel	NOUN
ct-11250	245	9	(	(	PUNCT
ct-11250	245	10	pfizer	pfizer	PROPN
ct-11250	245	11	inc	inc	PROPN
ct-11250	245	12	.	.	PROPN
ct-11250	245	13	,	,	PUNCT
ct-11250	245	14	new	new	PROPN
ct-11250	245	15	york	york	PROPN
ct-11250	245	16	,	,	PUNCT
ct-11250	245	17	ny	ny	PROPN
ct-11250	245	18	)	)	PUNCT
ct-11250	245	19	use	use	VERB
ct-11250	245	20	caution	caution	NOUN
ct-11250	245	21	when	when	SCONJ
ct-11250	245	22	handling	handle	VERB
ct-11250	245	23	this	this	DET
ct-11250	245	24	product	product	NOUN
ct-11250	245	25	to	to	PART
ct-11250	245	26	prevent	prevent	VERB
ct-11250	245	27	contact	contact	NOUN
ct-11250	245	28	with	with	ADP
ct-11250	245	29	skin	skin	NOUN
ct-11250	245	30	.	.	PUNCT
ct-11250	246	1	wash	wash	VERB
ct-11250	246	2	hands	hand	NOUN
ct-11250	246	3	thoroughly	thoroughly	ADV
ct-11250	246	4	with	with	ADP
ct-11250	246	5	soap	soap	NOUN
ct-11250	246	6	and	and	CCONJ
ct-11250	246	7	water	water	NOUN
ct-11250	246	8	after	after	ADP
ct-11250	246	9	use	use	NOUN
ct-11250	246	10	.	.	PUNCT
ct-11250	247	1	[	[	X
ct-11250	247	2	note	note	NOUN
ct-11250	247	3	:	:	PUNCT
ct-11250	247	4	because	because	SCONJ
ct-11250	247	5	this	this	DET
ct-11250	247	6	product	product	NOUN
ct-11250	247	7	is	be	AUX
ct-11250	247	8	used	use	VERB
ct-11250	247	9	to	to	PART
ct-11250	247	10	induce	induce	VERB
ct-11250	247	11	cervical	cervical	ADJ
ct-11250	247	12	“	"	PUNCT
ct-11250	247	13	ripening	ripening	NOUN
ct-11250	247	14	”	"	PUNCT
ct-11250	247	15	in	in	ADP
ct-11250	247	16	pregnant	pregnant	ADJ
ct-11250	247	17	women	woman	NOUN
ct-11250	247	18	,	,	PUNCT
ct-11250	247	19	it	it	PRON
ct-11250	247	20	would	would	AUX
ct-11250	247	21	seem	seem	VERB
ct-11250	247	22	prudent	prudent	ADJ
ct-11250	247	23	that	that	SCONJ
ct-11250	247	24	pregnant	pregnant	ADJ
ct-11250	247	25	women	woman	NOUN
ct-11250	247	26	use	use	VERB
ct-11250	247	27	extreme	extreme	ADJ
ct-11250	247	28	caution	caution	NOUN
ct-11250	247	29	and/or	and/or	CCONJ
ct-11250	247	30	avoid	avoid	VERB
ct-11250	247	31	handling	handle	VERB
ct-11250	247	32	this	this	DET
ct-11250	247	33	product	product	NOUN
ct-11250	247	34	for	for	ADP
ct-11250	247	35	veterinary	veterinary	ADJ
ct-11250	247	36	use	use	NOUN
ct-11250	247	37	]	]	PUNCT
ct-11250	247	38	.	.	PUNCT
ct-11250	248	1	oxytocin	oxytocin	PROPN
ct-11250	248	2	many	many	ADJ
ct-11250	248	3	generic	generic	ADJ
ct-11250	248	4	formulations	formulation	NOUN
ct-11250	248	5	no	no	DET
ct-11250	248	6	specific	specific	ADJ
ct-11250	248	7	safety	safety	NOUN
ct-11250	248	8	warning	warning	NOUN
ct-11250	248	9	regarding	regard	VERB
ct-11250	248	10	human	human	ADJ
ct-11250	248	11	exposure	exposure	NOUN
ct-11250	248	12	provided	provide	VERB
ct-11250	248	13	with	with	ADP
ct-11250	248	14	product	product	NOUN
ct-11250	248	15	.	.	PUNCT
ct-11250	249	1	*	*	PUNCT
ct-11250	249	2	*	*	PUNCT
ct-11250	249	3	*	*	PUNCT
ct-11250	249	4	see	see	VERB
ct-11250	249	5	product	product	NOUN
ct-11250	249	6	label	label	NOUN
ct-11250	249	7	and/or	and/or	CCONJ
ct-11250	249	8	package	package	NOUN
ct-11250	249	9	insert	insert	NOUN
ct-11250	249	10	for	for	ADP
ct-11250	249	11	complete	complete	ADJ
ct-11250	249	12	details	detail	NOUN
ct-11250	249	13	.	.	PUNCT
ct-11250	250	1	*	*	PUNCT
ct-11250	250	2	*	*	PUNCT
ct-11250	250	3	although	although	SCONJ
ct-11250	250	4	no	no	DET
ct-11250	250	5	specific	specific	ADJ
ct-11250	250	6	safety	safety	NOUN
ct-11250	250	7	warning	warning	NOUN
ct-11250	250	8	is	be	AUX
ct-11250	250	9	provided	provide	VERB
ct-11250	250	10	with	with	ADP
ct-11250	250	11	this	this	DET
ct-11250	250	12	product	product	NOUN
ct-11250	250	13	,	,	PUNCT
ct-11250	250	14	it	it	PRON
ct-11250	250	15	would	would	AUX
ct-11250	250	16	seem	seem	VERB
ct-11250	250	17	prudent	prudent	ADJ
ct-11250	250	18	to	to	PART
ct-11250	250	19	avoid	avoid	VERB
ct-11250	250	20	direct	direct	ADJ
ct-11250	250	21	contact	contact	NOUN
ct-11250	250	22	with	with	ADP
ct-11250	250	23	skin	skin	NOUN
ct-11250	250	24	and	and	CCONJ
ct-11250	250	25	if	if	SCONJ
ct-11250	250	26	contact	contact	NOUN
ct-11250	250	27	occurs	occur	VERB
ct-11250	250	28	to	to	PART
ct-11250	250	29	cleanse	cleanse	VERB
ct-11250	250	30	the	the	DET
ct-11250	250	31	affected	affected	ADJ
ct-11250	250	32	area	area	NOUN
ct-11250	250	33	,	,	PUNCT
ct-11250	250	34	and	and	CCONJ
ct-11250	250	35	for	for	ADP
ct-11250	250	36	other	other	ADJ
ct-11250	250	37	routes	route	NOUN
ct-11250	250	38	of	of	ADP
ct-11250	250	39	exposure	exposure	NOUN
ct-11250	250	40	to	to	PART
ct-11250	250	41	seek	seek	VERB
ct-11250	250	42	medical	medical	ADJ
ct-11250	250	43	attention	attention	NOUN
ct-11250	250	44	or	or	CCONJ
ct-11250	250	45	consult	consult	VERB
ct-11250	250	46	a	a	DET
ct-11250	250	47	physician	physician	NOUN
ct-11250	250	48	.	.	PUNCT
ct-11250	251	1	clinical	clinical	ADJ
ct-11250	251	2	theriogenology	theriogenology	NOUN
ct-11250	251	3	•	•	NOUN
ct-11250	251	4	volume	volume	NOUN
ct-11250	251	5	3	3	NUM
ct-11250	251	6	number	number	NOUN
ct-11250	251	7	4	4	NUM
ct-11250	251	8	•	•	NOUN
ct-11250	251	9	december	december	PROPN
ct-11250	251	10	2011clinical	2011clinical	ADJ
ct-11250	251	11	theriogenology	theriogenology	NOUN
ct-11250	251	12	•	•	NOUN
ct-11250	251	13	volume	volume	NOUN
ct-11250	251	14	4	4	NUM
ct-11250	251	15	number	number	NOUN
ct-11250	251	16	1	1	NUM
ct-11250	251	17	•	•	NUM
ct-11250	251	18	march	march	PROPN
ct-11250	251	19	2012	2012	NUM
ct-11250	251	20	48clinical	48clinical	ADJ
ct-11250	251	21	theriogenology	theriogenology	NOUN
ct-11250	251	22	•	•	NUM
ct-11250	251	23	volume	volume	NOUN
ct-11250	251	24	4	4	NUM
ct-11250	251	25	number	number	NOUN
ct-11250	251	26	1	1	NUM
ct-11250	251	27	•	•	NUM
ct-11250	251	28	march	march	PROPN
ct-11250	251	29	2012	2012	NUM